var title_f23_0_23552="Cylindrical bronchiectasis RML";
var content_f23_0_23552=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cylindrical bronchiectasis in the right middle lobe",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 338px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple circular lucencies (arrow) are seen in the contracted middle lobe, most likely as part of a so-called right middle lobe syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23552=[""].join("\n");
var outline_f23_0_23552=null;
var title_f23_0_23553="MVG calculation";
var content_f23_0_23553=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79915&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79915&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 471px\">",
"   <div class=\"ttl\">",
"    Calculation of the myocardial velocity gradient",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 451px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The peak negative myocardial velocity gradient (MVG) is obtained from tissue Doppler imaging (TDI). The endocardial and epicardial boundaries of the left ventricular (LV) posterior wall are manually traced from an M-mode image and the velocity between the two lines are extracted from the corresponding color-coded image (left panel). At each point in time, indicated by the vertical line in early diastole, the velocity profile across the myocardial wall is obtained and provided for the least squares linear regression analysis (right panel). The slope of the regression line was determined as the instaneous MVG; the MVG calculations are repeated at each point in time throughout the cardiac cycle and peak negative MVG is determined.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Shimizu, Y, Uematsu, M, Shimizu, H, et al, J Am Coll Cardiol 1998; 32:1418.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23553=[""].join("\n");
var outline_f23_0_23553=null;
var title_f23_0_23554="Arteriovenous malformation hand";
var content_f23_0_23554=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Arteriovenous malformation of the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23554=[""].join("\n");
var outline_f23_0_23554=null;
var title_f23_0_23555="Wire resection uterine septum";
var content_f23_0_23555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F53717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F53717&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Wire resection of uterine septum via hysteroscope",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 393px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGJAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5sDgjIQ4z6dakU/LhYhknbxjiqpwvIGSeoPapFfDFgeM5AHrXtciMC3DgpnYAFHIIwae7xRqWZUBx3FVIZAi/KDlTk5OacZgyuGbAJ7jsf51DhrsWhzTxgg7AQOMFRzURmDHIQBQOhHX6UjsPu7sjjHYfhUWVEZAOT6ntVqMV0AfK+XJXaAV4BHTNI05AZcI3bgdKrnnHIpoOKrlj2AkVhzwOmBStIQuABz16Goh1qQRb32x5fjPFNpAizAUVNxX5e+RkA9qUTJs44zyWKiq+ThUIJKnp2FIpI6fd9Mmo5EO5YnZgiEBQcZ4HWoHk3HhRz1JApZApHy4xTUi7n9KaUUUk3oiVH9F/HA6VKuS2AoOfQda1NB8O32rSBbeI+X3kbhRXo2h+GbDRlDzKLq79SPlU1yVsTCGi1Z6eGy+VXV7HH+HfB19qREk4Fvbnks4A49hXf6ZoGkaVEqwW0dzP3llUNz9KvM7T5LMQAOg4Ap4PCjpXm1Ksqm57dLBU6a2Kl1DDITuggwewiUY/SqbWtuEJ8iHHp5YrSmGQQfl759arjJJIGB61MTSUUlsZ8dvDkfuISP8ArmK6bQ7S3YJutLb/AL9L/hWGqtkYAwa6bQ4igUD0zQ9Dhr8tjtNJtbBcD7BZsPU26H+ldNa2OnMwP9m2H/gMn+Fc1pisBz7V1VsoUZ5rCRwOKexJJp2m4/5B1hn/AK9k/wAKj/svTijf8S6x3Dp/oyf4VKZQGxih5MLkE4PbNJGsYozJdPsMn/iXWI/7dk/wqlcafprLj+z7MH/rgn+Falw6HJ3Dp3rFv5zEm/PHpVJNm0YnOaza2W4qtnaDr0hX/CuUubK2Dn/RoMd/3S/4VvzTNdXbEHANZusQNFCX6itkjtgktLFK2t7PeM29v+MS/wCFP1C1tliB+zW4B7iJf8KzIZzuU85BzXQeX9ps8OMfLnjtSkdCjFNOxzFza27H5YIgD/0zFQxW0OSjRRL3H7sf4VamDqw5xg08IXUhiCRznFC1R6UYwtsV1hiUDMEH/ftatg2yw5+zwEd/3S/4Vnzs0bFdxz7im2speXa56nmkkZ1KUX0LhezdwfIgXnGDEMfyqy9laOmY4ICTz/qxx+lVrm12pg9xkEVDaztA4RmJU1Vkzn9lF7IZc2kSudsEP/fAqCKKISA+RCf+2Y/wrVcrNyQMGiCzzIABxmk9C4RglZo1tL063ni3/ZbfkY5jH+FSiygt5Rutbbr/AM8l/wAK19BttihSOO1O1S2AZSV6Gs5ELlbtY0dIsbKZQfsdoSfWFf8ACtuPS7LgGxsx/wBu6f4VQ0n90gJGPet6GTdgkc1OpjViuiGxadYgYl06wdD2Nun+Fcr4q+Fmga6rS6dEmnXZH/LNRsJ91/wrvYwHx0zT2gIJNNScTjdr7HyZ4x8Ba34Zlc3NqsluOksagr/9auQR8cMihh7Cvt6dFlhMNzEk0LdVYZry3xt8HrHVkkufD7LazkkmEj5CfT2rsp4lbSOerhaVRaKz/A+dC4ByVA+oFNmmCFQQuSM4xWv4k8P6hoN+8GqWrxOucArwfp61zswLtgDOOB78V3Q5ZHk1MNKm7NE4ucPglAoHUDNKbvGeAWxnpVM4YDjnHPbFJgb8HdgdPWtuSJk4IvreHJ+bH1FAvmJxuIyM5GKzxgsep9DTtrcYA9wBQ6aJ5Ea4upR0kbHTFNa+mU/6xs1TiYqiknBb16UOuAScbm647VHLqRYvx6lcFcLM2PrzUq392cfv5B+NZyJ3Q45781YOSB0JFTJIVkaI1S8AGbqUH60jaxfjO27m496zgw79elK5IHGOaSQWRfOvakPu3s303Ui+I9WAH+nzj0ORWNNIFKrnIIycdaijfavzADHarUEHIjol8T6upA+3z4POcj/CisLf8p9M9DxxRS5F2FyozUO5gJOM9D6UA5GBznge1S4ADDIB6jdzmpRGiMD/AHDjp3rpbIuQeUysyvwwHBzj86cI22HGwAgck0g3c5OSTz69aegG0dEJHGT+VO4EUgG3oSR36VGzBuTnpg1YKlm3MGJA6HvUBUgED5R796EPcj6cnvSZGenFSKuG6ZBpCu1huHA7UwCLBccfnzinIw8zGVGO+ODSQrukOCF74z+lOwpLEKQPc0MEPl3CJCyjJyc+tNRCzrleM4xU6xBwgdyO2M5rp/BPg/U/FOqx2WlW7SOcF3P3UHqxrGdVU43Zaic5FZSyyJFBE7yMeAozu/CvTfDXwykiiS98SK0EY+ZYP4m+te6eCvhro/gu3WSRVvtYIy0rD5U/3R2p+vadLdOzyAkn9K8PEZk5vlhoj1cHSjvI81lMcMYhtIlit1+VUA5quqDg5PFb95pMkTkhenesua1aPB2syjk57VjGomfQwnG1kQiM5AUfL60xiSzMuRjrUpXgDqRUbKf4QQau5V0Qs2fp6VAZARjkdsVK69hjnvUbg8Y4HTNXEyqNElum8rjg56V2GgwgbCQelcpZoN6g9B/Ou10UBUX1x0pyPKxDudRZR/MDjitiHhRjP0NZ+mlDjnmtcbdvykDjnNc8tzmjuVpBiU7hkVJlQDzziq8s4Qcc0w3IcEdOKaVzqiindOCWyOnNc/q7tIoXPWty5ZTn5gK53U5gMkEYBrWJrEz4AkJy/B9TVDXLiJ4jHkZNVtVvDGhZDWXbk3auzEjJrQ6IQ6sqwxlZRgjJrrrJQ1uuSckc1iw2hygYDI710Fsqxwc8YXrUyOhyuYeyFnZHODmke1AJEfWqV3MPtabCdxOfpWmkv7vLHBNC2OxScUYGtR4G/GDnFZ1s22RD29a6i+s1uICyjdjmsU2RyMrggdBSTVjX2l1Y2ZITPp6OmWYVkXEDA4cBf0rS0q6NmyxzYMTd+tbUlpb3C7lIyecUvQxUuV6nHKkg6E4xxWrprv5sYOcCtSPS1VuQpX2q3b6WscgJxgnOaXMOUos3LGaIQZB+bHSmyMZyVfr7UyCCMAZP5GoLmTyJwqvknpUMyhHU24MeSoA5NatmG2j0qhpsXmwqSOe9dJptqCMY60jOrNRWoy1Z1IyMitiP54skUtvZD05q6lvtBGKlnmVasehQMSk01rbGWjbB7VadNjYxxUiRgc0iHO2pz+uaJpniGzaz1q0jlVhw+MMv0NfOfxM+E1/4baS90zdeadnIZR80Y96+pp413dKr3DA25jlQOmMFWHBFb0q8qb0C99Oh8GOrRttKLgc8+tV3QAgowyOK+lPiX8J7TUUl1Dw0iRz/AHntugPuPevnvUdPntLl4LpGSVBhlK4IxXrUcRGoclbDfajsZrs2FJ6jvjFKhzldzHnGTzinbcMTkNnqCadGAzjAwGBH09K6WzhloOUlckHcq9sUFm3lmIIIzjuacx3YIzkHJzQGCnqT2+lQncy1LMWM/N/FzTwMdOPaog3yEkbT05NOWQDhuDis2iR0uNvzAEEY9j9aayxpAjROSRwyNz+INPZQwIwDng1RmYZKKCFB4HrTirha4wyZkycE9cHsaWNvmYoQDnHXrUaru5K8npipUXEgJTg9wa1Lew8MvyluRnqTjFFOjXepDEkg9aKltENlRsooDKxxz7D3pVXKbskrnn3GKVE3xueQuOBmpNmQBjPUfWtGzAqzfMTgkMOMe1PwzIrsdw44A60XIMYZVwAfU9utNikYlVBOSQPf2p7q5XQsSRseQ4DHGQOh/CoJAAilmDEAYBORUhxhiSCwPIzz/jUEjA7huCqM4HXJoV9gImcZO0AAetRk5PNKxycgYoUE9K0KQqD5wDxVi2Tcxyw2+hqFVLYz2rf8O6HPqc+FXbCo+d2HAHt71lVqKCuzajQlUdkW/CuhvrV+icRwA/PKR91RX0J4S1zS/Dtoum6CgjQn95Nn55D6k15OsaWcAt7X5Yx3HBatvwxaSXF5G2DhcGvExM3V1ex9BDAQowvLc+g9GuDfKCSTnnPrW1PpqyR5wPrWL4ShKQoPQCu4hTKdBXi1dHoefUqcrujhL/QdzkhRjHpWBe+GwSSFwTXrptlbqBUMmnxOCCo/KojUkioYpxPCLzw7KGbYgH0rLk0eaNGVlI5/OvfZtEjfOFH5VRm8NROuCo/KtY4prc6I448Bn010BOM/h0qqLNgOcj0r3ibwhCzZEXPsKqy+Brd+qH61vHGR6jeNXU8dsrRvMBwAK6/R7YjaxAxXaW/gWBDwDW5YeFbaFQCMke1W8UmclSsmczYWcp+6pxWhcW80EeSuMjvXa21hDCgCoBUeoWayxEYHTisnXe7WhnCqrnml1Lyc8Csy4vdoIHU1reK4DbMxC8CuNupGYhlOQRXVTlzI9OmkyW91Zo4yV5x2rlrnUpbmRs5AJ4FX5oJJWO77vtUcWnFW5U4roSSOhJIpPGZYtpG4nv60ml27rKEYDg8YrYS1CFiOhNTRRpEQRtz3pmikTC3AKEgHbWZrF59nhcJjcRg1qPMVX5Rk461yficn5cHljmk1cqmryMNZGebfvyc9q3YnJiCueevtWGiBcHj1xV2GUsBjpjpQdps2NwqSeW/3SO1NvI0jlyoyp5471leaUmXJ4zwTWnCyG6WJ+Q44NTJFWtqRLD5oA4A9KsG1nhhDQMynGeeasG1MEmDn8avxuNuOAPU1JLdtjFj1C7iiy6LuBp669cFceUM/qK2TbxtuCgHNZ8mniMlmGDQUpxe6K7alPImXfYvoKtWtz5jLJKxZu1ZN+hUqF5A9OtTWS4CjnHWpaVjojFHoWh3qbOD0Nd7pGySJXHFeO6SZI5QEJIJ6V6j4bLvbKTkEdqlHm4+laNzqYlxz1qxgOCR2qpFnAFaFumM5pNHz1R21M2ZCrEkGot2CD+ta00IYfWqUtoT90mpLhVTVmVZeVJrIvHxkE1r3EbImKxL0MCeOadztoJPUgSXbMmDiuO+JngOw8TxvNGFg1Lb8soHDH0NdLK7oQQuTTpblbiLaWCsK0g3F3R0um9z4/wBe0G80a/ltb+Fo5U4IPQj1HtWUQ0LckbT6jp6V9V+NvDNr4l0/yrpVW7Vf3UwHP0r5x8Q6Jd6LezW90nlsh7jqPUV6dGvzaM83F4P7cTn5GDJvH4gjuaarAY3crnJUVMVQ4CjBzk96iKfOTgYPODxXYmeS1bQlQ7Y1yQBnAHqPQ+9Tgqy4bqOoqEI20LwAwzyOlKAQMSAMR3zUNGbC5cJGAu4HPGOhqmDg7udw9ulSS5YtnkZ6E96QoFILkc9hkZrSOiKWg1mDBCBj196mDAg7zg4zz6VAQSqqPXkH+dS26nIAA57ntTdrCkTJkY449cfrRSqT6YGeDiisSChyqdeGXgHtU0cuEIkbIAGBUMoJY8DcT1HFLC6qjqyqeeMmum10Y2JSrAK4U8g89xTDFuG4ZaTndz27VZjuQybHABU8mnLJEOMjPU/SoTa6DM2TK4GW3fxf0qFzzVm4lV5SVUcjHNQ/MU2jp1rVMZGBnpUscef8KRYu56Vu+HdIm1a+S3gU88seyj1qKlRQjdm9Ci6krIn8J+HbjXtQS3t1Pl9ZH6BRXtFn4ct7OxFraDEQ4Ld2qPwtaW+nxizsQihQN7Acsa7+C3j+zABVyPavFrV5VZXex9Lh8N7CPmclovgmbV5yBmOBOsh9K7Ow8C/2b+8tHWUd/Wtfw1qVnGTbXIZGY4BHArubCC1jDNHIJA/c9q5qs7I5sXVqJ2exk+G4NsYVuCK62IAACqMVokcm6MYzzWhGvIFeTJ3Z5tSVybGaXbSqKf0raNO5hcj2UhjBqbFGMVr9XTQuYh8senNHlj0qfFFWsLEXOyERinBQKloreGGiuguZke0UyRRjHrUzdKhnYLGWJ4HNFeMVHUIt3PNfiXtjjUD77dK8yWOXq3Art/GGqRX2rNESGCHAGax5I4jHkqM+lRhY2jc+ipR5IJMy4gmAePfNNmljiP8AnmpbuWKFSCAvFZrXUU8mBjFdZoost+asq5QY+tVkIabacE9TST3CQD+VR20g3l3I3Hmg0jFl5zHGnJGT2Fcvqym5mYknC/w1uxyi4lYc4WsmW0P2yTLHYT61DZ10adndnNzFkZh0B6VLbHbIV5IrYm0wMSQQWPGMVBPYtCMlO2PU0cx3RSZRvsMU28HPUVLZuxmQlidpGKrmGSRwNpJFbGl6dIJlZwAKL6FSgkjoLpDLaxyjk9Pes9nZDjORjpW40SG32K2GAzWQ9tLJJgEbfpUnPGJLpEzmVlcjH0pmqXipc+WvX1PaphHHaIxbg49aw58y3JbOSaCo07u5OojlfeSME4q5BFE0gTgH61SjtZWIMY+UitDT7RVnzI3zdM1Eja1jdsrIRsrZI56ivQfDTBEC+1cdp0eQAG4zxXR6dmOQEvjHvSODFpzjZnbQru9Kuw8Cs6xmUxrk5rRjI9aD5iqmnZkhAPWmbcHAp4IPSnAUrGV7FO5hBB4rFvbZeTiumZMis+8tjtJAzSN6FblZxU+AxQ+tZ80Chvlrob+yO8tt/Kse5jMS/N3NCPdp1E1oZ7DdC0Tk5HKtnkVy3ibw5B4k0+W2ul23aAmOX+ldXcRSCPIx9ahtG37/ADOHWtYTtsbWutD5V1zRrnRb+W2u4ysinAyOCPUVl7Q5+cD147V9HfELw1b+IbVlVFW9jGYn9favn3ULKWwu3huEKPGSGBGDXp0KymrPc8fHYLTniVMcIPT1pGVhtIPPepQQV+XAJ700gZznFbnhNWIJI+p4GRg0jZAxt/Ln/wDVU0i/KAGwf1qLgHjAb19auLuNDFB3Ln7oH41KnUDHPfPGaYV3ZYEbugPr+FSIDswcFs9aGJijfuAPc9B2opxHTGB3NFSIzjJ0yMqP73rTDgqFyCcjgVIAjsd2cDpmlZ08vauMjjOOa6TErnhmxwCen0qV+baM7l3lieDyBx1H5VC27A3HIJ7UMOBjOOn1psoVV+U84x39fak2lgS2asWy/uZcj7wwDTzGSQFJYYx+tS5WNKcOZ2JNLsZb66itrdC0rnaqivZNP0eLwzpZtUIN7IuZnHb2qH4c6HFomkNqt7GPt0wxCrD7i+taFyPPkaRmPPOfU14+Jr+0lyrZH1WW4JQXNIraVcvbSlgCB612en6yCmDxnrXDTMq59AKSC+kRlzjFc+57MqakemWU6S3YdGUn0NegaDdIsSb3GenNeCWuoYYFZSpB9a6TTddkt8AShl9zWNSN0efisPzLQ+grW7icYDgkCtKNgcEGvIfCmuNcSAB92SOnSvUtMkMkQLc150ocrPnsRQ9maiU6moc9qdXTSOBjhS0gpa7IogKKKK1SAKKKKoBpPasPxTeiz0qZywB2kCttzjJry/4sak6wi3ibk8kVwYyd7QR2YKl7WqkeUakk0+ozXKsQWYnIq7b3DSRhJXIbGBzWS9yUUiR+B6VVF3vPytgg8GtqS5VY+o9m2aF7DKzYdsjNVreErkrnA6VPHO0ibWbJ74q7DbAxq3I9OK1bsNQsjLnbzG24fgck00Fs7I8nPU1os0KyFWOSeOlW7O2UnCj5c1N2bRhZXItNtdkQyMdzVJ3Zbt2UbhnAFdBcqsFq2PvVy5jkllzGxBJzU31N6UL3ZYCyvIDv+XuO9btssDR7JQPrWYumyrEWLE+9W4LHy7RZN2T15NFy5JPZlz+yLVSHAU+9Ur27trcFUC7ugqlPqvluUbPHArNlV53GOtCQ40v5mXpZZniEsbYI64pY7mddhJGD396swx404qfvDmqU0gZEGcbeeKZoo32HazBPLJGyHII6CqlrYys+dpB6ZrYtLrdGocBgOhI61rWYSR1ITj6UnciTcVqNtdOkFiXCZYDv3rNaKchsRdD1HFen+GbEXI2yR8Y71pXnhmMq21OvtWbPP/tGFKbhM860VpBwQQPeulsoix4PJqYaMbYldh6061gkjk+6etK4Va8al5RNjTY5RxvrctlkX73Ss7TYmyO1blvGcc1R4OKqaj0HANTYpqpUgFB57Y3FRyLlTU9IRQ4iUjIuYQwIxzXPatYlx04rrriPcMjqKzpo8qVYZNQehh6zjqcS6EoVYEDtWTMGglbI6jrXW30AjlwwwprE1S13ZPYU0z2qNRSOZup1kQZG2RTkGuL+IPhEa3YNqNmiteRL86r1cV2Wp2zoMqMg9jWfbXctrKoC/umOCDzxXRTnZ3OyVJThofOEiGCUoVO8cHnFQP0XPSvVfi14S+zn+2LCPFvJ/rVUfdPrXlR3KBuJ9Bj616dOfOrny2Owns5XWwSk7WKEAccmmKu7OCN2MZp7HAPseRinrA+3zB93sCefrj0rZOyPL2K67ThcEAVJjAwO5z16VIq4yWHJ60uPbilcQ0DcDnp14opWAHr17UUgKcsfkxjZwTxnHJqAZIIwOTgDuPxq9PhkOSMLzz2qk52EKOxzjPWumLuZIhPGRnHoPWpYB84Lx7tvVWJAI/CmhdzlgpAPrzU6LhRuBz3yaG7GkUToh+zKxUAFuma9E+FPg9dXvX1TUFIsLP5ju/ibsB61yeh6TPq+p2lnbLuklOBgdK9/khh0bRrfRrDiKFcyMOrP3NeXiq9lyLdns5bhXUlzMwdXczXRIOI/uoo6AVQlXIx0q3OQZCM/nUR5Xnk1wo+tilGKSM6SLLE8Y7A1XeLg/LWukDSNgZxintpzbScHGOKL2IdSxz23BPynPerNu+ZQC2M8Ut1AY2wCcnqKhtoyLpAQSuetVdNGVSWh6/8ADyyC7DjqM17Pp0ZSBfpXm3w5t8wIcdh17V6pAmEAUcV5VXWdj5fG1G5WJozTxTFGOlPralfqecx9FIKWu2DMwooorZAFNY9sU6msT+FDdgIbiRY4XYnoM14T4yvGv9VmYHKA4Ga9W8c6gLHR5ju2uwwK8HTUCWf7Rnkn5sV5i/eVW+x72V0rRdQyb+3y5C4XPNRQaYXbjJPqBWyfIuC5R0J7VBl7cD5+M5GK7Ue2piRW3lHGSMfrU5nWIqm4szVAbhnIIXd71Wjt5JLrzJGIx0HaqQ9XqzTlgWc4CgEGtGxtkiUFiARVMXKQMN5BFSyX32keXAo2926UhqVyLUJDNOYk+4Oc1UgiEdznjOcVtQ2wSDc/LBeorDfzGnZ2BAz0qdEdVN3Vjq4Xia3Gcciq80KG2ZcVm/aQlsFzz2qfTbkT2pjc88jNSyfZuOpz93Ery7NqnFW7W32AAKMHpTbqLyrtinOehNaGnNvZVcjnHWnfQ6G9LlKVmXejE46Cks9PdyQBnNdY+hLOQ4IwRW3ofh4K4+X8cVK1OeeLhTje5z+i+F5JyNynbnJrutN8KJHGpKDjtXR6XpqQRj5R+Va6R7RwKtI+bxebTnJqJR0/To7ZBtGDV0x547VMF5p+0d80+S6PGlVcndlGS0jk+8oqA6VCxztrV2r70oAHSj2SBV5rZmbFp4ibINXUTaKlIB60DjpVKFiZVHLcjK5P0pHHepQMUEA9aHEnmK5OB0pV+bNTMgIpmzbU8rRXMmQSrzjtVOWPIPNaMnWoZFBXpWUlqa052Oc1W23xEDBbtXPSKCCkhBI4rtLmPPUVyWu2ZWTzFzzz9Khux7GDqc3usxbiONiY3HB4FZV5pgXOwAHtV65l+bk89BxT4GW5jBf73TmtIu5665oK6Mqa1jvNLls7kB45QUYHtXzl4y0CbQtWe3lDBMko/qM19H3qtEwbHAPOK5jx1oCeINHkMS5u4V3R46mumjU5JGdekqsGmfO4A3LnoRwKkSY4dSqnOOSMkfSp7qBoZ2jYESKdpDdjUDgbztGF7DvXppqWp8lXpunJpkarzk8n1p/C4PJ+lN6LgDgUHB2kEEEZFMwDrRSjG7migCvcN0Tbu749aqKu+THAb6Y4qZ0yoUkkj0zToYxkDkEcke9dCdkQhgiKqQQAD2zVhULqu0DaeDn6U8KQp7e9df8ADLwxJ4n8U2lng/ZVYSTt2CD/ABxWFWpyq7N6MHOSR6X8IPCjaV4fOt3ke25uF224bqF9fxrXvIHLkYyfWu41CSLKwWyhbeBRHGo6ACsaW3U7jmvDm3J8zPrMIvZxRw13atE24qeeOmagiiLzFcEjPpXR6qQM4HTvUGlQJIwYjJJ9aUWd7quxY03SwYwxH6VcvbBVQfLyB6Vu2EKLEuOeKi1RSRhR1FDZyXcmeeanaYcnv1FZFvC4uBgEc8E12UljJeXSwoMsTXXad8N7+WBJHMIB+YAnmto03YnEYmFKNpM1/h0pWGNT1wDXp0I4rktF0KbTPLLoABgEg5rrYT8oxzXnSjy1dT5vEzU3eJLSgULTq6oQT1ONsSloorZRsSFFFFUgENMY4UkmlJz7VU1GdYLd5GOAozXPXqcsWy4RcnZHmPxX1LzGW0jYcda8uVTJlG7HArS8Xaq11rs7kkqGwAelZkRyynPB/nWOGi1G7Pr8PS9lTUSq1s8bBkFW7WbeAJhznrT/AN4p2unHUEVNHCsi5C9811HTpYmRoenfrST7WjJRealMSRqGHWr8NussKkoKAdrWZyLQyTTcswzWvb2MlvCWQE8VoSWP7xcZIHOK831LxxrWmtfxSxI8elTSxXjCPG/fu+zkenQZ+tO7ehnWrwo2ctv6/r5HoNhcTT5WT5ccU+4iZZQo5B9K82utZ1XSf7buW8hdThs7FnYxcb3kCsCPQZOKt+LfEXiHR9TgsmvrSMi3MoupYRFFPIXPyfMTgBcDAO49aOUz+twjeTT/AKbX6Hb3ViQQ2T6D61VjE1vIMDIHcd62nunns7aXyx8yKxx0BIzxVO/lHBz8w7CobPSg5SS7FpLQXJjB4OKtWmkFJgrknBzzVGzu/wB6uzOMV0Ns8ss0bL+NQKcpR6kG28gvBFFISpPANekeG7Zhbo8/3veub07TWl1GJ2OQa9DtbcIigDjFXE8HNMSuVRW5ZjAAHFTAU1BwKkArZI+bkwAxS0UVZIUUUUAFFFFABRRRSaAKRqWipAiYZphT1qcim4wcVDiWmZ9zHjPFZV5aiUMr10EiAjnvWXdxspzWElY66FRp6HA6hYlbny3X5T3qnHatbyt8+V7V2t9bJOOnI61xetTfZbvbnHrUrQ+gw9d1VylG/kZopAgDDHNUEfy0WRfkcDHrkUk2oqtwFBGG4NQatKIhhMYcdRWidtTuUbaM8v8Aix4fWCRNTtEHlXB/eY6K3/1681dSo5Iz3r3jxGgn042twMpIvy+xrxDU7d7a7lhcHcrbefT1r0sNUbVjyMzwb5faIoYOQcn6UuBSkgtlRwPanr9K6z5tqw1Rk9PailU88DpRQIp7Azh9xz0yT0qaIcc9e5qLBwFXsc881ZUc1rJ2JQqIDxjivpb4OaCfDvgZ9RlQLe6nypI5EY6V4R4F0KbxF4nsdNiXIkkBc+iDqfyr6o1do08m1txiC2QRoB0AHFeXjKl2oHsZfQ5nzMpd8kjJ4rO1GTauMYHtVtHLOB1Ge9VtSiDoecelcctj6BKzOWvpTIzg9qtaONmOCeetUrqIAkZ4qxpc20hG6VJtdNHZWsu2IZHNST4kTk81mRz/ALsEt27VILoYy3U0GfIJZMkOqRM5GA2a9tsGjktIWjOVKgivBLt/usDyOQa6bw946n02FLe5VZoV6HoR+NdMJJxseRmOFnUs4nrxUEYI4qIKFYgdK5+x8XWV5GDGQCeoLdKsTa7bocmVa5cWk0rbnjxw9ROzRukgcmlVwwzkVxl/4uhCFYBvb2p/h3U5bqfLHGT0rCFSUHfoavBTUHKR2VLTFPGT0pdwrsVS6ucTQ6kJwKTcKQnP0o5wsBri/iNqv2LS2jVgHkGBXX3DhIyScYGa8U8faut5qjIp3LHx9K4qt5zUUehgKac+Z7I8/wBSjaTMhbc3J6YNVrVmjcBskVeF4putkkbAHpxxVlQr8ohJz2Fd0aTSse8sZBaMsW0waMFhkjtVhhuX92u0+1QQDawYId3bAq1FO8ZBMLY7sRV+zZm8ZBbMd9i81Pnb8PSrdmGikVHORToyzKSQSOu4CniWNlA3ndjjip5GCxsXpclcrHL8w+U9Tis1byGbU7m1thuSBR5sueA55CfXHJ9Mj1rgfjbqMsQ0i3hlKSBnlLI20jAAH8zW/wDC+y1hNBZ9XiVVlcyR7/8AWuGOSz/j0J5/Sk421Jp41Sq+yS0XU6AbgxI6U1TiYM2cA1pGyYHci8jkVHLG+07kUnvipTPSVS+xBdSLIv7rhvesLV5vKl2lePU1pyQyuxdAcg8ClvrH7bbfMmH78VLVjejJR3KFi6tAG7jrXc6KFNorDBJ5yK4OzsXt2CMSATjnpXY6O/2WJUJyDSHidY+6eh+Ho0KhsgkfpXSxdPauQ8OSoAdp5J711kTjaMVomfHY6L9oyytPqJCe1SA5rQ89oWiiiqTJCiiimAUUUUAFFFFJsAopM0tK4BTD96l3CmsQOaTZSQ2XpVSfA5ap5ScHFZN/Ic4JrCWrOilDmdinqDeWrMnTOa4HxjAZJklU43DH413k4WSFlPRhXJ65AJbWROQU5FQz3cE+WVzzK8R0uBtPbmpprnNiGk+8pwM+taF5ah5sDKk+tYuuAKUtYTuYvuIFaRPdupFlyuo2QyhEiHqf8a85+ImkG2aO8RCCflfH6V6NagwAozHkDApfE2mx6xo7Qx8ykZAx1NaUpOMjmrRUouL2PnwggnNJU95DJazyQTZDxuVINQ16sXdHxuJpOnNoMUUnXFFUcxBGMZzjmpkY7Sg6MRn/AD+NRp0yDU9tG00scaAlnYKAOuSac5dRwjzNJHu37PWjra6Zqevyr+8P+jwE/rXoso3BmJGTyah0rS00DwlpOlR/K0cQeTHdjzUcj4VuprxZS55uR9ThKXLDQRWQSADFRXrApwM+9Rb8kHP4CpWAdcHg+9JnbJHLXyOrkkVnrNtlYjjFdDqkQAY8YxXL3XDZ4BPGazLp6mzFfEqecHGMetTJdkEbm4xXPxTYYd+KvRSqQvOCKpI6Y2Rp+duPDdecGnEjoU4PeqKMH3ZPzY4xUE9xPAflbIz0q1oY1aXOtDZskkMoCuVyexrqrfS55EBZmK9+a83tNVkjuUL9M9q9f8L31teWaYf5/SorNo8mtTlTdxtnpSAnOOexrpdAsRCwbpimTxxeWChyfatTS/8AVYFcMp30OOvWbgbEf3adUSHAqQHNa059DyGhaKKTcPWtU7iOe8YakthpEzlsNjivE4hBeyvLNKCSc16x8Q9EvdTsc2bghclk7ke1ea+HfD8eoiVdxjkQ4x3qaScJNyPawcaUqNr6lO4ksbQ7fLD8Z5FZk+twRNG0UKLk457VQ8e2N5o99GksjFSMg+1ci8shB2kE9c16CnfUv6hFa3vc77+1zuLqUVh/D61IuuSn5nEe1uMHtXnoublyVyrAc8VZgvDgh0IXpmndgsFDqegW3iCaJcxRxuvTFWoPEVg2Be2xjk9R0rhYGcqGiKlTWtZ7JbfHRx1BpcxTwMOhr3OkaDrmupqck+97eIJDCw+VGySXPqeR9MflvGCVFUxNvPqDmuHuIFGXgBT1x3q3pWrT20iokjNns1LRkfUpw1gzpri+nQbJF244zVjTYZJ1UsxYdc02PVIJYlS7RVLcZPSpLG8S3YxDlP4SOlZtWNqU5rRluS3KghcbvTFVEfbMUlAPatJJYpSCOTUTpHK+doz0zWbid8JvqUrrThdEtF8p64plks1vMElHTpV5o3gYNG5PqKTzo55AXG2QdPepsdEZu2uxsaTdFZODjBrtNPvhJEM1wMLbZomUbc9a2WujCiurYPerTPNxdBVTvI3BAI5qVXzxXK2GrGQLzW9b3AfFUpHhVsPKm9TRBzS1W80DqRSecCcdKrmRy8jLVFQJIO+akD89RVKQuVj6KTI9aWnckKKKKQCUhOO1OpppDRHI20VXaUBankOBis+5YLyaxk9TenG46S4wcVnXciktmoL67EJ3Z61hXeos1yoU9TUnp4fCt6ovXl6sKckAVxXinWVgtlnVuc4wO9O8SarI4e3tlLSbsZHauL1QSmRY3YySY5X0NB7mFwqik5E8Wti5f98oTjgmkjtIXU3rSbnzx71mahDFHJGoP7wLyD2rc0FUltnLYCIvAPTnvVNWR2VLRV0Z+5riQu+FGegFTafPJFcvyXjHYCmpKsN4qbQYs8mtOLyROxh6NzTTOepPTU8l+LWkrZ68l4ikx3IBOP71cEff6GvcPiHpz6h4fm+XM8B3rz1FeH5JAyMV6VCd0fO5jC/vIQ9TRSEZIoroPGGDORuxiu0+Emk/2t440+Fx+6ibznPoF5rim3ISTyK9i+A8P2aLVtUkUDCiFDjp61hiZctNs7cDSc6iPX9RuzLdSuTlc4H0qqZQy9uao+czJ65qPzWzmvMWx9ZClyqxYkCq/p3oWT5h3qpJMSvIBNLC+SAfrxTLcSPVDvgyO4rkbpgz7dvQ967C65XkDB4Fc7fW2WLMuPUetQ1qOnZMoW0Zdt3TvVvaN/JPtgVBBHslVozkdOa0U2tgFcfNVhUlbYfFCdoYZ561WuoN3AY8VtwIqxgE8e9YmpXHl3gWPGM8+9NHG8RJMyp7SSNi+446ketb3hjUJLeSNVY4NLcqj2e7YM4rn9PuGS/ITpnipmroylVdRO57not408SBuQa7DTmARQp615l4LvjcMkJA3Hgc16TbwSQKrED6151anJanl4hrZmsrYHNSAkdKqxPkVMGwKzhOx50okpbjk1ma1frZ2ckm7btGc1anmEUZZjwK8a+K/it1T7JC4Afg1alKTsjowuH9rPXY2U+JV7EZYxp6XODhJA2PzFcrpw1WK8m1FMIZnL7B2JridE1j7LOCSCh65rprzxrDZwJ9lxI5HINehaVkj2KdKFKTcFuYHj/WJtTkEdzy8eR6VxwbYDgcHipNWvJ9RvpJ5ThmOQq9KSC3YoN7kjuoGRXRCNkdNSUbJRKm5g52sR6YrTtbqJoNtwW3D9agltMSAKCpHPTk1G0BAywGQccGruZ7mlFeR2wGzaR6Cr+l3bSSMYlILZJWueO7BAAOO1WdPvnsZ0kChlA5BqWjaKsb41BxIFkVRzg5q3aPA0u9gSvsfu1zFzqKeYZXXO49COlaujqZlBQ7d/OGPFRy21Nny21OqCR3KYBBGPWltSYFMeSdvTmqEAltA5YjPQYpNPkmnuN5yADU3EqUZK50djcneFJ9jWtvwQPQ1zbsYW3xjI7nvWnZXPyAscg+tIvkNmF8v8w4q29pDKof7snrWSZh5eYyc96sJffKu480m0S6cnsXNwiUK46d6fdFmtwysCKqm4V0w3INPsgxDLuO3tUi5WtR9pK8SqyE5z2NbFlqU6yLkn8a5qW4uop9kcYOTwau2l1OmPPjGfWknYmrRUlqjtItSUL+8fn60warGWPzD865C6nkwrjO1jjiqk90UkO0/rTucscviz0eO/XbkHmrdte7+M8159Yak0g4PHStqC4cFSDVJnJWwHLodxG5YAmpVz36VmaTM00WW5Nag+6K1SPEqx5Hyi0UUVVjIKYxB/Cn1GeM1D2GiCdsgEVlanN8mM1pTMBwa5nWpcH5T2rDc9DCw5pJGDq92+/C9BWNLceXvnJ5C8D3q7dpvcEnk8YrLv5o0Iiz8qnLUH01KCSUUhttG/kSSSAeY/IrmpLO9kv1ZYzgck461vahcvFpiXURI52kHpVKW/ZbZJElA+Uk4pHRBtXaMm50OeW6eeZtq5+bNadnb7IlTcixenrWZeXM0ts13NI3kD7qj+I1Yil/0OFwMZGfmPSncmo5Naj9Rt4j94BWzkEVDPcCBFO3k8cU8XHnAl1BRcCku5rbOyQYGPvCrSOSUraMjmkM8bKMESLtx6V4Lr1k+n6tc27gjaxxmvbJLqCLAt2LY/WvNfibEv8Aakd0qkCRcHHGTXXh3Z2OHFJTgzjfr1opaK7z51rUiOCpyD/jXv3g+zXSvBOnQqPnuf3z+teE2Vubi+to1yd8gA9a+h74rBLZ2kfyiGFUIz3xXBjJXsj3smp3fMXUc4C5zUu3nC9fSqaE7segq7CTn5sdK5T6CSsVHAzk8HPSrMDY6elV7rCkkU62kxjn9KCW9CSUFiQRjHTmqN0g24bO6tEgZGM81BNGJFxwAetBk5WOaZdspI+UnvWjYp5jDnJ7mo7q0ZT8p6dfel0+YwtjGcfhTQVHeOhvPETD8oz/ADFcnqpKT9Ohz0rrUlEigg4z2zXP+IYN8ZdMgj0HWqtY4eupUh1ONoHiOVboa52O9WHUWOBtz1rHkvJo5myzcHoaj85nfccZ9qrlBQUT0Kz1qS3ZJLJ8SLyMV6PoHjXWbyBYpkhYcfNjk14dpV0iOglHHt1r1Dwxc28RRlkUqawqqyMa0IPdHsGm3plQbxg9x6Vp+cu0GuS0+9j8oMhyPXNGqa3HbW7NuGR2FeY430R58qHNLQm8XaqLSxkbzAOPWvnDxPqZ1LU2kLEqDjmuz8a69Jdq8aucH0Neb3AAXqN3euzC0bas9KhBUo2GsUZlXpilIxjHOaqkEDcxAHbFWLNjgbs47e9egXsTIitIu9Tn0Aq7FMFwrnaAcYHpUlmmXwgG4evepbkROT5ibXB69qBN3IrmTMW1MnPcDmoo4V8oSS8Y6Zq1HHvbHRUGd2arT8/Ih465oGiCUKF3xjjvxiqsY8wsYsHj7ue9acY8u12sAS3PXmqX7tZEKEAnnHrQbwZVZAyEMvIPSug0q4t4YF2Z80die9ZUqmSTdt2+opke3IxywPWgrc7YubqASEgcdKhsrmS1ztAYA1kWEzFCjTBV7Zq+ufKIXlj0rCWmx0UIdGaMmqKPmxhgcFTWnazCaMMVwTXMICWwyZ9cda6OwXfaAYIZP1pHTOKitCaO7KkoTjHarUcjyDcnCj9ay7hAG3FcEirFrMY4wD3qB2Vro0baYsxXPerLXnkoAOCeKx3faTIrDIqnPfMQpYmgapKTOntbtWlDyH6VpyP50OU4xzXBwXkpb1B961Rq8tuilccfjTsZTw+t0dBaTht0MpNQ3tkSx8pgw68UWM6akgljGHxyKdEkizEykxnp04qTHVN9y1o9oWwB1zzXXWOms+M1meFbdp5iTygPXFdxb22zFaRR42YYpxnyodYW4gTAHUVcHQU1RgjHSn1vFWR8/OTk7sKKKKZIVGedwqSmHqahoaMm+Zg+B0rmtVZyTjrXW3kRdeOvSsk2JHLdSa5z1MLVjDVnLwWkhBlkGT/CKpPpUTOzXMRHOcjvWrfW92+qxiJiIl646Gm3/wAx27gSvXFSz141ZXunuczrqxmNYY0zEhztHc1g3NjtChl2tjlc/dFddemO0IZlDbuuB0qjfpGsAkKZLDjPU0JHVCvyqxyF/M4jW2swWjT72RUSRSmALcERxL0x1Jree3KwErjk9hWPe27NMJHb7varihSxCeiMy6luJg0UAMUKnBPdqhCvgDcGx1yetWpZZNsm0cscZ7CqktuFiAkYsxOcitkjllVuRm4iiB+Ubxziuc8exvqGgLKQMRN0C9q32YR5BEag9D1JrK1YGfTrqEZI25xWtN2dzGfvI8sU5UHI/DtRSAEM4OMBjjiivRR8/VVpNHR/Duz+2+MNNjKlk37uOnHNexXBM2szkheHIrz74IW3m+KJp3XIggZgewyMV3bPtuHkI6knj1ry8S71D6jJ4Whc3YodyggdatRRAD375rN0+8DjHb61pB93KnArI9KaaepT1CH5gdzDacnaevsahtyN23Aq1encPXj86zIpCZyMHA9KaVyLXRsdEJGPSsyZwhPPPvWhGxKDGBzWddqSx4zg0WM2iGWVs5A79KqsFJL89ccVZCb0wckjvVZ8oSEGT6U7EE8MxQYBOPWoNS1BEgbe3bmq4uA+OzdKq38Svavkbs8jNUZyitzh9TlD3TFMEZzxUcILewP6VHMNsjYHzZNLCxB68960S0FJWNeAAKCrYNbNhdTQN8jK3pg9axrJQ49T71pRQKOp28cYqJK5hI6O28UTwKQZHGO1Om8Qyzq24nDjIJrm2t/MJ2SksPWmJ5sT/NjHbFR7NEcqLd224li+4+uawtQkBPy8/Wrl7c5O1Mc9cVlOSWIHaqirGkY9xyI0kYBIqaFhCFJB46ZqO3XPIOc0941DhSTjr9ason895cYBTHIxV6znMitFM+c/dPoayySGGDx0q0rBWIwBgZoCxYZplMikZyOtJbo20hto47mhbn5Bhg2eOnIrW09VkwNo3HHUUA9EZTow5zwOw5qD/lnvkUZBxnHNdFe2yAZwVLccdqyJdPl8zKMrIeetBUZXKryDy87jmo1jJcvGMA+tXks18w+YF47DpQIS5IXAwcYoZomOsbdZJTvcAAZwD1rctJIQ/VeOfWsFbJlZgGOcetWrS1KZIckgfnWLO2k4pHQ6PbLc3hdCCobnJro/KSGUBDgnqK5jSZFtJDIW256+9dBb3iNE8gxk9CaCajcnoJqMY29ME8gisieXa6ouS2OfatWdmuYsIwOBnIrGut8Sb1UMc4/CoaudFF9GR3M7rGcnJ7VmS3DyKAeg96t3TFlBCggjvUmj2QlnzKMoemTTSsdXOoxuNsZmGFB6HJzWnJMrWrKSCx7VQuQsF3hBhScVNEA7OUGSDQ9jJvm1NLw9cSwuuOMV6ho8UN7GjSKpNedaVZlypHGa9A8PgwqATUxPMzHWN1udjp1ukAIRQo9q0RVCykyoq4GxWqPj6t+Z3JV69KdVQ3UQfYzgH0qcMB05rRNbGLi1uSUUmRS0xBTW6UrHAplTIaI3UbhxVS5HHFWycVXmx94njFYSN6bszHEYCyM55PI9qw1BJkd1zuPHtW/Iu6RmP3f51SljBkBA6VB6lKdjBvtPE0YZ8j+tYV2Q7lmJeNPlUe9dRqUqouFzuIwK5oosSYPTJJFUkdCm7GXNKzMYlOMc/hWVfoUDMWyT09BWtdKTM7Z4YY+grL1ALsCls89K1SFKZQKEQncOO9UblhjbkKo7mrWpMY7cIpwzGsm8gdrUrvLOeB7CqI5upTncNJ8hL7e/aqzlwkgYAbwRgVqW8UdvCsSjJPU4zzUEqBrhWcA4YEYqloxudzyO+i8q8mTGCG5orR8WReVr9zwArHOBRXfB3VzyK6987v4FwqlprtzyCECA+9dWqEg4PzAcmsD4MLs8Ia05yGaUD9K6eJOQOnHSvMqu9Rn1eV+7TI7OIod3H0B6VoGcCPgnOaBCqxlh6VSklAO3aMD1qT0n75eE28EDgj1qs8ZEmRwD6U2B8HJGc9+lWnwy9gfancylGxLA25Md6jmXkkdKjthtcgVLLnYcjAp3OacWUifLJ3HGe4qGcCTkYPvRM4EmWyR6U0YKEZ/KrMpR6mczKkoVgR9KsXIDw8BSpH40y4gBO7260QD/AEc5yMUidGjgNUi8i+dMYBOarqMP06966PxBYStH9pRdygnJFc6hIbjBxWkSXqa2n3flAAoxXpmtAXMLzADcY+/HOawYy2FKnGasiRgwwfxNJmLhdmyZ4lc7Cdx7DpVZ7vaCMZNUGuWztLHFNLkseML60rAoCySHHQ575qFOZlAxwM4p8wI5bJX2pkAO8nnB4NMst26oMLnBH5VGxLyMAcgcU5Jf4UAwDjNSwoOZH4OaCW9SNtyDO0knjAp4aQgblI/CriR/KGBB3VPDbMWLOwz/AAgelA+eyK1sgQKXxknvxiuriaNI1/hAGcrWFKgDg9R6VpQyofvfMAuaDOXvCX96m7YMs55BrMmadyd6g+gHetSPy7iTaAC5647Cmz2zjOzJ55OKT0N6dkZcM4DFZsJ9RU8GWlbay7R0A7VNLZFR80e/uc84psNokbl42Az0ovdGll0J9hVsryCM1aT5U64UioopHRTlQfQ5pXlAb5gRWbN6ewXK70yvQVpyRmLTo0RsbhnIrCMqsCFJHPOa6KQqbCEKd3A6dak1WjRYsJDbWZZyXbHPqKzbi5eV/wB0px1xitCX5XQrkqR0xUsdqsY3oRnqaDZNR1MsRh4kDgByenYVcaN7aNfmG49Kgu7SdHE0X3c/hWffy3DyKfNyMdBQVbn2ZLHE0tzmQnCnNaWl2X+k5X7uc1U0pJHO5mDEjpiqkfjGzt/EsujtbyRvCwEkkkqRnG3dlUJ3MMdwKLXM61WNFe87XPTtLRIwAFGB1966GCVVddq4GK8SsPixpv2K9um0+7EMFv8AakKsjGRN6pg4b5W+YHB7Vpa38TruwiuILXRJl1G1vra2mgnkjP7ubJRgQ+MnBHUgHrxScXfQ8WtWpz1Tv/X/AAD3W0uQi4zVLV/ECWylUYb/AK15VefEyG0t9Seazuo5LG4gtZY8oTvlCkYIODjdz9OK5nU/iOs+ryWsek30+Lx7FXV4wrzKuQoyw4I7nAFPlZjTw1Hn5qjPVV1h5rgzbjweua7PRdYWW3Bk68CvEvC/iKDXNFt7+3jkhSUMPLfGVKsVI49wa7DSbqd7i1WF8IWw+RRflOvE4OnVppx2/Q9cjkDKG9elSZPtVeEjy0C4xjtTZLjy5VRujd6057bnynJd2RaZht5PNRElsgnj2p+QabjGc96UtQWgxxwayZ5iZxGhzt5NaspwprOWJEmZyOTWUzpo21bK8jbAd1Y9zchY5GyeBWpO/my9MDvWHrJTaIUHGeTUnfRjfczVd3Q+Zyx6VSvFCRsQNwYflWjEudzIMjoKqXsvOwL2qom832OZvo2t0iDOW5ycVmXhY3W0HBxmt2+UeYpbucEntWBeKRqMrLyvQYrWJmzPkjMjhpCxZTjmn7VAXdgKKm2lVJYZxUEm14lQAEnk5qjN6lS6QqCIQSCaoSfKo5yR3rXlKhSoG3H45qgeFkBHB55FBUTzXxwuNWEn94fnRVz4hx/vLR9ozjFFd1N+6jhrr3ztvhLlPAmoHu1wAfeuhtjvIP6Cub+GEgX4fzZwSbjmuhgyrAqBkV5s/jkfU5cv3RosrNESo4FY9wWD46A85rftfnjIX1qhqFqcnA4HSkd0ZWditbgHk81eiAUdOoqCzhbBHfrVl15zjntQEtxY9oPI6HrUzqCh6/jVMMVkxgjPrVtJARhhwaaMakTI1BAnzDscVTilALA+tbN3GjjjGOtY11BtLbRjirObfctYDx5HIx2psMIKHufT0qpZ3RVSpznpirdvMVn+ZThu1UrdDGUWirDCyzywyD9y46dq4vWrH7FfOEb5cjp6V6LcLiVduOa5TxpB/q5kx7imZKTuYKQllz+VQSnaSMgEe9amnIrxjA7c1Turc73YYGO9UHNqRBCQCCDx2qWPAVSenpTI5GKgEDJ/OrAARBz949MU2DZHIx2549KRFwjY6n3pSMyfdxjn61MsYCZAOc55qWK4luqquQCW9fStW1iTYGkAOap20Y28rnOTxWpaR5wSPk9DSImyS2tF5d1GD2FWJYFVQQCGxwBVqMKV5UqD0pxR2PyIAP7xoMOZ3Mhtw5wSD2NNV5HhKpGMA4zitS6jjiXGQWxVfTOLoocKGPekjeMtLkullYAWMDjPViP6Vp2f70llOVPY9KtwRJcDhCOxHrUj2KplUVs+1MpVE2YuqQNtYxvjJ5A7Vixo0c5GGPP4Vv6lbm2Q7Szb+3pWNHEc7JQcnnOalHXT2NFLdQNz7eRwAaS4hBRSOCOTmo7ZysvlREscenSn3s6odm4ll+9x3pSLjF3IfKRiCOTW/pkHl24aRGZiOBWVpCLcXajHyjmuiUSElhnavHSs3obJakbIx2mRSFU9MdqmVlZxjpSLdBsqR+JoKCDEknA7Cg3Sb0ZPdyBbJuOMcCsAWhln9jyOKvz3u4bSuPTI61askWaMsV+bvigcU6aux1jaxxAELjHXHeqzeFNIn1hdQnhmmmWQypHLcO0SORjcIydoOPatRLdh9w4GehpCZY3GMEmg55xVX4tTmte8B6a/hu/03TZ7i1+0x+VGr3MssMILqx2xFtozt7VLL4Y0U2N1amGeQ3UyTyzSXMjTNIn3G8wtu+XHHNdBd2swi81+3assXJZSQMstO7IpYSjvyowdT8KaLPdyXNxazGaQxlybmTDtHjazDdgtgDk/1NVhpWmRXZmEJ3/a2vgd54mK7Sevp26VtLc/aARIrZB9KPLsnUqFO8cmi51QoUY/ZX3FbQLKDSNOitLRdkKFioLEn5mLHk+5NdHZai9tLGyseP4awGdV24JZQOtSfbF3K38I4NS7lulFrlS0PcPB2vx6jarC/EyCt29XzIhjqDXjPh3Ukhnjmgfc56ivS7O/leKMynLHk4pXurHy+NwPsqnPDZnQCVRgU2W5VFLHoKyRebnKKDkDOapa1fiK3UZOc4OKfM7HFDCuUkjdS681CwHAqmJt0jF+npWbaanH9lG3kdzT550O142471LXU2WHcW1YbczeWx2HjvVF4hLljz6U+S7hDEMcHFZt5clEBjbbzmkdUINFjbsQhR07VkXEYLNxhs9as/azLk5IJ55qpe3AVA3fPWnEbgzJ1OP7pLYA5NcyrH7VMx5OelbuoN5kmVckH26ViTYS5nXI3ZzmtYkSVkDFsHIBbFNVVKsSnOOwpqEt8y8/WrMYGzcetWYMoSRgw5wRzzx1qjcAbMA4Fal052/eyGrHvWCRYbOG4yKBxRw3xAUmG1Y8DNFWPiGoTTrM8/e60V20tYnNXXvGx8OZR/wgFwMjK3IrqdOlV4uT8w9K4z4YP5nhLUY2/hlDcV1NjheV6d68+orVJH0+W60joLKTy3UkjBOK1RAs2T19MVzSTrvUE559a27C7z3xihK501Itak0dkFbPYVDdwlRgVrRMrA80txGrj7vWk0Yqo76nJTMQenzelNSUgBWJrQvrQBu9UPLKn29KE7HTdNCb2LZ4IFQTOWRh0xVpTl+VOccVYS1WUEbevWtDkqNR1OdjjZJS2MClef8AeqoBABxWxc2pQE4xisZYib8enWmjHmTRppExUFeo61heKURLDDjk9Oa6K6kaG1dhjgV57rOoveS4cnap4FUlc5+tyvbXTQEIV+UCrVw8TQBsgEjJrNXfKS23Iq3HGuB5gIHSqJdrkUQKkcY570OpNyQSdgGc1LJhvlTlh0rU07TXuP8AWJjPcmgTmluULELJLtxjtmtV7N1kJfaEHXFXBoaRpvV1LdSAetMkSTzPLY4X3qWQ582xWhg3OAv3F9+taNko8zAGcepp1vaxou137fw9Kti4t4AQEzjvikZSlcmiZVzuOeOlUpS80mMsq5/SiJbicu6RHHqetSF7ghYxHjnkmgcURCBRnBMj1ettOZiGKkf1qaytSh3hQTVp2eBt24n1xQa6luCJkCJgoM9OpNXoonkLL9wDvVCOWfeJVyq9a1omBXkEk85pMFGxk6lZtLAyjg54PesBLHbMiuGZvUmusmOWyPQ5qlOqFt2NxxwuOlI6aUmtDHmRLRNyYDEHnuDWWls4hJkOXbkk1tzxrGMzDkngD0qvJGXX1ycj6UmrnXBlTRnKXoKoeRgj0rfM0oj2AkAnkVmWFpPNdRCAbSDyRXWzaRNFbh2UHI61ElY09pFPU55POExdQCv93FXZszwlWyrDkVJCPKlycccYIqe6G+Pem33A7VNjZzu0UorRZ1B431q2dpJAgwAaq2GXlQoMHPbvXRkYgBYU0ZVqjWhnBTzgd6WGBpJ1YDBB79KnZCZPlq48TxRDYCT1oMJTsW5YYZbcB8dMcVzF5pCoXMYIyK7fTreOeIEjt+tYHiK3uVD/AGZGfj+EVTMKFa03BM4V7YpBIqPhv7vpWZCrgsVI465qZxdSXflFJFdjjGOc1sDw/eQ20x2Lv2Z5apPUclDdmTbTRTKyNwAe1U5wEbEYyG6ZqaKCa3s2doyhPtjmrdtpVxOiP5ZYtjkmpZtGSWrYzTd8UiYY/wD169a0+8MenRs4GdoxXFWejx2RRrrLE9BnpXQrcZjWJeUA4pJ6nBjOWtaxvWF0zRlnIzmor2QtuUKDnpmqEMhjtjnu3FTC4DNgHJ96rRnm+ztJtFKGdraMpMMbjgcVNHcmJmUc56UupsJgFZQCvIx3rNhcyhmHY4+lM6FFTV2jQeQOnmuAAOnvWXe6gUYKsfyE4rSZQ0anoAOlZl7DGd277xHApcqHBRTsyl/akMkuJCUA4zU946NallO5eoPrWRqkcMaK6qQe9GmXKyOqYARu1FjepQi1dEmWeMOg/CsK8cHUATkMy8jFdIUMRcKD6r6Vz+rReXco5PPeriebUiImCBwM56VOjcEYqqjhZQW4zTkc5YL0qziaIrxsLjrgHpWNdDem3kEflWtPlmJAxis2Ygu+RjI69jSHE4v4i/LpdkH6FjnBopfiIf8ARbNewzgd6K7qOkTkrP3h/wAKbnFjqsRYkbQ2B3NdbaTkdCN2ehrz/wCFkwXVLuDoJIT9a7GM7WPUCuOsrVGfR5S70zV8wyNkZBPf0rT0+cADcTkVnWyK2C3Qir0aYB2549qhaHqyeljoLe7O0enbmtCGbI56HrXOQvgj9a0LeXK+3vRe5yzprcuTqsmcj6VnzQjgDGKsM4wOevvUMr9wBgVAopooFGViO2avW3AyARnnmqkj9eT+VIt5sKgkZ/nWiIqQbRauwWUgkYrLMSrLuBGavmZJEyxxn0qizKZgATj+VNHHytEHiOYx6YdnUjGBxXCpaBm3nG70B612viJFkstoyT61yFvZzM52ICe2TVoza0GQws/3sJ7GrH2bcApPPr2FXrfT2jGZ/vHoKvxWgdcKqj17GqMW7FTT7C3SQEqGc457VtpChcAnA/urVeG1eL7q/KfU81cTCDag/edyaGZPVkiEAbSgUD86hvdPa4RHg2kj171XufPGCXz7AVYsZ5jJhh8hGBUGsadlcbaW7FRuAJHUVbFpGG/eRkrjgVK/lgkqpBx1HrS75WOFbI65xyKCHB9BELLlvu44xUCSgylQpY+lWxE00ZDZLU22jhtJ0iY/O3egcY23J7S2bdvk+UDkCpi0AZh3zjpU5YmMuBnisO4895WdHxsPTFBvCNzeGWQbQPxp4kYj5VBxxisy2d9mZXw3oKtRF5F+U7VHWpZfJYglZml+R+h5Gav2tsJkJJ565qiFWGRhEAZG+8xqNLt7eUKG59qDXldtDQutOUR8DecZJNZSxNdS+TswF9DjNdLYl7iPbsOCOtOs9H8m5aRieTQJTsrEOiaatrICyjqMYrsNqvCAQCMdKyo1C/QcCpvtS24XewGffpSZhNOTujL1DSY5bjcOPXFNjs9zFQoCKMHPetuNo3bcGBBHWs/U7yONmRCMnsKjlN4VZP3RLSGCHaFjBIORV8R+bGRMABXPSS3p2mLAB9qnQ3NxIFllIA/u0WQTd3c34bWJeAFYdsU24IjPPTHWub0u/a21f7PJOWVz0PauvktFK8NnPPWkzKT5WuYr2c5t9uPmRveta3COGdWxkd6w3spIZPM3FkB+7Vm5XdabkdkBHOKaehnUhGWqe5Uu1sU1KN3jj80Hg8Vj+ItagUssRUHOGPpWde2MkV8LhJnbHdqwdcgM8WxFJ53NilzHqUMLFyTbua0LJqMSHO7ccgDoa25JYbKAErsIGATXJ+GZNjqnKhBnBrRvrtZ70DBZV/Kg2q0vf5eiIJdUM1wVlJCg5U5rqPD5huoM5+euNnTdMyqBjHXFb/heOeB2wSQR6UnYWIpr2emh0MqgAqRwe1Zd1fCC4CkH61qTBwA0h/DFZt6sM2Q4AIppHHSa+0WobhbtcoTuAximQJ5VswUDcTzmq1gsaSsY3Jx61JK0nmMXxs3Z+WmOUbaLY04yFtlUYJPU1Qn2ESMcbgO/apGuGICwjg9Se1ZOpTOX2IcA9T60MmEPeM693TxSbULfwqKZp9gsCq+d7j72P6VbuHQCNC+046VTXUEUmKJtxHXaOAKR0OT5bIuXkpMaBCOOnsKy9Zt3ltiYRl8ZK+tXjEZIXYEgjtWZfLPAyvvO70HpTRwygYkM+VCOMSjqD2rQt3U5PvTb6OOdk34VnHEg9fQ1VjlICxnG5etWclWnbVFiaTAIxnPWsqbBDZO4elXZnJ7gCs6XCnOec9KZgjiviM2JLNNpAxkj29aKq/EGcy6wqc4WMfhRXdBe6jgry94zvAcwtfE9t82FcFTn3r0NwPtLjB4Y5rybSLgW+r20u7IEg5HpmvXroBbndj5XUOPTmubEq00z3clndWNawjLwjauSBWvEgAGc/SsGyuzGFUZxXSWqiYKwHPcViz2araEaEYJHftTomWPjv71NOpUY9uKzJJWDYFZkwfMaIfKjOCMml3Ky81Sh3Mw55znFSnf5Z6Y6cUFNJDZBljtP4VXu7fKj1HNWIVzywPI6GnthxgZFUkTJ2M62UquGOc014yspC5wPWp7iNozuUHHoKrrK7H5zhvarMJq+pHPumjKSEYFULeOSNiYiPYNVy7ZkTcByaW3WO5Pyttcfw1SZzVIaETlto35Y9SahRDdShMsMdxxVlbGcM3zgg9qsW6/Z0G9QT6GqucrhbRDY7IxqPmk4/i61chYJHlQpx6dadBqKDiSPHuK0N0csO6HywGHPrQ7k8rvqZLzCRvnBHPpVq2RdwKgH0qCeIRyAsQQe1WklRGXb1A6KKk15dNBJLR5nKZ2D1qzDo/kkOkjMQORmnw3O/aCvzVpRjfHncF5pEyTRBaRqFZcEc9TS3MaRIHKKxHcir6RrtUfLu702aBT0GRjv0pXJRjtqCSMsQTZ6YFReVHHcu6k7W5K96ueUJbjCRfd74qC83wSbht255wKdzeKIVgeYhwNqE96sNtWIIj5xVqBPOgI2/MOc1n/Z2UkynHPC+tJmqV2Q+ZskkIGT0xWno2nfan8yUd+9Z9yhiwsajB6nvWhpdyY1EYY5zxSRpO/LodPHElsqqgxxT87Iwx+YVPax+dbJkAnHWq+pI8cOEHFM407uxDczqIywxkdMVx3iS9a4+RLjYw7Yq9e34X5ZG2YHesnTxFeahulUMCeO9B00463ZueHUdbCNprli2OeauCJJ7zckgcDg1YtbSNUCooGamS18iTgKu4dqTdhNq+46V1jG0EYqveSi1s5pVGSFJGPWo9WgY7WDHZmmxxGW1KPlg/AFS3cagrXMbQrCSYrcSOxkJ3Zrsbe4e2B3HIJBzUNhbJDCquNiAcVakRDEQpGc8ZqGRUlzPlexoC6ikiV+Qv8AFikl8mWLYDjNZttbzKpCglc9KvQ2UrfwlB70zncIx6lTUbAyQ+XGFPFcjqFk9szDbyR1r0N7aZQDjNRXGmJcxfOmGqHubUMX7PfY840rTSZzKBkYwavrYKrMzLtA6CukGmG2nGFwtVru2d5AEBI3Z4pHY8Vzu99ChY6MJyG24+tb9vYLaqMjGOOKv2VqVhXsRU0mBFyOR0q0jgq4mU3a+hg6q7svyAnHeucmW4muBs5XvXSalMACrHgjtWUlygGRgDPSmnZnXQuo3sUrqKRYGZhtGO1Yyz3FuxZZGKjnBrq5ZfOTAXcvTGKxL2wQN5j7gOm2qudFKataRUi1h1ucxnAPVe2a0dL1K21FWRl2TqTxjrWBqEPlhnjAXd0+lUbO9MMiJv8ALlDdfWqauVOkmro3tXilWOSWLG8jaM9qTRLJIrJnkYGQjpV64IkhVZJAGZcg+9RxW7JGdx/Ed6gxlK6sQSmZUwpIBHb0qtqgk3ReWCwbG4npV4T28DpG8qhm4XJ5qwy7l2lMgelCOad0cjd2lyH4K7O3qDVMSOzN5iHzF43AY3fWuouEKxOeGPbPNY98iumUxvPPFWcznfRmfuWU4DdKo3AdZMgggHJp0ayRzlyxAHaqeoyybHZT0UnFUtzBxPO/E0/2nWZnbJIOOKKzryUy3kzEYy3X1or0IrQ8jENc5QJZWBycg5GOtey2cgvdGsJyeDGEPPcV44ykjIznNeleAbgXfhy4t85e3fI57GscXHRM9HKa3JUsdDAwWRRu4rt9FZDGrEjn9a8/5ZOOCOlX9O1V7cBW3cHqK5FsfVVYc60PQLtU8vhgPxrn5UAk46Z61CNVWVPmyeO5qnNqCq4B4FTYwhTktDagGMDj+tWDgjrgGsayvg55fJzxjtWms+U2frRylOLCTjoPpULvj5s4INOluOdvFUZZvmBB74waSQ1BssySBshutVZIggbkEt0NDBmUsfwqhcXTQthxkj1qyJQZayQgycoODxzVVIWaRZLOQb88rTEvYZF27sE9QanggCyK8Oc549KaMJdmXonmAUSxjNXxGlwACChA61RN3IgDSDABIzjrQupQu5DNjtgimckot7Fk6fleFQ8HoaYjQ2q4kB9sDNWLUxumFbtxzVe9tpyco2FHpT1RmvMmgW3mXIBbvyOahYlGbahCg/ePeoY5lVtjsQ+Op4qlLM3nMoZyuc4qWbwV2aovY1A35HPatOynV4gAR0yDWRaRq6AuBzzg1Zg1Kygd4yhZwPugUbFuN9EablAFcSEN1zmrCziRB82AeKyo1S5AcEjJ6elRahbzp81tOVC9RjNIXskbctykI2o67j1FUpWid1LNkA81SgBYIZSM9c45NTlYzg43c9DRdItU0ieC5LSSpFlR0U1ZVW2/PzjnmorWXc+1Ywij0rRCqYjg84oG1Yx7xDuZiOo4pthNHBcKZCB65qDV7neuxDzuwaoTKxmXdkgdalFpXWp6jpV0skW4Y244qaZxIuCFx1Nc5okuy1jTvitbfwOSKo4ZU7S0Oc8V+HpNRTfaNtZeSPWudtLG7tHj3gxuDjJ4FemwsDnkZ+lUtZsI7iHcB84qGrHRSrW92Rk6bPcRrifDe4rUL75Y+DkCqdtFGuzcCB61eADSptPFJMc7Xuh8zZ2qeVHYirNtAoTKdfp0qncN+9QJ+NaAUxwLz19KGzGWyKlxuQgN096vWlqrQBtuSaY1i10meTVyxs5dwADKq8UJmdSolHc0dNttq/Oa0lhAbg5ptvDsUBhzir0aLtAxQePWqtyuV/IYkDjH0qUWq45Aq0q8Y9KeF45quS+5yuqzNmsI2TkCqJsUVsBMj1IrfZMmonjBzWbhY0hiJLS5itBt6daz7yNyoC4roZYuc5qhcw7gQuB71N2zrpVtdTlbqxYruJyTWPLphZzuB2jmu4+ykKN5BqndWwIISml1PTo4trQwbeJUhx3FVNQszIm9WyOuK03tZomYquQe1QPHKEPy59qo6Iz1vc5G7gDDbg/lVebR4jIkhUMMc8d66UW+ZGBHNNuLIkgoM1SZ1+1OejjSVPs0jbZUO5M9xWmtof7OO5mLegrYXTYspM8al1GBT5GigQsYmYnoooepzOpf4TldR0y1XTI7h1O5Wzk9a0UlzZRlTwQKxfGd1c3Np9ntInUk5bjoKytJ1S4trYw3ALIvHPUUi/ZynHVmxcONzqT8p9OtZd7bHO6JjntRd6vYwzZJZvlzxU0VzDfIv2Zx06HrmmrmMsPJanPXm4xOzjocYz3rC1mc22m3JYYYrjBrqdQgKuzldp6bc9a4rx/ceXpUMZx5rN+YremruxzVo8sTz8De5+Yn1zRSpwec8UV3pHztTWRXbDgqeP6113wwuDFrht5GxHcoU6cZFckPkGSBjrxVnTLxrHUbW5Q48twaVaPNFo0wk+SaZ67JD5TyI2Tjiok2rINxyTWxfxCWO3uowClwgkDD1rJljCNk568/WvLR91h6ntIKRpQ7NobpUNwqsevNUvNZA2eR0qJrvkgD61Ruqbvc1bY+WSRwtWI7oswBJ44qjbSblGQMH3p6LmXI4oG4mvAd5wxBHYU2WFWPANLaxMVyDWrFaF0XPQVLMZS5TJIdI9u0HA61k3nLHeQVPqa66SwDKe1Y1/pu4HYc456U0yVUizmLhcHK4AzVyzvXiT5jS3Fq8aneOMVVVSZCvO36VSM6kVI2UvvPi24xjmqrfNKMgA1FCpiHAOaWYljleD/KmcvJYsLPLbODuygPY1u6dqO+MFSCe4NczCrzKV5544ptoLi1uQCDjpimmTOmmjr5UtLhy7gK44rOvbcW7eZGSTjjnrUFxdeUQzxhwOoq5DeW92gV0wewNJrsYJOLMOS9vRkLCNo74qaC4kRjJsw2OSeK3mtiEDQIp579CKc0EdxEYZFTeRjI6ipOmFVdjMtNUh2cOd5rWgvB5Lux346ViDSrmzlIYKIccMBWhZQoiYLli3r3osbOULXRMs8lydy8e2P5VsWsEcibmypHek0vTgG54HYVrta4GxBUSdjKVSPQqwRxDLJgtiq1zcPlljU+5xWxFp/kqzZJz2xTZYyQBtrN1TLmuzm/scc0MizcSHnNM+ysm3ndgYrQu7u1iuktywMp7LRcAhDhTtI4OKFM6Ist6Texy4iUBXHBrbKttAzmuQtAI7lPLyWFdvZjzLdScBsVqnc56y5XchRig5496lSRT/umkuImYEjnHbFVEB3DrxU3M0lIvx+W0i4Qe3FWpbaEkDGDVG03NdJzxWxMoAz0NVa5nUbi0jLWw2sWHzc9a0DbNJEFTj3q9bMEUcAg96ujZ1AApOJzVMRLsQabblIwhycetacMCjGVzRbhduR1q0gyPepPOq1HJtgsa5zipVAzikAxTlBrWKOVscq4NOooqjN6hTXHFOJwKr3RYrhTjmoY4q7GTDBJqt5IcE9jVpmAxkZJoMfHoKho3jLlMqeHqAeaqBCDtJ5rceNVUnrWE7O87YHQ+naptY7KM3K4k0QHJwaq3NuhXjgmrwG9sOaJIQRwaZ0RnynNtaHzSwGamjtTtzjn0rW8vbnK5oI+UnbjFB0Ou2Uvsw8njBPWs28i4z0reVhsGepqC6jVl5AxTYo1GmcjdWauxLHIrC1TTYrqJox8rjo3vXZ3cW0Y4xWHeRNv3AAUj0KczzG/08xrjB3A4Oe9RQK9tdRsCR2yK7XV7DdMrKB0zmsS7t4kiAc7GBwMjrVJnaqiasS3dxAwgFwRl+M968q+JkgfXVtI2DJCg7+tdxrcyhoGbhYlJPua8j1K4e91OadhwxPNddCKvdnkZg1CFyFep9KKFBB3elFdh8w2VgMnvinN930HtSLwCRz60vf8aqRMXZ3PbPhtejWPBn2aQ7rmxbHvtPSp7m3Jycc+lcH8I9Y/szxJ9mmf/R7weW2TwD2r1q7tPKuJFYY9K8qrHkqNH1mWYi8bHKTRgptKnd6Yqk9uRMSAcV01zbjHy/eIxk8VXjtFONq5+tI96FXQw13xHjhant7h96gtkE9Ku3dgVzxweelUBDsk4AB/pQbJqSudVpZBRcHdx1rdtyBwe9c3pUixoBWyt0M4BxSOCtHXQ0ZAuMKcgjFU5FAIzUtvOp4J5pLho8ZXrTOfZmPqaK0XCcVhNBiQkdPUmuqYo4YEfnWVfWjM2Y8baaLTKjQqFyCDkVXlic5baOmOlWNjYAOMgY+tOiU/KpbHOKZNjPRzAcE/lVtpFdMgYPfFSXOnnaCuSx9Kjiglxt24oJfKwNyquq5z2OauSpHJHuTCsPSqzaRcuwkCe9WrWxcHD5z6UGUlF9SvaXtxFJsY5T3NXZbhlPmBlAJ5z1q9b2UAYNKhDdM1Jc6dBcI3lzLu6YzikyYyimJptx9qjaOUgqRxUtjpZjlLSSgqDkDHSssQXFguFGfcHrW34feSdysvNS2VJK10dHptoCdxJK4rf0vSPOPmPwgPp1qnYgLgFcZ4GK6e2lWOAKODXLWmeXXqyjpEa2l2xXG38zWffeHxLGxgkIJ6GteONpTuZ8D3qz+8ChY9p9zXHc5FXqQd0zz7TvB9tHcTfaZl8w5OT1pk1vbrYvbqztcKcAAdq9ESwh3GRxvkPUmlWwtolcpAgLdTt5rWMpdTdZjZ3Z4ZqUTxSYgJWQHpWv4S1K4aVorgcjoa6zX/AAe11M1xavhz2xWLDoUtlKryKVbvjvWtKumeosTSrQ0Z0NuoYuHHJrOuIPKn+prQtyflB6j86hvuZB9a6L3OaDakRWcWbgHB4rZkRSuSazrMFMsTirDyhvl3Hj0q1sTUvKWhIJMDC9KniuByD2rOEgyVHbnNL5m5s9qaIdO+50dnOG4zWmmMcVy9rKF2kHmt+1nBXBOaFY83E0nHVF1RmnjpUStmnhj6VSOJpgzc4FNDZPU4pWORioowVyD36VF9RpaExbjFMBB44JqBpCzlV7VEoKSlmY80nLUtQLY2lgcDikkYIhJ7CmR4A+XJpLgEwN8pb29aGHLqV7e4RwQTxk02TyEyVUFj6VDb277SzJsBPAptz+7IwOak6eWPNaLILtAGDrxSRuo4bk1HPmRSrNgVDACBjOcd6DrjH3dS443DjrVdjtcZ5qzHygNRSxbsfWmTF2KzplxwMDmoWG1SDznpV/aAuKqyJkEnk9vakaqRk3UJYsVrJuY2A5zitu7LRAmqlwgMeV6jmg66crHP30aG0zGx3A4ArmtRgSRVZwCR2NdNfhkbJPA5xXNaoy5+VwMnnNNbnZBnBeOZRa6X8pHmSkr+FeYuT0BxXU+PtTF3qXkROGihyoI9a5UnH1r0aMbI8PNKrlPl7Cj0ooXOAR1orc8hlZFAA5C89SeKUfUHmnFDgikZhnOOPpVPXYzTHW8jQypKjbXjIZSOuRX0Xo2qx6/4as9TUhpQvlzD0YetfOOVZBg7a7/4ReIhp+qS6Xdtm1uwAM9A3Y1yYmneN+x6eAruE7HqrpGyr71F5art96py3Zt7p4XPAOB9KmNypUjg9x7Vxo+shdpMsBI3GGANZ13Zx/eUAe9N82TzMbuOwqwrNKigqRmnY3vy9SmFSMKOh9arXN+IWwDitM2LO2c4HGCagl0ZGblgT1pFKcXuOtdT80cttPY1PcXLqoOSfbNSWmlrGEyARU11YgxkKpz2oMpSje5jSXkzEBPvE4AzSx3Uy8OuR9KkOn3ERLFep+tXIdin5o8t1yadyvd6EUMiSAF1I/Sp42tUf94CCO9Woo4pNqnirE1jFImVIY0XMZJJlVr+1QbTyw7GmLqiBRhV/Kql5pG59yD6k1Hb6TPvHlDPY5p6GbjFHQWGpbxiQAj6VeklgfBMQB9RWVa6ZcoMyEADpVxomVSC4z0+lGhzSXYhnQuD5bZ56Vm3ME6n5l2j2qyzGF8iVDg+tSpeLL8r7SfY0NCsyvaztKpgfOR0JpGaexnDI2V9K1FsI5V3oSD7Ckk0qSZWUH5fXFZyGpdzoND1DzhHuPIFdnFPGkRY88ZrzHS7SbT3w5JUd66RdSRYh5jcngAGuWrG5z1qPO9DqrS8aeXJYrGOAMVvWxV1BHSuFt9ViitlZiFXvmrsXi+IxCO2hY4/iPQ1jGm29TjrYSpP4EdtwBTMcnArC0Oe5vW82Rjg84rokTB55+tdEad9Dy61P2UrN6kEok2ny1Bao/s/nRj7Qi7u4q7tGDTdtX7BXu2Zqo0tDn7zRTuLwHHtWTd2kqyDcD78V2jHGeD+FROkUikOvPuKh0Zw1g9DrpY6Ufi1ONVNhZe9QXGU56cV0l3pPzb4jz6VzeqxzRyYdSFHrRGutpaM9ShWhVejKnmYPWpo2OeGrPU5aptwA461spHa4l5JiQMNzmpo76WOYBWIx+tZqdBmtC2xnkA/WrTMJxSWqOr065E8AcdfSrnmDIy2PasfSMor8nHarkrHPNDl2PEq01ztI0AwPel71Tt5D0OTVsHNCsznlHlK90Sm3YhJJ6ik8t2xkYFWqXHy0uUanZaIZGm0U9lx9KVOtOb7pq7ENkDIDVKe3JJJ5NaFQyAkGokjSE2mZjQrg8ZNCwZ42gCrjDBI61FI4Q4qTpU2yoyCJwvahs4qO8kz0PNQmQq209cUG8YtpMkY9RUB/nUhBIJbpVOWQL2+lBrFEc6hskc4rOuDsG7sautKQ2cYFUbxxKMelB0QTTMbUWSWM7RzXnPjWQWGmy3TtjPyqD616NcphNq9fWvFfjDrKS3kOl2zDZB80mD3rWnHmZvKr7KLkeZTM8k7ys24knioyectzTmJz1plenFWR85WqOpNyYoYgdfxoo7+2aKZgyV4huIBzjvUMi4PWpwwCYPP0pMKSSe1BmVv4hxT0LxTrLFw0bBlOae4zjBXP5VE2c4z09KGrlxk07o9m0W8i13RIb1W3XEYCzDPOfWtCIclT2HFeW+BNeOharsl5s7gbHU/zr0q7uhFJkMNpO5T6g151SnySsfV5dinUjymhCoHUA46Cr8Soq8kD0rnP7RZTmrdtrSsAJMYHFJI9JxbN5s/wsDikSCWVsnG2qUFzC5wH68/Srq3UcWcS5Heixk7olaB4yAD06VMlwyEI4BA61V+320jfeb0p5nikHBH4UWI16moPIlTCqN1ZupWQI3JkYHUGohOEZSp4HUinz3WUOcgHpUtdhxunoYomeCXazc/WtCC+O3hupqpcRLIwIAz3oKIseAQT7UHXdNamh9rUsN54qzHdR8YOPcVzjMxA/pVi2RsjJ47e9A3BM6RbhHG3d+NUr2J3B2MfqDUEMWcDI45q8sRIyTnvQZOmlsYv2CV/mL7c+tT29kUYlmPHoa1pUJwCOBSJCjdOTRcVrBbLkrmR+D0retp1jjwB9azLaHy2HA9s1PK+0YZsDvSMZLmNGa9h8vDgE1kPdWzFiDtIOapXMa7T+87Z61m6dZyT3J3N+73dPWpcbgqcVqa5muL793GDsxW5o1p5exSD71Lp8cVuAETB9a34oV2owHJ9qzasZ1a9o8qOu0OFY7QEcZrTqpYLi3jB64q2OK0h8J8jWlzTbYUUUVaMhMCggEcjIpaKoBpUVXurSKdCJUDVaoqJ04zVpIcZOLujj9S8Ocl7X8jWHPZTwMRIhHbNeksvtmoJraOYYdAa5JYedPWDuux6dHMpQ0nqeexRkE7vwrQtE3SAYzWzeaJjLQ457VWS2a34YfNVQq9JaM7Xio1F7rLduQgxnmpWYtKq5+Q1VUleRUin5d7sODV812cco63Lq/u+hxU8UwwSxrP+0K4BHNIZMN6VV7GTpt7mqJQT7U8OGPBrJknXgDqakhbpls5quYzdHS5qA9aCeKr78LwaRHPc03Iy5CYtkVBLIFPNKzjB55qhPNwR1qHqa06dyUSHPJqrOwLZJ5qJpsLk8j3qhc3LFtoOOO1B2U6Lb0LEkihieuKIx5g3N0qhGzbSCck05JZSgXgYoOl02loXtww2TVSRQ2WqOeVU71ALjEZ5oBQZBcO+9gD8tUJpCqkfrVqRt5PGF9aoXHzggEYxyaaOqK0sYvijWYtH0W4vpiMKp2D1btXzFqN3JfX09xMxMkjlmJ96774veJRqOoJptnJm2tfvbejP/8AWrzdia76MLI83HVvsIaRzjrSE/MB3oPTigdOetdJ5DYtFFFAhyksM/8A66ljOD6/XtVdeO9So2R6kim0QO47r09qY67gTyM8jirJZmZfMLA9Ceu33x9KiZSdo9O/SkBSlBO3pnOAcciu+8Kax9vsFtZSDND90nqQK4iZSMsBx7d6NPuJLS7jngYgqefpmoqw54nbg8S6M0elmQ5IP60xXKE8n1x2zTbeeK/s47uAg7vvD0NEeUfafTnnpXBtufYUMQpxui/BMzE5LDFWftOGzjqMVTgXOckZ7CpgGzjAwKDbnTLCytnGMDqav20rA9Rj0HFZoHcZq5EVY9emKCWzYt8MuMfrVl4gUz37CqlmvTp+Fa0QG0cZoOeUrGLdI+evI54pIgAADk55wa0r2MAggVQJCnO0detTY1hO6JkhUgZA6VKI8IDn9KreeVw3XAziniZmGT0p2LUtRwnKNzwPzq7Hcgr9axZWYSEjpj1p0CSFsc/nSNdGjfS4TPJFTrMuewyKyFspniC7iWq/aabMMbyWA7k0GMnEmW62tgZJ60kkkzBm28Z7itK3sAgyQo+pqSS2YgAFT6Ujnc0cnL9pnkKxodpNdNoOnvbqHmYZ+lWYLUrztGav21pKxwSdvWi5Mql0WlQAZBH0rSsZCzoDjAqjFCUI4zV1CsEQkPHNZy20OWburHcWbDylPtVgHNY2iXazwDDZwK11PFZ06ltGfOV6bhNpj6KKBXSmYC4NG0UoOe1LVANxxSU+koAbRRRQAVFJAkgwQPyqU0VE6cZ7oabWxlXNjwWTr6VnvE4yrjiulPIqCWBGBytc0qUqesdUdVPEtaSOagBTKEd+tSFguATmrN/B9mUv/DWZDby3U/mCUlD0C1ManNsd0ZKS5+hMeZAO1Jc3PkAY61oQ6QSSzuR7VzviuN9NkiJYmN+hNbJNLUdKdOpNRubllcl0GTWh2zXN6NP5kYyPxrog3yD6UzGvDllZCO2CRmqE4OTVpwAxIzVW4bqaB0tylOHKkAgA1XMIILfxGm3Fw3IY4GeMU0zhUZuwHWlud0YtIY5KEkdAM5ql9rMcTyFiw/hHeoJL9Z1YZ9gPWqGqKY7dEjOGPf0qbnZClraRPJfvcDhTjvTYbjhhk4rn45JbdiQzbcfN71pW0+6FZMY3etUtTedJRWhdkmwqkMQMVyvxF8Rr4d8PSMHH2y4+SIZ5HvWzf30FnayXV2wWCFdzHOK+cPHHiSfxLrMly5PkKdsSH+Ff/r100ad3c4MTUVKNzCnlaSQsxJZiTn1qMnNB60wseBXoJWPnZzcndgxIYAUucLk03nmjsAKZm3cfRR2ooEMHT8alVtvNMCind/bNXJkkwkOCAetJncVBY4HvTUBIHPNKV+Y7ecVADXHYjmoWGOFO3nn61YbLH6VXk4Y85+lNAtDY8KaudNu/KuW3Wsg+YehrupoMEPGwaJvmVh3rylgjqA5wcg/jXa+CfEMabdL1BiYm4jc/wtWFel9qJ6+AxrpvlZ0yA4BxnNSKxKlc/MeMmnXFu0MxUkjuPQioM7exNcZ9JSmpq6LkZyAMnjirEPoDknrVGOQM2Ac+1XYRjkj8qDWxrW0wQYJwBwD61pW1yu/BzjtnvWFJlV2qKdbSlHGRwKDNwudO6iReOaoz2hL/ACjLVHFdhF69eanjvUJyMEigz5JLYomxlJOOmTxQsE6Dgc5xk+lbUVyrYDYBq15kD4Hy0EuclucwyShtrgY+nWrcasrcYHQVsSWyOM8e1RPaKq9frU2NI1e5DAXzkMc1r2020DJyfWqMEA7HJq2jBQOAe1NjbuSXFxLj5QcHvUdnd3DEApVhJQWAKjA6VdtyGXgflUkuSS2JreUnG8DitWGdVXAXrWYsbZ4GPwrStoSQCRwO1FjmqWauTjG0sawtcvJJIjDAfmPcHpV7V7oRRFVPJ4xXPrIFkAbn1qGVRp/aZ1nhKaa0t0EzZJFd1azCVODXAWGTACuTxmtzRryVTtkUge9c848rPMxlH2l5Lc6xTTqghcMOufpU9a06l9zxJRaFBx1pQc02lWuhO5I6iiimAlGKWigBpFJStmkoAKKKKUnZAVLyITRuhGQRio9NsEtYgAoyKt8bjmn7hXHRhebka+0ajyoXArjPiRj7Larzksa7BpFUZJwPWuJ8W3JuWK5UheFH9a7Ga4NP2ql2KPhyQrEA557V1SzrsXJ+bFcTpAbqM8Gtaa4ckDPA9KwctT1alL2jubklx8p5GKzL24AXJGfaoUleRepFQXL4XB5btQx06KixZiJUKqAD61Tvo5BavGvBI6+tWLNAI+TuJOSTTbqQDJY844qXsdMXZ2RzVrauu75gWXnOeBU80iiACTlj0qSVkhRlXjccmsW8vVQnd1HQ+lI7o803cbJKoLeYcjHSq7XwlHDbY16n2rGvb/exVBlnOK4bx14qWzsG02wfEzn944PKj0ropQcnY1qJU480iL4q+MhqUg0vT2P2SM4kYHhzXnP88U0DBO772cmgnIOO1enCKirHyWLxHtZabA3IpFI9x9aD0z3pM+tUcAE5PtSjnikHLe3alA+Y80AOHTAooPTFFAE/lNtHFAiz1XpWy/8AWkHQ0XJMoRFRwOacilcnFaR+7TP4aLktmdskUMw49KqurbvmGTWw/wB1f96mS9qaYXMjyyeq8UqxHlgpVugOa0jS9hSci07anZeEdeS8t49O1EgSpxFIfT0ropbMqxVl5xXmWnf8hOL/AHhXttz/AKq3/wBwVw1kovQ97LsTJrlZzkNiwcBgc4xxWnBp7lQwHQYq8v3B9TWpZf6qsz1pVWkY/wBhb+LOOuKsR6dtwSM4FbTfe/CpF/1iUCVWT1ME2JyMKSKmh0/Byy9a3T0/Clj+9QHt2zINpsXcc49qZ9lIY7AefWt09DUf/LSgfOzPiSXpjAx61K4c7c5464q0f9ZU7dKBuRnIWDLtDYJ9Ke2VySGz9Kvw/cFTL938aVyfaMgs4iwGRxmta2jEZHAwOar2n3jWhF/F9KRMpNsWWQrgLxUNzqDRIewxRJ97/gNZ19SbsghFN6lOSaSdyzHvxT7G1eW53EZA70n8K1saL91azN5z5I6HRaYiJEBjA96t3D4TdGBxUB+4lSN9xvpVNJo8eWsrmhpF+CAjNW6jZANcVp//AB8fjXYwfcX6VxvRnDjKSjLQsA8Uq0JTq7YO55wUUi9KWtACiiigBrHtSU+mHrQAUUUj/dNTLYCC4lSEF3YAe9c5qGv7nMVvgn1zV7xF/wAeh+lccn3vxrkp6u510oK1y/NrkluGW4YvjnArktV1iS7nVVUome/U1qah9x/pWBf/AOthro59DtopLWx0GmXSiMBSRWomX6VzWndvrXTW3/Huv0qWdr0WhZiUYOOvpUMtuSC2M1Zi/pUx+4KTdjJVGmZMpaMcce3rWfesXALDaK17usnUPuCpbudNOVzFuiwkLliwHY1zOoSM8zOQNo4AFdJd/wCr/GufufuvTitT0aUranD+KteXR7SVIsNeTDAx/AK8odpJpjLMxMjevWuh8Yf8hm5+p/nWEfvV6tGCijws0xU5S5OgzYc80wrg4HNTfxGj+EfWtjxN9CAg5oVSO1SD75pp60CGgc4NL3PGCaXtTh0FAhoB+lFSn7/4UUAf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Laufer MR. Structural abnormalities of the female reproductive tract. In: Pediatric and adolescent gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23555=[""].join("\n");
var outline_f23_0_23555=null;
var title_f23_0_23556="Calcipotriol (calcipotriene): Patient drug information";
var content_f23_0_23556=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Calcipotriol (calcipotriene): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/54/5988?source=see_link\">",
"     see \"Calcipotriol (calcipotriene): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F144061\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Calcitrene&trade;;",
"     </li>",
"     <li>",
"      Dovonex&reg;;",
"     </li>",
"     <li>",
"      Sorilux&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5383147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dovonex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F12676148\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014810\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat psoriasis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014809\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to calcipotriene or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703612",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: High calcium levels or too much vitamin D in the body.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014814\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014815\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705324",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         All products:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s3870483",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Cream, foam, ointment:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake foam well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4016662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Foam and solution:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Comb your hair to get rid of dead skin before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694434",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected part of the scalp and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694552",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid spreading or dripping on forehead.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014813\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014818\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4016662",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Foam and solution:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699261",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from heat or open flame.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11622 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-36135ECCB4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23556=[""].join("\n");
var outline_f23_0_23556=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F144061\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5383147\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12676148\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014810\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014809\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014814\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014815\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014817\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014812\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014813\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014818\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014819\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/54/5988?source=related_link\">",
"      Calcipotriol (calcipotriene): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_0_23557="Nerve convergence";
var content_f23_0_23557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64245&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    Nerve convergence",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 354px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Convergence of sensory nerves from the viscera and superficial areas onto the same neurons in spinal cord.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Bear M, Conner B, Paradiso M. Neuroscience, Exploring the Brain, 2nd Ed. Baltimore: Lippincott Williams &amp; Wilkins, 2000. Copyright &copy;2000 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23557=[""].join("\n");
var outline_f23_0_23557=null;
var title_f23_0_23558="Uterine descent";
var content_f23_0_23558=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F67287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F67287&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 512px\">",
"   <div class=\"ttl\">",
"    Uterine prolapse",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 492px; height: 410px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Prolapse of the Uterus Prolapse of the uterus results from weakness of the supporting structures of the pelvic floor, and is often associated with a cystocele and rectocele. In progressive stages, the uterus becomes retroverted and descends down the vaginal canal to the outside. In first-degree prolapse, the cervix is still well within the vagina. In second-degree prolapse, it is at the introitus. In third-degree prolapse (procidentia), the cervix and vagina are outside the introitus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Bickley, LS, Szilagyi, P. Bates' Guide to Physical Examination and History Taking, Eighth Edition. Philadelphia: Lippincott Williams &amp; Wilkins 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23558=[""].join("\n");
var outline_f23_0_23558=null;
var title_f23_0_23559="Amelanotic melanoma";
var content_f23_0_23559=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51998%7EDERM%2F62791&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51998%7EDERM%2F62791&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Amelanotic melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Amelanotic melanoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23559=[""].join("\n");
var outline_f23_0_23559=null;
var title_f23_0_23560="Cervical AIS histology";
var content_f23_0_23560=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52908&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52908&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Histology of adenocarcinoma in situ of the uterine cervix",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 348px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cervical adenocarcinoma in situ showing tall columnar cells with nuclear stratification, hyperchromatism, and irregularity.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Scott JR, Gibbs RS. Danforth's Obstetrics and Gynecology, Ninth Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23560=[""].join("\n");
var outline_f23_0_23560=null;
var title_f23_0_23561="Pharmacotherapy for obsessive-compulsive disorder";
var content_f23_0_23561=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pharmacotherapy for obsessive-compulsive disorder",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/0/23561/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/0/23561/contributors\">",
"     Blair Simpson, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/0/23561/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/0/23561/contributors\">",
"     Murray B Stein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/0/23561/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/0/23561/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/0/23561/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 16, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H12522780\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obsessive-compulsive disorder (OCD) is characterized by recurrent, intrusive, and distressing thoughts, images, or impulses (ie, obsessions) and repetitive mental or behavioral acts that the individual feels driven to perform (ie, compulsions) to prevent or reduce distress.",
"   </p>",
"   <p>",
"    OCD can be effectively treated with serotonergic antidepressants as well as cognitive-behavioral therapy. However, patients frequently experience a partial response to treatment. A number of augmentation strategies have been studied.",
"   </p>",
"   <p>",
"    Pharmacotherapy for OCD in adults is discussed here. The epidemiology, clinical manifestations, and diagnosis of OCD are discussed separately. Psychotherapy for OCD, deep brain stimulation for OCD, and OCD in pregnant and postpartum women are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36564?source=see_link\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34391?source=see_link\">",
"     \"Psychotherapy for obsessive-compulsive disorder\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42582?source=see_link\">",
"     \"Obsessive-compulsive disorder in pregnant and postpartum women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30678?source=see_link\">",
"     \"Deep brain stimulation for treatment of obsessive-compulsive disorder\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H540845640\">",
"    <span class=\"h1\">",
"     MONOTHERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1492696\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two classes of serotonergic antidepressants are strongly supported by randomized trials for OCD, while evidence for the third is weaker:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Selective serotonin reuptake inhibitor (SSRI) antidepressants:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       Fluoxetine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"       fluvoxamine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       sertraline",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       paroxetine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"       citalopram",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"       escitalopram",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       Clomipramine",
"      </a>",
"      : A tricyclic antidepressant that inhibits the reuptake of serotonin and norepinephrine. &nbsp;",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"       Venlafaxine",
"      </a>",
"      : a serotonin norepinephrine reuptake inhibitor (SNRI) antidepressant",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12522756\">",
"    <span class=\"h3\">",
"     Selective serotonin reuptake inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The SSRIs have been shown to be efficacious for OCD in large, multi-site randomized trials. A meta-analysis of 17 randomized trials with a total of 3097 patients with OCD found SSRIs to be more effective than placebo in reducing the symptoms of OCD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/1\">",
"     1",
"    </a>",
"    ]. No individual SSRI was found to be more efficacious than the other SSRIs for OCD. All of the SSRIs except",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"     citalopram",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"     escitalopram",
"    </a>",
"    have been approved for the treatment of OCD by the Food and Drug Administration (FDA) in the United States (US).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H594864477\">",
"    <span class=\"h3\">",
"     Clomipramine",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of seven randomized trials of 392 patients with OCD found",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    to reduce symptoms of OCD compared to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/2\">",
"     2",
"    </a>",
"    ]. A tricyclic antidepressant, clomipramine inhibits the reuptake of serotonin and norepinephrine. Clomipramine is generally less well tolerated than the SSRIs or SNRIs. (See",
"    <a class=\"local\" href=\"#H540846978\">",
"     'Side effects'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Head-to-head comparisons between",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    and several of the SSRIs (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"     fluvoxamine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    ) have not shown either to be superior for OCD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/3-9\">",
"     3-9",
"    </a>",
"    ]. Some meta-analyses of randomized trials that did not directly compare clomipramine to SSRIs have suggested that clomipramine has a greater effect size than the SSRIs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/10\">",
"     10",
"    </a>",
"    ]. However, the studies of SSRIs generally occurred in an era later than the clomipramine trials, and thus likely included more patients who had previously responded inadequately to another agent.",
"   </p>",
"   <p>",
"    In general, SSRIs and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    lead to improvement in 40 to 60 percent of people with OCD. On average, OCD patients who receive an adequate trial of one of these agents will experience a 20 to 40 percent reduction in their OCD symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Thus, they typically offer amelioration rather than elimination of symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H540845838\">",
"    <span class=\"h3\">",
"     Serotonin-norepinephrine reuptake inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on their mechanism and similarity to the SSRIs, we would expect the serotonin-norepinephrine reuptake inhibitors (SNRIs) to effectively treat OCD. There has been limited study of these medications in OCD, however, and they have not been approved by the US FDA for OCD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/13-18\">",
"     13-18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One small, eight-week trial that randomly assigned 30 patients with OCD to either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    or placebo found no significant difference in OCD symptom reduction between the two groups [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/13\">",
"     13",
"    </a>",
"    ]. The maximum dose of venlafaxine was limited to 225",
"    <span class=\"nowrap\">",
"     mg/day.",
"    </span>",
"    Two additional randomized trials compared higher doses of venlafaxine to SSRIs or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    , finding similar rates of response among the agents [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. However, these trials lacked a placebo control. Larger, placebo-controlled trials are needed.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/62/37864?source=see_link\">",
"     Duloxetine",
"    </a>",
"    has not been studied in OCD in randomized trials. A case series reported on four patients with OCD treated with duloxetine (up to 120",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    after having an inadequate response to an SSRI or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    , three of whom experienced a reduction in OCD symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H540846978\">",
"    <span class=\"h2\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common side effects of serotonergic antidepressants are described briefly below and in more detail separately. Serious adverse events, including serotonin syndrome and suicidality, are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=see_link\">",
"     \"Serotonin syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43783?source=see_link\">",
"     \"Effect of antidepressants on suicide risk in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H540847016\">",
"    <span class=\"h3\">",
"     Selective serotonin reuptake inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;SSRIs are generally well-tolerated. Potential side effects include gastrointestinal problems (eg, nausea or diarrhea), agitation, sleep disturbances (eg, insomnia, vivid dreams), increased tendency to sweat, and sexual side effects (eg, decrease in libido, trouble ejaculating, delayed orgasm). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H540847030\">",
"    <span class=\"h3\">",
"     Clomipramine",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients may not be able to tolerate the side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    , which include sedation, dry mouth, constipation, urinary delay, orthostatic hypotension, and cardiac conduction delay. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=see_link&amp;anchor=H11#H11\">",
"     \"Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects\", section on 'Clomipramine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H594864731\">",
"    <span class=\"h3\">",
"     Serotonin norepinephrine reuptake inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;SNRIs are generally well tolerated; the most common side effects include nausea, constipation, dizziness, insomnia, sedation and sexual side effects.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     Venlafaxine",
"    </a>",
"    may cause elevated blood pressure and increases risk for gastrointestinal bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=see_link\">",
"     \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13853573\">",
"    <span class=\"h2\">",
"     Medication selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;When medication is used, we recommend SSRIs as first-line treatment. There is much greater support from randomized trials for SSRIs than for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    ; the SSRIs have a superior side effect profile compared to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/19\">",
"     19",
"    </a>",
"    ]. Because none of the individual SSRIs have shown an advantage in efficacy for OCD, the choice among the SSRIs can be made on the basis of prior treatment response, drug side effects and their acceptability to the patient, and the potential for drug interactions. (See",
"    <a class=\"local\" href=\"#H12522756\">",
"     'Selective serotonin reuptake inhibitors'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H540845838\">",
"     'Serotonin-norepinephrine reuptake inhibitors'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H594864477\">",
"     'Clomipramine'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H540846978\">",
"     'Side effects'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A beneficial aspect of the serotonergic antidepressants for OCD is that these medications can provide effective treatment for several depressive and anxiety disorders that commonly co-occur with OCD (See",
"    <a class=\"local\" href=\"#H88195853\">",
"     'Comparing pharmacotherapy and psychotherapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    If an adequate trial of the SSRI results in no response, the patient should be given another trial of monotherapy, either with a second SSRI,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    It has been estimated that less than half of patients will benefit from switching from one SSRI to another, and the likelihood of response diminishes as the number of failed adequate trials increases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If a trial of one of the serotonergic antidepressants results in a partial response, but the patient continues to experience clinically significant symptoms, we suggest augmentation of this agent. (See",
"    <a class=\"local\" href=\"#H13853216\">",
"     'Augmentation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13853669\">",
"    <span class=\"h2\">",
"     Administration and course of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most fixed-dose trials of the serotonergic antidepressants studied in OCD suggest that higher doses led to greater response rates",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    greater mean rates of improvement compared to lower doses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/20-24\">",
"     20-24",
"    </a>",
"    ]. A meta-analysis that supported this dose-response relationship also found that higher doses are associated with a higher proportion of dropouts due to side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/25\">",
"     25",
"    </a>",
"    ]. The suggest the following therapeutic-dose ranges for OCD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      SSRIs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       Fluoxetine",
"      </a>",
"      40 to 80",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/50/29481?source=see_link\">",
"       Fluvoxamine",
"      </a>",
"      200 to 300",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"       Paroxetine",
"      </a>",
"      40 to 60",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"       Sertraline",
"      </a>",
"      200",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/56/13193?source=see_link\">",
"       Citalopram",
"      </a>",
"      up to 40",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/56/25481?source=see_link\">",
"       Escitalopram",
"      </a>",
"      20 to 40",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       Clomipramine",
"      </a>",
"      &mdash; 100 to 250",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"       Venlafaxine",
"      </a>",
"      &mdash; 225 to 350",
"      <span class=\"nowrap\">",
"       mg/day",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients should be started at a low dose to enhance tolerability (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    10 or 20",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"    The dose can be increased every week or every other week (as tolerated). The patient should be maintained at a dose within the therapeutic range for at least 6 weeks before concluding that he or she is resistant to the agent. This usually amounts to an 8 to 12 week trial overall, given usual titration schedules. An adequate trial of medication for OCD has been defined as the maximum dose tolerated for a minimum of 6 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/19\">",
"     19",
"    </a>",
"    ]. It is important to explain to patients the 4 to 6 week delay in drug response, so that they do not prematurely stop the medication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=see_link\">",
"     \"Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Evidence is limited on the efficacy of higher-than-recommended dosing of SSRIs for OCD (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    120",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"    A trial randomly assigned patients with OCD who had not responded to 16 weeks of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/3/44089?source=see_link\">",
"     sertraline",
"    </a>",
"    (titrated from 50",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    to 200",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    to continue sertraline at 200",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or to continue at an increased dose (averaging 357",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/26\">",
"     26",
"    </a>",
"    ]. After 12 weeks of treatment, the higher dose group showed greater average improvement than the lower dose group. However, the difference was clinically modest. Both groups continued to have clinically significant symptoms and similar rates of adverse events. Thus, increasing SSRIs to higher than recommended doses may be effective for certain OCD patients, but this is not a highly effective strategy for all and can lead to more side effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88195202\">",
"    <span class=\"h3\">",
"     Duration of treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although clinical trials of current medications for OCD are mostly short-term, extended trials of SSRIs and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    , which randomly assigned drug responders to continued medication treatment or to placebo, have generally found that patients who continue medication have a lower rate of relapse than patients on placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/21,27-30\">",
"     21,27-30",
"    </a>",
"    ]. Relapse rates have varied widely, in part due to methodological differences among studies. As a result, American Psychiatric Association practice guidelines suggest that OCD patients who respond to an adequate trial of a serotonergic antidepressant should stay on that medication for at least one to two years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/19\">",
"     19",
"    </a>",
"    ]. However, this needs further study. If the medication is discontinued, American Psychiatric Association practice guidelines recommend that it should be slowly tapered (eg, 10 to 25 percent every one to two months).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88196066\">",
"    <span class=\"h2\">",
"     Other medications as monotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a paucity of data supporting the use of other medications as monotherapy for OCD. No other drugs are approved for the disorder by the Food and Drug Administration in the US. Small, limited trials have suggested possible benefits of several other agents:",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    (an antagonist at presynaptic alpha-2 adrenergic, 5-HT2, and 5-HT3 receptors) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/31\">",
"     31",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"     tramadol",
"    </a>",
"    (an agonist at the mu opioid receptor as well as a modulator of noradrenergic and serotonergic systems) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/32\">",
"     32",
"    </a>",
"    ], and stimulants (eg, D-amphetamine) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. All require further study with randomized trials to determine efficacy for OCD.",
"   </p>",
"   <p>",
"    There are no randomized trials of antipsychotic medications as monotherapy for OCD. Small, open trials have shown inconsistent results [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13853216\">",
"    <span class=\"h1\">",
"     AUGMENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;With many patients experiencing a partial response to a serotonergic antidepressant, there is considerable interest in strategies to augment these medications for OCD. Common approaches to augmentation include adding:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"       Risperidone",
"      </a>",
"      or another antipsychotic medication",
"     </li>",
"     <li>",
"      Cognitive-behavioral therapy (CBT)",
"     </li>",
"     <li>",
"      A low dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      (to an SSRI or SNRI)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12522843\">",
"    <span class=\"h2\">",
"     Antipsychotic augmentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antipsychotic drugs have been shown to be efficacious at further reducing OCD symptoms when added to an SSRI or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1491626\">",
"    <span class=\"h3\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meta-analyses of randomized trials have found",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    to effectively augment the effects of SSRIs or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    in patients with OCD who experienced incomplete response to the antidepressant alone, while studies of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"     quetiapine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"     olanzapine",
"    </a>",
"    have been mixed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/38-44\">",
"     38-44",
"    </a>",
"    ]. It is unclear whether varying responses found across antipsychotics reflect differences in efficacy or methodological issues specific to the trials.",
"   </p>",
"   <p>",
"    A 2006 meta-analysis of the augmentation of SSRIs or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    with first or second-generation antipsychotic drugs identified 9 randomized trials of 278 patients with treatment-refractory OCD [60]. Patients who received antipsychotic augmentation were generally more likely to respond (defined as a 35-percent reduction in OCD symptoms) than patients who received placebo augmentation (32 versus 11 percent). The data supporting efficacy were strongest for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/50/32553?source=see_link\">",
"     haloperidol",
"    </a>",
"    . The authors estimated that about one-third of patients will have a meaningful treatment response to this strategy.",
"   </p>",
"   <p>",
"    A 2010 meta-analysis of augmentation of SSRIs or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    with second-generation antipsychotics (SGA) differed methodologically somewhat from the 2006 meta-analysis [61]: a total of 396 patients with OCD from 11 randomized trials were studied, only second-generation antipsychotics were studied, inclusion was not limited to treatment-refractory OCD (one trial included non-refractory patients) [62], and the primary outcome (treatment response) was defined as a 25-percent reduction in OCD symptoms. However, the findings were generally congruent with the prior meta-analysis: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Augmenting SSRIs or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      (four trials) resulted in a higher rate of treatment response than placebo augmentation. Low average doses (0.5 to 2.2",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      of risperidone were used.",
"     </li>",
"     <li>",
"      Augmenting SSRIs or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?19/56/20361?source=see_link\">",
"       quetiapine",
"      </a>",
"      (five trials) led to a response rate not significantly different than that of placebo augmentation. Quetiapine showed superiority to placebo in a secondary outcome, mean reduction in OCD symptoms.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/36/37449?source=see_link\">",
"       Olanzapine",
"      </a>",
"      (two trials) augmenting SSRIs or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      did not lead to a significantly different result than placebo augmentation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The efficacy of newer antipsychotics like",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/11/43193?source=see_link\">",
"     aripiprazole",
"    </a>",
"    remains unclear. Case reports and an open-label study suggest benefit in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/45,46\">",
"     45,46",
"    </a>",
"    ], but randomized trials are needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1491675\">",
"    <span class=\"h3\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Side effects were incompletely reported across studies described above, but available data suggested that antipsychotic augmentation was associated with greater weight gain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sedation than SSRI or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Side effects of antipsychotic drugs can include metabolic syndrome, extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H347652853\">",
"    <span class=\"h3\">",
"     Administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the delayed onset of action of SSRIs or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    , the antipsychotic should be added only after the patient has not responded following a trial of at least 12-weeks at the maximal antidepressant dose tolerated [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/19\">",
"     19",
"    </a>",
"    ]. Low antipsychotic doses appear effective (eg, 0.5 to 3 mg for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"     risperidone",
"    </a>",
"    or the equivalent). The antipsychotic should be terminated after one month if the patient does not show a clear benefit. This limits exposure to antipsychotics&rsquo; known risks. (See",
"    <a class=\"local\" href=\"#H1491675\">",
"     'Side effects'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=see_link\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7562?source=see_link\">",
"     \"First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Efficacy trials of antipsychotic augmentation for OCD have examined short-term use only. One small retrospective study suggested a high risk of relapse when the antipsychotic was discontinued; 13 of 15 patients had a return of OCD symptoms when their antipsychotic was stopped [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/50\">",
"     50",
"    </a>",
"    ]. Thus, patients who respond to antipsychotic augmentation are advised to continue the medication for up to six months before an attempt is made to gradually discontinue. &nbsp;If symptoms recur or worsen during the taper, then the antipsychotic can be restarted for a longer period provided that the patient is not experiencing long-term adverse effects of the antipsychotic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H347653027\">",
"    <span class=\"h2\">",
"     Augmentation with CBT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two randomized controlled trials have demonstrated the benefit of adding cognitive-behavioral therapy (CBT), consisting of exposure and response prevention, to the treatment of patients with OCD that have partially responded to a serotonergic antidepressant [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H88195853\">",
"     'Comparing pharmacotherapy and psychotherapy'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H88195842\">",
"     'Combining pharmacotherapy and psychotherapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In one trial, 96 patients who completed three months of medication (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"     venlafaxine",
"    </a>",
"    ) for OCD were randomized to a 6 month continuation of the medication alone or with the addition of exposure and response prevention (18 45-minute sessions over six months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/51\">",
"     51",
"    </a>",
"    ]). The augmentation of the antidepressant with exposure and response prevention modestly increased the proportion of patients achieving remission compared to continued medication alone. The mean reduction in OCD symptoms did not significantly differ between the two groups.",
"   </p>",
"   <p>",
"    In a second trial, 108 patients who continued to experience clinically significant symptoms of OCD despite 12 weeks of a therapeutic dose of a serotonergic antidepressant were randomly assigned to exposure and response prevention or to stress management therapy (17 90-minute sessions over eight weeks), while continuing the medication [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/52\">",
"     52",
"    </a>",
"    ]. After 8 weeks, patients who received exposure and response therapy plus the medication experienced a greater decrease in OCD symptoms, a higher rate of treatment response (74 versus 22 percent) and a greater proportion with mild to minimal symptoms (33 versus 4 percent) compared to patients who received stress management therapy plus the antidepressant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1491859\">",
"    <span class=\"h2\">",
"     Other pharmacologic augmentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not systematically studied, we have used low doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    (10 to 50",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    to augment an SSRI or SNRI in cases of OCD responding partially to the antidepressant. Higher doses can result in markedly increased levels of clomipramine, and should ideally be used in conjunction with monitoring serum levels of the drug and its metabolites [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other medications have been tested in augmentation of serotonergic antidepressants in OCD. Although promising in case reports or open trials, several did not show clear efficacy in small randomized trials, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/19/30006?source=see_link\">",
"     buspirone",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    , L-triiodothyronine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/15/10487?source=see_link\">",
"     pindolol",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/14/39144?source=see_link\">",
"     desipramine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/19\">",
"     19",
"    </a>",
"    ]. Other strategies that have shown promise but need further study in randomized controlled trials include: adding",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/54,55\">",
"     54,55",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/31/19962?source=see_link\">",
"     morphine sulfate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/56\">",
"     56",
"    </a>",
"    ], d-amphetamine or caffeine [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/57\">",
"     57",
"    </a>",
"    ], or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/2/21544?source=see_link\">",
"     ondansetron",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19408557\">",
"    <span class=\"h3\">",
"     Novel medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the limitations of current medications for OCD, medications that affect other brain neurotransmitter systems continue to be studied. Medications thought to modulate the glutamate system have shown some promise as an adjunct to SSRIs in case reports or open-label studies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/60\">",
"     60",
"    </a>",
"    ], including N-acetylcysteine (an amino-acid derivative that has glutamate-modulating properties) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/61\">",
"     61",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"     memantine",
"    </a>",
"    (a noncompetitive NMDA receptor antagonist) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/62-66\">",
"     62-66",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/31/22004?source=see_link\">",
"     riluzole",
"    </a>",
"    (an agent thought to modulate glutamate both by reducing neuronal release and increasing glial reuptake) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/67\">",
"     67",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"     minocycline",
"    </a>",
"    (an agent thought to modulate glutamate by enhancing glial glutamate transport) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88195853\">",
"    <span class=\"h1\">",
"     COMPARING PHARMACOTHERAPY AND PSYCHOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Available evidence suggests that cognitive-behavioral therapy may be more effective than treatment with serotonergic antidepressants for non-comorbid OCD. The type of cognitive-behavioral therapy commonly used for OCD uses exposure and response prevention (ERP), sometimes with adjunctive cognitive restructuring. A 12-week randomized trial compared ERP (provided intensively for 4 weeks followed by 8 weekly maintenance sessions),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"     clomipramine",
"    </a>",
"    (200 to 250",
"    <span class=\"nowrap\">",
"     mg/day),",
"    </span>",
"    ERP plus clomipramine, and pill placebo in 122 patients with OCD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/69\">",
"     69",
"    </a>",
"    ]. A greater proportion of patients responded to ERP compared to clomipramine or placebo (62 versus 42 and 8 percent, respectively). Mean OCD symptom reduction was greater in the group receiving ERP compared to patients receiving clomipramine or placebo.",
"   </p>",
"   <p>",
"    In OCD comorbid with major depression or other anxiety disorders, the serotonergic antidepressants have the additional benefit of being an effective treatment for several of these disorders (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36564?source=see_link&amp;anchor=H2#H2\">",
"     \"Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis\", section on 'Epidemiology and spectrum of disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88195842\">",
"    <span class=\"h1\">",
"     COMBINING PHARMACOTHERAPY AND PSYCHOTHERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H347653355\">",
"    <span class=\"h2\">",
"     CBT and clomipramine or SSRIs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combined therapy with medication and CBT may be more effective than monotherapy for some, but not all, patients with OCD. Studies suggest that how CBT and serotonergic antidepressants are combined (specifically the dose of each treatment and the timing of when they are combined) can influence the effectiveness of this strategy. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the aforementioned trial, the effects of exposure and response prevention (ERP) did not differ from that of ERP plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      for OCD [",
"      <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/69\">",
"       69",
"      </a>",
"      ]. This trial studied OCD patients who were relatively free of comorbid depression, and ERP was delivered in an intensive format (daily sessions for four weeks). Moreover, the CBT and clomipramine were started at the same time, such that the full effects of clomipramine were not yet realized during the CBT treatment. (See",
"      <a class=\"local\" href=\"#H88195853\">",
"       'Comparing pharmacotherapy and psychotherapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In contrast, in the two trials discussed above of effective CBT augmentation of serotonergic antidepressants, patients were already stable on a serotonergic antidepressant, and the CBT was delivered less frequently. (See",
"      <a class=\"local\" href=\"#H347653027\">",
"       'Augmentation with CBT'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88196405\">",
"    <span class=\"h2\">",
"     CBT and D-cycloserine",
"    </span>",
"    &nbsp;&mdash;&nbsp;D-cycloserine, a partial agonist at the N-methyl-D-aspartate receptor, may speed up the time to response to ERP in OCD [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/70\">",
"     70",
"    </a>",
"    ]. Specifically, three small randomized trials have compared ERP to exposure augmented by D-cycloserine [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/71-73\">",
"     71-73",
"    </a>",
"    ]. In two of the studies, D-cycloserine reduced the time to response but did not result in an increased response by the end of the trial [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23561/abstract/71,73\">",
"     71,73",
"    </a>",
"    ]. D-cycloserine&rsquo;s proposed mechanism of action is to enhance extinction learning in exposure therapy. D-cycloserine has been found to enhance fear extinction in animal models.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13853208\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend that patients with obsessive-compulsive disorder (OCD) be treated with cognitive-behavioral therapy (CBT), a selective serotonin reuptake inhibitor (SSRI) medication, or both (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      We suggest use of exposure and response prevention (a type of CBT) rather than medication as first-line treatment of non-comorbid OCD (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). An SSRI can be used in patients who prefer medication to psychotherapy, or when CBT is not available. (See",
"      <a class=\"local\" href=\"#H88195853\">",
"       'Comparing pharmacotherapy and psychotherapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34391?source=see_link\">",
"       \"Psychotherapy for obsessive-compulsive disorder\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Higher doses of antidepressants have generally been found to be more effective for OCD. As an example,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/49/15130?source=see_link\">",
"       fluoxetine",
"      </a>",
"      can be gradually titrated to 40 to 80",
"      <span class=\"nowrap\">",
"       mg/day.",
"      </span>",
"      The medication should be continued within the therapeutic range for at least six weeks before concluding that the drug is ineffective. (See",
"      <a class=\"local\" href=\"#H13853669\">",
"       'Administration and course of treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with a severe, comorbid disorder that responds to SSRI treatment, we suggest treatment of OCD with an SSRI. (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H540845640\">",
"       'Monotherapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13853573\">",
"       'Medication selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If an adequate trial of the SSRI results in no response, we suggest treatment with a second SSRI,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/45/22233?source=see_link\">",
"       venlafaxine",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H540845640\">",
"       'Monotherapy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13853573\">",
"       'Medication selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If a trial of an SSRI or SNRI results in a partial response, but the patient continues to experience clinically significant symptoms, we suggest augmenting the antidepressant with CBT or an antipsychotic medication (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/33/11802?source=see_link\">",
"       risperidone",
"      </a>",
"      0.5 to 3",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Another approach with less supporting evidence is the addition of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      (10 to 50",
"      <span class=\"nowrap\">",
"       mg/day).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H13853216\">",
"       'Augmentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      SSRIs and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/20/43336?source=see_link\">",
"       clomipramine",
"      </a>",
"      generally lead to improvement in 40 to 60 percent of people with OCD. When patients have an adequate response, practice guidelines recommend that they be maintained on the medication for at least one to two years, though more research is needed on this issue. (See",
"      <a class=\"local\" href=\"#H88195202\">",
"       'Duration of treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9285642\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Drs. Wayne Katon and Paul Ciechanowski, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/1\">",
"      Soomro GM, Altman D, Rajagopal S, Oakley-Browne M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2008; :CD001765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/2\">",
"      Ackerman DL, Greenland S. Multivariate meta-analysis of controlled drug studies for obsessive-compulsive disorder. J Clin Psychopharmacol 2002; 22:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/3\">",
"      Freeman CP, Trimble MR, Deakin JF, et al. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry 1994; 55:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/4\">",
"      Koran LM, McElroy SL, Davidson JR, et al. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol 1996; 16:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/5\">",
"      Mundo E, Maina G, Uslenghi C. Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 2000; 15:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/6\">",
"      Pigott TA, Pato MT, Bernstein SE, et al. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry 1990; 47:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/7\">",
"      L&oacute;pez-Ibor JJ Jr, Saiz J, Cottraux J, et al. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder. Eur Neuropsychopharmacol 1996; 6:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/8\">",
"      Zohar J, Judge R. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. Br J Psychiatry 1996; 169:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/9\">",
"      Bisserbe J, Lane R, Flament M, Franco-Belgian OCD Study Group. A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder. Eur Psychiatry 1997; 12:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/10\">",
"      Decloedt EH, Stein DJ. Current trends in drug treatment of obsessive-compulsive disorder. Neuropsychiatr Dis Treat 2010; 6:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/11\">",
"      Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 1999; 60:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/12\">",
"      Greist JH, Jefferson JW, Kobak KA, et al. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 1995; 52:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/13\">",
"      Yaryura-Tobias JA, Neziroglu FA. Venlafaxine in obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/14\">",
"      Denys D, van der Wee N, van Megen HJ, Westenberg HG. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. J Clin Psychopharmacol 2003; 23:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/15\">",
"      Albert U, Aguglia E, Maina G, Bogetto F. Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. J Clin Psychiatry 2002; 63:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/16\">",
"      Denys D, van Megen HJ, van der Wee N, Westenberg HG. A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. J Clin Psychiatry 2004; 65:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/17\">",
"      Dell'osso B, Mundo E, Marazziti D, Altamura AC. Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series. J Psychopharmacol 2008; 22:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/18\">",
"      Dell'Osso B, Nestadt G, Allen A, Hollander E. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review. J Clin Psychiatry 2006; 67:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/19\">",
"      Koran LM, Hanna GL, Hollander E, et al. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007; 164:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/20\">",
"      Stein DJ, Andersen EW, Tonnoir B, Fineberg N. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study. Curr Med Res Opin 2007; 23:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/21\">",
"      Hollander E, Allen A, Steiner M, et al. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. J Clin Psychiatry 2003; 64:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/22\">",
"      Montgomery SA, McIntyre A, Osterheider M, et al. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group. Eur Neuropsychopharmacol 1993; 3:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/23\">",
"      Montgomery SA, Kasper S, Stein DJ, et al. Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol 2001; 16:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/24\">",
"      Greist J, Chouinard G, DuBoff E, et al. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 1995; 52:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/25\">",
"      Bloch MH, McGuire J, Landeros-Weisenberger A, et al. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder. Mol Psychiatry 2010; 15:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/26\">",
"      Ninan PT, Koran LM, Kiev A, et al. High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trial. J Clin Psychiatry 2006; 67:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/27\">",
"      Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry 1988; 145:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/28\">",
"      Koran LM, Hackett E, Rubin A, et al. Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder. Am J Psychiatry 2002; 159:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/29\">",
"      Romano S, Goodman W, Tamura R, Gonzales J. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo. J Clin Psychopharmacol 2001; 21:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/30\">",
"      Fineberg NA, Tonnoir B, Lemming O, Stein DJ. Escitalopram prevents relapse of obsessive-compulsive disorder. Eur Neuropsychopharmacol 2007; 17:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/31\">",
"      Koran LM, Gamel NN, Choung HW, et al. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation. J Clin Psychiatry 2005; 66:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/32\">",
"      Shapira NA, Keck PE Jr, Goldsmith TD, et al. Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder. Depress Anxiety 1997; 6:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/33\">",
"      Insel TR, Hamilton JA, Guttmacher LB, Murphy DL. D-amphetamine in obsessive-compulsive disorder. Psychopharmacology (Berl) 1983; 80:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/34\">",
"      Joffe RT, Swinson RP, Levitt AJ. Acute psychostimulant challenge in primary obsessive-compulsive disorder. J Clin Psychopharmacol 1991; 11:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/35\">",
"      Joffe RT, Swinson RP. Methylphenidate in primary obsessive-compulsive disorder. J Clin Psychopharmacol 1987; 7:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/36\">",
"      McDougle CJ, Barr LC, Goodman WK, et al. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. Am J Psychiatry 1995; 152:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/37\">",
"      Connor KM, Payne VM, Gadde KM, et al. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry 2005; 66:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/38\">",
"      Carey PD, Vythilingum B, Seedat S, et al. Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]. BMC Psychiatry 2005; 5:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/39\">",
"      Fineberg NA, Sivakumaran T, Roberts A, Gale T. Adding quetiapine to SRI in treatment-resistant obsessive-compulsive disorder: a randomized controlled treatment study. Int Clin Psychopharmacol 2005; 20:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/40\">",
"      Shapira NA, Ward HE, Mandoki M, et al. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biol Psychiatry 2004; 55:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/41\">",
"      McDougle CJ, Goodman WK, Leckman JF, et al. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994; 51:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/42\">",
"      McDougle CJ, Epperson CN, Pelton GH, et al. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/43\">",
"      Bystritsky A, Ackerman DL, Rosen RM, et al. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial. J Clin Psychiatry 2004; 65:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/44\">",
"      Denys D, de Geus F, van Megen HJ, Westenberg HG. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry 2004; 65:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/45\">",
"      Storch EA, Lehmkuhl H, Geffken GR, et al. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depress Anxiety 2008; 25:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/46\">",
"      Pessina E, Albert U, Bogetto F, Maina G. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study. Int Clin Psychopharmacol 2009; 24:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/47\">",
"      Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006; 11:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/48\">",
"      Komossa K, Depping AM, Meyer M, et al. Second-generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev 2010; :CD008141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/49\">",
"      Marder SR, Essock SM, Miller AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/50\">",
"      Maina G, Albert U, Ziero S, Bogetto F. Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued? Int Clin Psychopharmacol 2003; 18:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/51\">",
"      Tenneij NH, van Megen HJ, Denys DA, Westenberg HG. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry 2005; 66:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/52\">",
"      Simpson HB, Foa EB, Liebowitz MR, et al. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry 2008; 165:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/53\">",
"      Szegedi A, Wetzel H, Leal M, et al. Combination treatment with clomipramine and fluvoxamine: drug monitoring, safety, and tolerability data. J Clin Psychiatry 1996; 57:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/54\">",
"      Van Ameringen M, Mancini C, Patterson B, Bennett M. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series. Depress Anxiety 2006; 23:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/55\">",
"      Mowla A, Khajeian AM, Sahraian A, et al. Topiramate Augmentation in Resistant OCD: A Double-Blind Placebo-Controlled Clinical Trial. CNS Spectr 2010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/56\">",
"      Koran LM, Aboujaoude E, Bullock KD, et al. Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2005; 66:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/57\">",
"      Koran LM, Aboujaoude E, Gamel NN. Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 2009; 70:1530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/58\">",
"      Pallanti S, Bernardi S, Antonini S, et al. Ondansetron augmentation in treatment-resistant obsessive-compulsive disorder: a preliminary, single-blind, prospective study. CNS Drugs 2009; 23:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/59\">",
"      Soltani F, Sayyah M, Feizy F, et al. A double-blind, placebo-controlled pilot study of ondansetron for patients with obsessive-compulsive disorder. Hum Psychopharmacol 2010; 25:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/60\">",
"      Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 2011; 132:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/61\">",
"      Lafleur DL, Pittenger C, Kelmendi B, et al. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl) 2006; 184:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/62\">",
"      Poyurovsky M, Weizman R, Weizman A, Koran L. Memantine for treatment-resistant OCD. Am J Psychiatry 2005; 162:2191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/63\">",
"      Pasquini M, Biondi M. Memantine augmentation for refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/64\">",
"      Aboujaoude E, Barry JJ, Gamel N. Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. J Clin Psychopharmacol 2009; 29:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/65\">",
"      Feusner JD, Kerwin L, Saxena S, Bystritsky A. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial. Psychopharmacol Bull 2009; 42:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/66\">",
"      Stewart SE, Jenike EA, Hezel DM, et al. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. J Clin Psychopharmacol 2010; 30:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/67\">",
"      Coric V, Taskiran S, Pittenger C, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry 2005; 58:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/68\">",
"      Rodriguez CI, Bender J Jr, Marcus SM, et al. Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial. J Clin Psychiatry 2010; 71:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/69\">",
"      Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005; 162:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/70\">",
"      Chasson GS, Buhlmann U, Tolin DF, et al. Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine. Behav Res Ther 2010; 48:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/71\">",
"      Kushner MG, Kim SW, Donahue C, et al. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry 2007; 62:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/72\">",
"      Storch EA, Merlo LJ, Bengtson M, et al. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol 2007; 22:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23561/abstract/73\">",
"      Wilhelm S, Buhlmann U, Tolin DF, et al. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 2008; 165:335.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14629 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-83.177.194.223-2AD339225F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23561=[""].join("\n");
var outline_f23_0_23561=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13853208\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12522780\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H540845640\">",
"      MONOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1492696\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12522756\">",
"      - Selective serotonin reuptake inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H594864477\">",
"      - Clomipramine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H540845838\">",
"      - Serotonin-norepinephrine reuptake inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H540846978\">",
"      Side effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H540847016\">",
"      - Selective serotonin reuptake inhibitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H540847030\">",
"      - Clomipramine",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H594864731\">",
"      - Serotonin norepinephrine reuptake inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13853573\">",
"      Medication selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13853669\">",
"      Administration and course of treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H88195202\">",
"      - Duration of treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88196066\">",
"      Other medications as monotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13853216\">",
"      AUGMENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12522843\">",
"      Antipsychotic augmentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1491626\">",
"      - Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1491675\">",
"      - Side effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H347652853\">",
"      - Administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H347653027\">",
"      Augmentation with CBT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1491859\">",
"      Other pharmacologic augmentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19408557\">",
"      - Novel medications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H88195853\">",
"      COMPARING PHARMACOTHERAPY AND PSYCHOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H88195842\">",
"      COMBINING PHARMACOTHERAPY AND PSYCHOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H347653355\">",
"      CBT and clomipramine or SSRIs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H88196405\">",
"      CBT and D-cycloserine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13853208\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9285642\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30678?source=related_link\">",
"      Deep brain stimulation for treatment of obsessive-compulsive disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/48/43783?source=related_link\">",
"      Effect of antidepressants on suicide risk in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/24/7562?source=related_link\">",
"      First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42582?source=related_link\">",
"      Obsessive-compulsive disorder in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36564?source=related_link\">",
"      Obsessive-compulsive disorder: Epidemiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34391?source=related_link\">",
"      Psychotherapy for obsessive-compulsive disorder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/63/16376?source=related_link\">",
"      Serotonin syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/28/5578?source=related_link\">",
"      Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/56/31626?source=related_link\">",
"      Unipolar depression in adults and selective serotonin reuptake inhibitors (SSRIs): Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36169?source=related_link\">",
"      Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_0_23562="Congenital cytogenetic abnormalities";
var content_f23_0_23562=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Congenital cytogenetic abnormalities",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/0/23562/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/0/23562/contributors\">",
"     Stanislawa Weremowicz, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/0/23562/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/0/23562/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/0/23562/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/0/23562/contributors\">",
"     Helen V Firth, DM, FRCP, DCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/0/23562/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/0/23562/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/0/23562/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chromosomal aberrations are due to a change in the normal chromosome number or a change in the structure of a chromosome. They may involve one, two, or more chromosomes and may involve only part of a chromosome or the whole chromosome. Congenital anomalies, growth deficiency, and intellectual disability are findings often present in individuals with chromosome abnormalities, although some cytogenetic aberrations have little to no clinical effect. Rapid progress in human cytogenetics has demonstrated a causal relationship between various chromosomal abnormalities and their phenotypic manifestations. In addition, the specific chromosomal etiologies of a wide variety of syndromes have been established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18167?source=see_link\">",
"     \"Chromosomal translocations, deletions, and inversions\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/63/5112?source=see_link\">",
"     \"Overview of genetic variation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link\">",
"     \"Genomic disorders: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic reviews the most common chromosomal abnormalities and discusses when to refer a",
"    <span class=\"nowrap\">",
"     patient/parent",
"    </span>",
"    for a genetic evaluation. Diseases caused by point mutations and other small genetic defects are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=see_link\">",
"     \"Microdeletion syndromes (chromosomes 1 to 11)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=see_link\">",
"     \"Microdeletion syndromes (chromosomes 12 to 22)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/17/37143?source=see_link\">",
"     \"Microduplication syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/50/10024?source=see_link\">",
"     \"Sex chromosome abnormalities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"     \"Clinical features and diagnosis of Down syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fifteen percent of clinically recognized pregnancies result in fetal death [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/1\">",
"     1",
"    </a>",
"    ]. Cytogenetic abnormalities are more common in spontaneous abortions (50 percent of fetal deaths&thinsp;&lt;20&thinsp;weeks) than in stillbirths (6 to 13 percent of fetal deaths&thinsp;&ge;20&thinsp;weeks). A 1998 multicenter survey of 103,069 live births in the United States (US) identified major chromosomal abnormalities in 1 in 140 live births (",
"    <a class=\"graphic graphic_table graphicRef52347 \" href=\"UTD.htm?34/3/34876\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/2\">",
"     2",
"    </a>",
"    ]. However, the incidence of chromosomal abnormalities is dependent upon the sample and population studied and the type of diagnostic testing used. As an example, the incidence is lower among live births than among abortuses, second trimester fetuses, or stillbirths. Trisomy 21 (Down syndrome) remains the most common chromosomal abnormality among liveborn infants [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnosis of chromosomal abnormalities by conventional karyotyping has several limitations compared with a subsequently developed technique based upon microarray analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/1,6,7\">",
"     1,6,7",
"    </a>",
"    ]. As an example, analysis of macerated fetuses and nonviable tissues from spontaneous abortions and stillbirths has low yield. In addition, chromosome banding techniques can only detect major structural abnormalities. Array comparative genomic hybridization (aCGH) can detect smaller copy number variations (eg, DNA gains and losses) and has a higher yield when performed on fetal tissue from pregnancy losses. Thus, aCGH may become the preferred type of testing to analyze fetal loss as it becomes more readily available, less costly, and easier to perform. The use of aCGH in prenatal diagnosis of chromosomal abnormalities and postnatal evaluation of pregnancy loss is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7208?source=see_link\">",
"     \"Use of array comparative genomic hybridization (aCGH) in obstetrics\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link&amp;anchor=H15538597#H15538597\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\", section on 'Detecting cytogenetic abnormalities'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link\">",
"     \"Genomic disorders: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Total versus live birth prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of total and live birth prevalence of trisomy 21 (Down syndrome) and other trisomies vary depending upon demographics, race, year of data collection, regional differences in prenatal screening and pregnancy termination, and maternal age. A comparison of amniocentesis and liveborn data regarding the incidence of trisomy 21 (Down syndrome) is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef75423 \" href=\"UTD.htm?16/60/17357\">",
"     table 2",
"    </a>",
"    ). The maternal age-specific rate of trisomy 21, as well as other chromosomal abnormalities, is approximately 30 percent higher when diagnosed in the early second trimester by amniocenteses than when diagnosed after birth. These differences can be explained, in part, by an increased late spontaneous fetal loss rate (after the early second trimester) for fetuses with chromosomal abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/8,9\">",
"     8,9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A European study of 21 population-based registries for the epidemiologic surveillance of congenital anomalies (EUROCAT) that included 6.1 million births from 1990 to 2009 revealed an increase in total prevalence of trisomy 21 over time to 22 in 10,000 (1 in 455) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/10\">",
"     10",
"    </a>",
"    ]. This change was attributed to an increase in the proportion of births in population to mothers aged 35 years and older from 13 percent in 1990 to 19 percent in 2009. At the same time, the live birth prevalence of trisomies 13, 18, and 21 remained stable overall (1 in 20,830 for trisomy 13, 1 in 9614 for trisomy 18, and 1 in 890 for trisomy 21). The stable live birth prevalence compared with the rise in total prevalence is most likely due to increased prenatal screening and pregnancy termination [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/10\">",
"     10",
"    </a>",
"    ], as well as an increase in fetal loss rate in trisomy pregnancies with advancing maternal age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no national registry for Down syndrome or other birth defects in the US. Thus, the exact number of trisomy 21 live births in the US is unknown. Data from the US Centers for Disease Control and Prevention indicated an increase of trisomy 21 live births by 24 percent from 1 in 1053 during the period from 1979 to 1983 to 1 in 847 from the years 1999 to 2003. In comparison, a decrease in trisomy 21 live births, from 1 in 900 in 1989 to 1 in 1070 in 2006, was seen in data based upon birth certificates from the National Center for Health Statistics (NCHS) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/12\">",
"     12",
"    </a>",
"    ]. The highest prevalence reported was from the 1998 multicenter US survey, with a rate of 1 in 730 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Data from spontaneous abortuses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-half of spontaneous abortions have an abnormal chromosomal complement (on G-banded karyotyping), which is the probable etiology of the pregnancy loss. Autosomal trisomies are strongly correlated with maternal age and account, in part, for the higher rate of spontaneous abortion in women over 40 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/7/31865?source=see_link\">",
"     \"Effect of advanced age on fertility and pregnancy in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A review of 8841 spontaneous abortions found that 41 percent had chromosomal abnormalities visible on G-banded karyotyping [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/2\">",
"     2",
"    </a>",
"    ]. The most frequent types of abnormalities detected were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Autosomal trisomies &mdash; 52 percent",
"     </li>",
"     <li>",
"      Polyploidies &mdash; 22 percent",
"     </li>",
"     <li>",
"      Monosomy X &mdash; 19 percent",
"     </li>",
"     <li>",
"      Other &mdash; 7 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Trisomy 16, with an incidence of approximately 1.5 percent in clinically recognized pregnancies, is the most common trisomy among abortuses, and is never encountered in live births [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. The cause of trisomy 16 in almost all zygotes is nondisjunction in maternal meiosis I [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/17\">",
"     17",
"    </a>",
"    ]. Embryos with full trisomy 16 are spontaneously aborted or have arrested development between 8 to 15 weeks gestational age. Some survive beyond this gestational age and are diagnosed prenatally by chorionic villus sampling or amniocentesis. These surviving embryos are virtually always mosaic as a result of trisomy rescue, a process in which one of the trisomic chromosomes is lost during mitotic cell division [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Data from stillbirths and neonatal deaths",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stillbirth in the United States is defined as a fetal loss at a gestational age greater than 20 weeks, whereas neonatal death refers to death occurring within the first four weeks after a live birth.",
"   </p>",
"   <p>",
"    In one series, karyotyping of a combined group of 823 stillbirths and neonatal deaths found a major chromosomal abnormality in 6.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/2\">",
"     2",
"    </a>",
"    ]. The frequency of abnormal karyotype in macerated stillbirths (deaths occurring during pregnancy), nonmacerated or fresh stillbirths (deaths occurring during labor or delivery), and neonatal deaths was approximately 12, 4, and 6 percent, respectively. The abnormalities reported were mostly comprised of trisomies 18, 13, and 21; sex chromosome aneuploidy; and unbalanced translocations. The frequency of chromosomal abnormality in this combined group was approximately 10-fold higher than the incidence of 0.7 percent observed in live births. In another series of 750 intrauterine fetal deaths, chromosomal abnormalities visible on G-banded karyotyping were identified in 38 and 5 percent of fetuses with and without morphologic abnormalities, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In fresh stillbirths with chromosomal abnormalities, sex chromosome abnormalities were observed in 20 percent, autosomal trisomies in 70 percent, and balanced structural rearrangements in 10 percent. In neonatal deaths, the type and frequency of chromosomal abnormalities were broader: monosomy X (7 percent), other sex chromosomal abnormalities (10 percent), autosomal trisomies (55 percent), triploidy (3 percent), balanced structural rearrangement (7 percent), unbalanced structural rearrangement (16 percent), and other unspecified chromosome abnormality (3 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fetuses with congenital anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of chromosomal abnormalities visible by G-banded karyotyping in fetuses with congenital anomalies ranges from 2 to 35 percent, with the highest rate in fetuses with multiple anomalies, as opposed to an isolated anomaly [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/21\">",
"     21",
"    </a>",
"    ]. The risk of chromosomal abnormality also varies according to the type of isolated anomaly. As an example, duodenal atresia is associated with a relatively high rate of abnormal karyotype (eg, approximately 30 percent of liveborn infants with duodenal atresia are diagnosed with trisomy",
"    <span class=\"nowrap\">",
"     21/Down",
"    </span>",
"    syndrome), whereas an isolated urinary tract anomaly carries a low rate of chromosomal abnormality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H857674\">",
"    <span class=\"h1\">",
"     WHEN TO REFER FOR GENETIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A cytogenetic abnormality may be identified during prenatal screening, or it may be suspected prenatally based upon ultrasound findings or postnatally due to congenital anomalies, growth failure, intellectual disability with or without dysmorphic features, developmental delay,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    autism. Studies used to detect cytogenetic abnormalities are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link&amp;anchor=H15538597#H15538597\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\", section on 'Detecting cytogenetic abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    All cases of stillbirth and neonatal death should be investigated to provide adequate counseling for parents regarding the cause of death and risk of recurrence in future pregnancy. The cytogenetic evaluation is an important component of perinatal necroscopy and is discussed in detail separately [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/36/31306?source=see_link\">",
"     \"Incidence, etiology, and prevention of stillbirth\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38839?source=see_link\">",
"     \"Evaluation of stillbirth\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7208?source=see_link&amp;anchor=H12423093#H12423093\">",
"     \"Use of array comparative genomic hybridization (aCGH) in obstetrics\", section on 'Fetal demise'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indications for prenatal genetic counseling and general and specific prenatal screening are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=see_link\">",
"     \"Initial prenatal assessment and patient education\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31751?source=see_link\">",
"     \"Basic principles of genetic counseling for the obstetrical provider\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/35/43576?source=see_link\">",
"     \"Routine prenatal ultrasonography as a screening tool\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22170?source=see_link\">",
"     \"Sonographic findings associated with fetal aneuploidy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28169?source=see_link\">",
"     \"Chorionic villus sampling: Risks, complications, and techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/11/16570?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnostic amniocentesis\", section on 'Prenatal diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/27/22969?source=see_link\">",
"     \"Overview of prenatal screening and diagnosis of Down syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indications for postnatal genetic counseling and testing in general for certain specific disorders are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=see_link\">",
"     \"Genetic counseling and testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=see_link\">",
"     \"Genetic and environmental causes of birth defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=see_link&amp;anchor=H30#H30\">",
"     \"Approach to congenital malformations\", section on 'Laboratory studies'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"     \"Clinical features and diagnosis of Down syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=see_link&amp;anchor=H28013163#H28013163\">",
"     \"Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis\", section on 'Chromosomal abnormalities'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=see_link&amp;anchor=H27#H27\">",
"     \"Diagnosis of autism spectrum disorders\", section on 'Genetic testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     NUMERIC ABNORMALITIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals with numerical chromosome abnormalities (aneuploidies) may have multiple congenital malformations that can involve one or more organ systems. Intellectual disability and small stature are the two most constant features; low birth weight, dysmorphic features, and failure to thrive are other frequently observed problems. The presence of mosaicism can lead to variability in the phenotype as well as the survival. Trisomies are the most common aneuploidies seen. Autosomal aneuploidies are reviewed here. Sex chromosome aneuploidies are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/50/10024?source=see_link&amp;anchor=H11420519#H11420519\">",
"     \"Sex chromosome abnormalities\", section on 'Numeric abnormalities (aneuploidies)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Trisomy 21 (Down syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trisomy 21 (MIM #190685) is the most common chromosome abnormality among live births (1 in 730 live births) and the most frequent form of intellectual disability caused by a microscopically demonstrable chromosomal aberration [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23-26\">",
"     23-26",
"    </a>",
"    ]. The three main types of cytogenetic abnormalities that result in the Down syndrome phenotype and their relative proportions are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Trisomy 21 (47,+21): approximately 95 percent.",
"     </li>",
"     <li>",
"      Robertsonian translocation involving chromosome 21 (",
"      <a class=\"graphic graphic_figure graphicRef81746 \" href=\"UTD.htm?23/3/23602\">",
"       figure 1",
"      </a>",
"      ): 3 to 4 percent. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18167?source=see_link&amp;anchor=H8#H8\">",
"       \"Chromosomal translocations, deletions, and inversions\", section on 'Robertsonian translocations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Trisomy 21 mosaicism",
"      <span class=\"nowrap\">",
"       (47,+21/46):",
"      </span>",
"      1 to 2 percent. Two populations of cell types, one with the normal 46 chromosomes and the other with 47,+21, are present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Most individuals with Down syndrome have trisomy 21 (47,+21) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23\">",
"     23",
"    </a>",
"    ]. Errors in meiosis that result in nondisjunction are almost all of maternal origin; only about 5 percent occur during spermatogenesis. This explains, in part, why the risk of this type of Down syndrome increases with advancing maternal age (",
"    <a class=\"graphic graphic_table graphicRef75423 \" href=\"UTD.htm?16/60/17357\">",
"     table 2",
"    </a>",
"    ). The recurrence rate is approximately 1 percent of the age-related risk if greater than 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In Down syndrome patients with an unbalanced Robertsonian translocation, the entire long arm of one chromosome 21 is translocated to the long arm of an acrocentric chromosome (ie, chromosome 13, 14, 15, 21, or 22) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23\">",
"     23",
"    </a>",
"    ]. The most common form of this translocation involves chromosomes 14 and 21 (46,der(14;21)(q10;q10),+21). These individuals have 46 chromosomes, but one chromosome 14 contains the long arms of both chromosomes 14 and 21. Therefore, they actually have three copies of the long arm of chromosome 21 (two normal chromosome 21s and a third long arm translocated to chromosome 14), which results in Down syndrome. Trisomy 21 resulting from a Robertsonian translocation is not related to maternal age.",
"   </p>",
"   <p>",
"    A parental carrier of a balanced Robertsonian translocation involving chromosome 21 (eg, 45,der(14;21)(q10;q10)) has an observed risk as high as 15 percent of having an offspring born with an unbalanced translocation resulting in Down syndrome (",
"    <a class=\"graphic graphic_figure graphicRef81746 \" href=\"UTD.htm?23/3/23602\">",
"     figure 1",
"    </a>",
"    ). The risk is highest if the mother, rather than the father, is the translocation carrier (10 to 15 versus 2 to 5 percent). However, the majority of translocations resulting in Down syndrome occur de novo, with only 3 to 4 percent having a familial etiology. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18167?source=see_link\">",
"     \"Chromosomal translocations, deletions, and inversions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Duplication of the long (q) arm of chromosome 21 [dup(21q)] represents a rare form of Down syndrome with an estimated incidence of about 1 in 45,000 live births. Approximately 95 percent of dup(21q) are de novo mutations. DNA polymorphism studies indicate that the majority of the de novo dup(21q) chromosomes are isochromosomes [i(21q)]. However, Robertsonian translocations [t(21q;21q)] have also been detected [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/28\">",
"     28",
"    </a>",
"    ]. Interstitial duplication of the critical region 21q22.13-q22.2, resulting in \"partial trisomy 21\", is another uncommon cause of Down syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prenatal screening and diagnosis of Down syndrome and the clinical manifestations and management of the disorder are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/27/22969?source=see_link\">",
"     \"Overview of prenatal screening and diagnosis of Down syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=see_link\">",
"     \"Clinical features and diagnosis of Down syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13224?source=see_link\">",
"     \"Management of Down syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Trisomy 18 syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The three main types of trisomy 18 (also called Edwards syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/30\">",
"     30",
"    </a>",
"    ]) are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Trisomy 18 (47,+18): Ninety percent of cases of trisomy 18 are the result of meiotic nondisjunction.",
"     </li>",
"     <li>",
"      Translocation involving chromosome 18.",
"     </li>",
"     <li>",
"      Trisomy 18 mosaicism",
"      <span class=\"nowrap\">",
"       (47,+18/46).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Trisomy 18 is the second most common autosomal trisomy observed in live births (1 in 5500 live births) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,31\">",
"     23,31",
"    </a>",
"    ]. As with trisomy 21, there is a relationship between advanced maternal age and the occurrence of trisomy 18 in offspring due to meiotic nondisjunction. There is a 3:1 female to male ratio among affected infants.",
"   </p>",
"   <p>",
"    The clinical spectrum of trisomy 18 may involve any organ system [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,32,33\">",
"     23,32,33",
"    </a>",
"    ]. The major phenotypic features include growth restriction (IUGR), hypertonia, prominent occiput, small mouth, micrognathia, pointy ears, short sternum, horseshoe kidney, and flexed fingers with the index finger overlapping the third finger and the fifth finger overlapping the fourth. Congenital heart disease occurs in greater than 50 percent of affected individuals with common valvular involvement. Ventricular septal defects and patent duct arteriosus are the most common defects. The gastrointestinal system is involved in about 75 percent of cases. Meckel's diverticulum and malrotation are the predominant abnormalities. Omphalocele is relatively common prenatally.",
"   </p>",
"   <p>",
"    The prenatal sonographic findings of trisomy 18 correspond to the physical abnormalities. Intrauterine growth restriction associated with polyhydramnios, especially in a fetus with abnormal hand positioning (&ldquo;clenched hands&rdquo;), is suggestive of this disorder. Choroid plexus cysts are common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22170?source=see_link\">",
"     \"Sonographic findings associated with fetal aneuploidy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of prenatally diagnosed cases of trisomy 18 die in utero [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/27,34\">",
"     27,34",
"    </a>",
"    ]. In a series of 23 pregnancies with diagnosed fetal trisomy 18, 14 fetuses died in utero, and the remainder died within 48 hours of birth [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/35\">",
"     35",
"    </a>",
"    ]. In general, fifty percent of affected infants die within the first two weeks of life and only 5 to 10 percent survive the first year [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,36,37\">",
"     23,36,37",
"    </a>",
"    ]. However, survival into the school-age years is possible [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/38\">",
"     38",
"    </a>",
"    ]. Severe intellectual disability is apparent in survivors over one year of age.",
"   </p>",
"   <p>",
"    A &ldquo;noninterventional paradigm&rdquo; of withdrawal of intensive treatment has been recommended for trisomy 18, because of the lethality of the disorder, the severe intellectual disability in those that survive beyond one year of age, and the lack of a cure, although acceptance of this paradigm is not universal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/31,38\">",
"     31,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite this recommendation, retroactive assessment of hospitalization data on 10,939 patients collected from the nationally representative US Kids Inpatient Databases for the years 1997, 2000, 2003, 2006, and 2009 demonstrated that children with trisomy 13 and trisomy 18 received significant inpatient medical care (eg, over 2500 major therapeutic procedures) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/38\">",
"     38",
"    </a>",
"    ]. Longer term survivors made up a sizable proportion of this group, with over one-third older than one year of age and about 10 percent over eight years of age. Data on intensive treatment of 24 Japanese patients with trisomy 18 showed a survival rate 25 percent at one year of age (median survival time 152.5 days), suggesting a role for alternative approaches to care [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Treatment and medical intervention depend upon the presence and type of major or life threatening abnormalities in the patient. Therapeutic interventions may include gastrointestinal tract, cardiac, orthopedic, and",
"    <span class=\"nowrap\">",
"     pharynx/facial/sinus",
"    </span>",
"    procedures, as well as tracheostomy. A multidisciplinary team including obstetrics, genetic counseling, pediatricians, surgeons, and social workers are important in providing information on availability of post-hospitalization care, educational programs, and support organizations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Trisomy 13 syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The three etiologies of trisomy 13 (also called Patau syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]) are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Trisomy 13 (47,+13)",
"     </li>",
"     <li>",
"      Robertsonian translocation involving the long arm of chromosome 13",
"     </li>",
"     <li>",
"      Trisomy 13 mosaicism",
"      <span class=\"nowrap\">",
"       (47,+13/46)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The majority of cases of trisomy 13 syndrome are caused by nondisjunction (47,+13) related to advanced maternal age. A spontaneous unbalanced Robertsonian translocation involving chromosome 13 and another acrocentric chromosome is less common. These individuals have 46 chromosomes, one of which consists of the long arms of chromosomes 13 and another acrocentric chromosome (eg, 13, 14, 15, 21, 22). Although a balanced Robertsonian translocation involving chromosome 13 and 14 (ie, 45,t(13;14)(q10;q10)) is relatively common (approximately 1 in 1000 live births), there is a low risk of bearing offspring with an unbalanced chromosome complement because of the high rate (98 to 99 percent) of early embryonic death [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/2,41\">",
"     2,41",
"    </a>",
"    ]. Mosaicism for trisomy 13 also occurs.",
"   </p>",
"   <p>",
"    The major phenotypic features of trisomy 13 are the result of an early defect in development of the prechordal mesoderm, which is the origin of the midface, eye, and forebrain. These abnormalities include holoprosencephaly, absence of the olfactory nerve or bulb, sloping forehead, severe eye defects (especially microphthalmia and coloboma [fissure or cleft of the iris, ciliary body, or choroid]), deafness, and cleft lip",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    palate [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/42-47\">",
"     42-47",
"    </a>",
"    ]. Other defects that may be observed are omphalocele or umbilical hernia, genitourinary abnormalities, superficial hemangiomas, scalp defects, polydactyly, narrow convex fingernails, rocker bottom feet (congenital vertical talus), and congenital heart defects.",
"   </p>",
"   <p>",
"    Prenatal sonographic findings of the characteristic central nervous system defects are the most common fetal signs suggestive of this diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22170?source=see_link\">",
"     \"Sonographic findings associated with fetal aneuploidy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/44/2762?source=see_link\">",
"     \"Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The majority of prenatally diagnosed cases of trisomy 13 die in utero [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/27,34\">",
"     27,34",
"    </a>",
"    ]. Approximately 80 percent of affected infants die within the first month of life and only 5 percent survive the first six months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,34,41\">",
"     23,34,41",
"    </a>",
"    ]. Intensive treatments, including resuscitation and surgical procedures, may prolong survival. As an example, a retrospective study from 1989 to 2010 that included 16 Japanese patients with trisomy 13 who had received intensive treatment showed a median survival time of 24 months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/48\">",
"     48",
"    </a>",
"    ]. Severe intellectual disability, seizures, and failure to thrive are common in survivors over one year of age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,41,49\">",
"     23,41,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with trisomy 18, a &ldquo;noninterventional paradigm&rdquo; of providing supportive but not intensive treatment has been recommended for trisomy 13, because of the high mortality of the disorder, the severe intellectual disability in those that survive beyond one year of age, and the lack of a cure [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/31,38\">",
"     31,38",
"    </a>",
"    ]. However, acceptance of this paradigm is not universal, because survival beyond infancy is possible, particularly in those who receive intensive treatment. Options for management of trisomy 13 are similar to that for trisomy 18. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Trisomy 18 syndrome'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Trisomy 8 syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Full trisomy 8 is estimated to occur in 0.1 percent of all clinically recognized pregnancies and is usually lethal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/50\">",
"     50",
"    </a>",
"    ]. Trisomy 8 is almost always a mosaic form",
"    <span class=\"nowrap\">",
"     (47,+8/46)",
"    </span>",
"    in liveborn infants. The estimated frequency of mosaic trisomy 8 in liveborn infants is 1 in 25,000 to 1 in 50,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/51\">",
"     51",
"    </a>",
"    ]. A skewed sex ratio (3:1 male:female) is observed in mosaic cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasonographic detection of agenesis of the corpus callosum and ventriculomegaly should alert to the possibility of mosaic trisomy 8 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/54\">",
"     54",
"    </a>",
"    ]. In addition, mosaic trisomy 8 is sometimes associated with an elevated maternal serum alpha-fetoprotein. A diagnosis of mosaic trisomy 8 can be difficult to establish and can be missed at amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/55\">",
"     55",
"    </a>",
"    ]. A normal chromosome constitution in lymphocyte culture does not exclude trisomy 8 mosaicism, since abnormal cell lines are far more likely to be detected in fibroblast cultures (eg, skin biopsy, or other tissues) than in lymphocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/56\">",
"     56",
"    </a>",
"    ], making the condition difficult to diagnose.",
"   </p>",
"   <p>",
"    Trisomy 8 mosaicism is also difficult to diagnose postnatally due to great phenotypic variation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,50,51,57,58\">",
"     23,50,51,57,58",
"    </a>",
"    ]. The severity of the phenotype does not appear to correlate with the level (ie, percentage) and distribution of the trisomic cells in tissue types [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/59\">",
"     59",
"    </a>",
"    ]. Characteristic phenotypic features include agenesis of corpus callosum, ventriculomegaly, skeletal and joint abnormalities, congenital heart defects, deep palmar and plantar creases, facial dysmorphism, and moderate to severe intellectual disability. The growth of children with trisomy 8 is variable, ranging from small to tall stature. Life expectancy is usually normal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Molecular studies revealed that trisomy 8 mosaicism in liveborns almost always originates from postzygotic mitotic error [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/52,60\">",
"     52,60",
"    </a>",
"    ]. Parental ages of liveborn infants with trisomy 8 mosaicism are usually not increased [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/61\">",
"     61",
"    </a>",
"    ], and cases with uniparental disomy (UPD) 8 are rare because they can only originate from a meiotic nondisjunction error.",
"   </p>",
"   <p>",
"    Genetic counseling is difficult due to great phenotypic variability. Prognosis, management, and treatment depend upon the specific clinical abnormalities in the patient (eg, repair of cleft palate or heart defects, surgical intervention for hydronephrosis). Patients and families should be made aware of a possible association with malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/62\">",
"     62",
"    </a>",
"    ]. Early assessment for intellectual disability is recommended for additional assistance in providing special education programs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Trisomy 9 syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Full trisomy 9 occurs in approximately 0.1 percent of conceptions, and is almost always lethal [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/63\">",
"     63",
"    </a>",
"    ]. The phenotype appears to be similar in the several liveborn infants described so far, and consists of severe growth restriction, characteristic facial appearance (eg, micrognathia, bulbous nose, low set ears), cleft palate, skeletal abnormalities (eg, dislocated joins), heart abnormalities (eg, ventricular septal defect), hypoplastic genitalia, and renal and brain abnormalities. The survival time after birth varies between minutes to nine months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/64-66\">",
"     64-66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of liveborn individuals with trisomy 9 have a mosaic karyotype",
"    <span class=\"nowrap\">",
"     (47,+9/46)",
"    </span>",
"    that may be detected in amniocytes or a peripheral blood sample [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/56,57,64,65\">",
"     56,57,64,65",
"    </a>",
"    ]. The constellation of phenotypic abnormalities of trisomy 9 mosaicism is similar to that seen in liveborn infants with full trisomy 9 described above [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,56,57,64,65,67\">",
"     23,56,57,64,65,67",
"    </a>",
"    ]. Failure to thrive, severe intellectual and motor deficiency, cryptorchidism in males, and renal cysts are common. Death typically occurs at &lt;1 year of age, although longer survival intervals have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/65,68,69\">",
"     65,68,69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon molecular studies, it appears that trisomy 9 is caused by a meiotic error, and subsequent trisomy rescue leads to mosaicism in surviving embryos. In some cases, uniparental disomy (UPD) has been documented in the diploid cell line [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/70\">",
"     70",
"    </a>",
"    ]. Association with advanced maternal age is observed, similar to other trisomy syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=see_link\">",
"     \"Glossary of genetic terms\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The percentage of mosaicism appears not to correlate with clinical manifestations, and does not help to predict survival. Medical intervention depends upon the presence and severity of abnormalities. Genetic counseling and early assessment is recommended to provide any necessary special",
"    <span class=\"nowrap\">",
"     medical/educational",
"    </span>",
"    assistance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Other rare autosomal trisomies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other autosomal trisomies are rare and have been described largely in case reports. Most of these individuals have a mosaic karyotype. Mosaic trisomy 14",
"    <span class=\"nowrap\">",
"     (47,+14/46)",
"    </span>",
"    is associated with growth and intellectual disability, congenital heart defects (especially tetralogy of Fallot and septal defects), and body",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    facial asymmetry [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/56,71-74\">",
"     56,71-74",
"    </a>",
"    ]. Trisomy 22 can occur as a mosaic or full trisomy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/75-81\">",
"     75-81",
"    </a>",
"    ]. The major clinical features are intrauterine growth restriction, microcephaly, abnormal ears, ear tags, webbed",
"    <span class=\"nowrap\">",
"     neck/redundant",
"    </span>",
"    skin, congenital heart defects, renal abnormalities, and long fingers. Nonmosaic trisomy 22 usually ends in miscarriage; survival beyond the early neonatal period is rare, but has been reported.",
"   </p>",
"   <p>",
"    The risk level of having documented malformations associated with a given trisomic mosaicism, based upon cases diagnosed prenatally through amniocentesis and assessed at birth or at pregnancy termination, is as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/56\">",
"     56",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Trisomic mosaicism of chromosome 2, 16, or 22 &mdash; greater than 60 percent",
"     </li>",
"     <li>",
"      Trisomic mosaicism of chromosome 5, 9, 14, or 15 &mdash; 40 to 59 percent",
"     </li>",
"     <li>",
"      Trisomy 12 mosaicism &mdash; 26 percent",
"     </li>",
"     <li>",
"      Trisomy 7 mosaicism &mdash; up to 19 percent",
"     </li>",
"     <li>",
"      Trisomy 17 mosaicism &mdash; low",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prognoses of the remaining rare trisomies have not been determined due to insufficient data [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18961578\">",
"    <span class=\"h2\">",
"     Triploidy syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Triploidy occurs in 1 to 3 percent of clinically recognized pregnancies and accounts for approximately 20 percent of spontaneous abortions [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/82\">",
"     82",
"    </a>",
"    ]. The frequency in liveborn infants is estimated at 1 in 10,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/83\">",
"     83",
"    </a>",
"    ]. Triploid fetuses that survive to the third trimester usually have severe intrauterine growth restriction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Triploidy refers to a complete extra set of haploid chromosomes derived from the mother (digynic) or the father (diandric). Digynic triploidy can result from fertilization of a diploid ovum due to an error at either the first or second meiotic division. Diandric triploidy may occur through fertilization of a normal ovum by a diploid sperm or by two sperm",
"    <span class=\"nowrap\">",
"     (dispermy/double",
"    </span>",
"    fertilization) and is more common than digynic triploidy (90 versus 10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two distinct phenotypes have been noted due to an imprinting effect that depends upon the origin of the extra haploid set [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/84,85\">",
"     84,85",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/46/43750?source=see_link&amp;anchor=H4564852#H4564852\">",
"     \"Non-Mendelian inheritance patterns of monogenic diseases\", section on 'Parent-of-origin effects'",
"    </a>",
"    ). When the triploid is diandric, the placenta is enlarged and the histology is consistent with a partial hydatidiform mole (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13816?source=see_link\">",
"     \"Gestational trophoblastic disease: Pathology\"",
"    </a>",
"    ). The fetus is mildly growth restricted with either head size proportionate to the trunk size or mild microcephaly. By comparison, a digynic triploid is associated with severe fetal growth restriction, relative macrocephaly, and a small, noncystic placenta. The digynic triploid fetus tends to survive longer than the diandric triploid, although there is 100 percent mortality (usually intrauterine, rarely within a few months of birth). Fetuses with diploid or triploid mosaicism may be viable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11375661\">",
"    <span class=\"h2\">",
"     Supernumerary marker chromosome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The term supernumerary marker chromosome (SMC) refers to any extra, small, structurally altered chromosome in addition to the normal diploid cell line. SMCs were often uncharacterized by conventional cytogenetic methods due to insufficient banding pattern. Modern molecular technologies, such as fluorescent in situ hybridization (FISH) and array comparative genomic hybridization (aCGH) have allowed determination of marker chromosomes deriving from all 46 chromosomes. The overall incidence of SMC is similar at amniocentesis and in newborns, 0.6 to 1.5 and 0.72 per 1000, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/86-89\">",
"     86-89",
"    </a>",
"    ]. The four most common SMCs are discussed below. The terms pter and qter refer to the terminal parts of the short and long arms of a chromosome, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11375668\">",
"    <span class=\"h3\">",
"     47,+inv dup(15)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This SMC is derived from chromosome 15 with an inverted duplication (inv dup) of 15pter to 15q12 or 15q13. It is the most common marker found at amniocentesis. In two large studies, the inv dup(15) accounted for 57 and 25 percent of all markers detected in 39,105 and 100,000 prenatal diagnoses, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/88,89\">",
"     88,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postnatal studies have demonstrated a correlation between a medium to large size inv dup(15) and an abnormal phenotype that includes intellectual disability, developmental delay, early central hypotonia, seizures, and autistic behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/90,91\">",
"     90,91",
"    </a>",
"    ]. The prognosis is particularly unfavorable when the region specific for",
"    <span class=\"nowrap\">",
"     Prader-Willi/Angelman",
"    </span>",
"    syndrome is present in the inv dup(15) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/86,92,93\">",
"     86,92,93",
"    </a>",
"    ]. Thus, it is essential to determine whether the 47,+inv dup(15) marker chromosome contains the",
"    <span class=\"nowrap\">",
"     Prader-Willi/Angelman",
"    </span>",
"    syndrome-critical region when the SMC is prenatally identified as a de novo inv dup(15). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16516?source=see_link\">",
"     \"Epidemiology and genetics of Prader-Willi syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of Prader-Willi syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=see_link&amp;anchor=H86261867#H86261867\">",
"     \"Microdeletion syndromes (chromosomes 12 to 22)\", section on '15q11-13 maternal deletion syndrome (Angelman syndrome)'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=see_link&amp;anchor=H8964746#H8964746\">",
"     \"Microdeletion syndromes (chromosomes 12 to 22)\", section on '15q11-13 paternal deletion syndrome (Prader-Willi syndrome)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11375675\">",
"    <span class=\"h3\">",
"     47,+i(18p)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This supernumerary marker chromosome is an isochromosome consisting of two identical copies of the entire short (p) arm of chromosome 18, i(18p). It is one of the most commonly observed isochromosomes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/94\">",
"     94",
"    </a>",
"    ]. In the majority of cases, nondisjunction of chromosome 18 occurs in maternal meiosis II, followed by centromeric misdivision [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/95\">",
"     95",
"    </a>",
"    ]. Mosaic cases (ie,",
"    <span class=\"nowrap\">",
"     47,+i(18p)/46)",
"    </span>",
"    are rare.",
"   </p>",
"   <p>",
"    Isochromosome 18p is associated with a distinctive syndrome that results from tetrasomy 18p. The most common clinical features include growth retardation, neonatal hypotonia and feeding problems, microcephaly, facial dysmorphism [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/96\">",
"     96",
"    </a>",
"    ], cardiac abnormalities (eg, patent ductus arteriosus, ventricular septal defect, atrial septal defect), cryptorchidism, talipes equinovarus (clubfoot), congenital hip dysplasia, and mild to moderate intellectual disability and developmental delay [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most cases of tetrasomy 18p are sporadic, although familial cases have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/98,99\">",
"     98,99",
"    </a>",
"    ]. Parental chromosome analysis is recommended for a recurrent risk evaluation.",
"   </p>",
"   <p>",
"    Evaluations for patients with tetrasomy 18p depend upon the clinical features present and may include evaluations by ophthalmology, otolaryngology and audiology, cardiology, orthopedics, neurology, endocrinology, and gastroenterology. Patients may also benefit from referral for developmental services and specific medical treatment for congenital anomalies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11375682\">",
"    <span class=\"h3\">",
"     47,+i(12p)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This supernumerary marker is an isochromosome consisting of two copies of the short (p) arm of chromosome 12. Mosaicism with a normal cell line frequently occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/100,101\">",
"     100,101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Isochromosome 12p results in tetrasomy 12p, also called Pallister-Killian syndrome (MIM #601803). The exact prevalence of Pallister-Killian syndrome is unknown. It may be underdiagnosed because of broad phenotype variability. The major clinical manifestations are severe intellectual disability, seizures, hypotonia with subsequent contractures, coarse and dysmorphic facies, large and abnormal ears, short neck, and sparse hair [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,102,103\">",
"     23,102,103",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chromosome analysis (ie, karyotype, FISH, aCGH) is recommended in suspected cases of Pallister-Killian syndrome. Cells with 47,+i(12p) are tissue specific in mosaic cases and are more likely to be detected in skin fibroblasts than in peripheral blood lymphocyte cultures [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/86\">",
"     86",
"    </a>",
"    ]. Thus, different types of tissue (eg, skin biopsy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    buccal smears) should be submitted for testing.",
"   </p>",
"   <p>",
"    Early evaluation assessment for abnormalities requiring surgical intervention is recommended. Some patients will require multiple corrective surgeries. Enrollment in special education programs should be considered for patients with milder developmental delay.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11375689\">",
"    <span class=\"h3\">",
"     47,+inv dup(22)(q11)",
"    </span>",
"    &nbsp;&mdash;&nbsp;This supernumerary bisatellited marker is derived from an inverted duplication of the short arm (p) and proximal long arm (q) of chromosome 22 (ie, inv dup 22pter&mdash;22q11.2), resulting in tetrasomy of this region of chromosome 22. This defect is associated with cat-eye syndrome, a developmental disorder characterized by a highly variable phenotype [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/104,105\">",
"     104,105",
"    </a>",
"    ]. Cat-eye syndrome can be the result of trisomy or tetrasomy 22q. The name is derived from the vertical iris coloboma. Characteristic clinical features include preauricular tags",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pits, iris coloboma, congenital heart disease (total anomalous pulmonary venous return [TAPVR] is the characteristic defect associated with this condition), anal anomalies, renal malformation, skeletal abnormalities, and intellectual disability. The clinical manifestation may vary from very mild to a full pattern and lethal outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/106-108\">",
"     106-108",
"    </a>",
"    ]. Chromosome analysis of parents is recommended in children in whom the inv dup(22)(q11) chromosome is detected by cytogenetic analysis due to the significant phenotypic variation.",
"   </p>",
"   <p>",
"    Patients with cat-eye syndrome should be assessed at birth for presence of heart, biliary, and anorectal abnormalities. Early intervention and treatment can prevent possible future complications including patient death.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     STRUCTURAL DEFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Structural chromosomal defects include deletions, duplications, translocations, and inversions. Cytogenetically detectable autosomal deletions are present in 1 in 7000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/109\">",
"     109",
"    </a>",
"    ]. The incidence of autosomal duplications is unknown. The more common autosomal deletion and duplication syndromes that are primarily caused by macrodeletions or duplications (deletions or duplications detectable on chromosomal banding with light microscopy) are discussed below. Syndromes that are typically caused by submicroscopic deletions or duplications (microdeletions or microduplications) are reviewed in detail elsewhere. Structural defects of the sex chromosomes are also covered elsewhere. The mechanisms for structural chromosomal defects are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=see_link\">",
"     \"Microdeletion syndromes (chromosomes 1 to 11)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=see_link\">",
"     \"Microdeletion syndromes (chromosomes 12 to 22)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/17/37143?source=see_link\">",
"     \"Microduplication syndromes\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/50/10024?source=see_link\">",
"     \"Sex chromosome abnormalities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link\">",
"     \"Genomic disorders: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18167?source=see_link\">",
"     \"Chromosomal translocations, deletions, and inversions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     5p deletion syndrome (cri-du-chat syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cri-du-chat (cat cry) (MIM #123450) is a deletion syndrome, with an incidence of approximately 1 in 45,000 liveborn infants [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/110,111\">",
"     110,111",
"    </a>",
"    ]. Approximately 85 percent of cases result from a de novo partial deletion of the short arm of chromosome 5 (the deleted chromosome is of paternal origin in 80 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23\">",
"     23",
"    </a>",
"    ]. The remaining cases derive from a parental translocation involving 5p. The critical region for the high-pitched cat-like crying is 5p15.3, while the remaining clinical features of this syndrome are mapped to a smaller region within 5p15.2 (",
"    <a class=\"graphic graphic_figure graphicRef66560 \" href=\"UTD.htm?32/23/33150\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/112-114\">",
"     112-114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with cri-du-chat or cat cry syndrome have a mew-like cry early on in life that quickly resolves (apparently related to vocal cord abnormalities) and low birth weight, failure to thrive, hypotonia, psychomotor delay, intellectual disability, microcephaly, hypertelorism, round face, downslanting palpebral fissures, broad nasal bridge, and low-set",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    malformed ears [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,111,115,116\">",
"     23,111,115,116",
"    </a>",
"    ]. Genotype-phenotype correlation in one series of 62 patients with terminal deletions showed progressive severity of clinical features (eg, degree of microcephaly) and psychomotor retardation according to the size of the deletion [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/116\">",
"     116",
"    </a>",
"    ]. With advancing age, the clinical manifestations become less striking, making diagnosis more difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/117\">",
"     117",
"    </a>",
"    ]. Most children, but not all, have low weight for age, and to a lesser extent, shortened height for age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/118\">",
"     118",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     18q deletion syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;18q deletion syndrome (MIM #601808) is caused by deletions in the distal (terminal) portion of the long arm of chromosome 18 (18qter), involving genetic material from the region 18q21.3 to 18q22.2 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/119\">",
"     119",
"    </a>",
"    ]. These deletions are associated with variable clinical features including growth delay (some with growth hormone deficiency), intellectual disability, autoimmune disorders, selective immunoglobulin A (IgA) deficiency, microcephaly, midface hypoplasia, flat philtrum, carp-shaped mouth, broad nasal bridge, hearing impairment, eye anomalies, tapered fingers, and excess whorls on the fingertips [",
"    <a class=\"abstract\" href=\"UTD.htm?23/0/23562/abstract/23,119-124\">",
"     23,119-124",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H71\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A major chromosomal abnormality is found in approximately 1 in 140 live births. Trisomy 21 (Down syndrome) is the most common congenital cytogenetic abnormality. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Incidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Individuals with unbalanced autosomal aberrations may have congenital abnormalities that can involve one or more organ systems. Intellectual disability and small stature are the two most constant features. Low birth weight and failure to thrive are other frequently observed problems. Trisomies are the most common aneuploidies seen. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Numeric abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Autosomal trisomies, with the exception of trisomy 21 (Down syndrome), are almost always lethal. Mosaicism alters survivorship for some autosomal trisomies. Survival can be prolonged by application of intensive medical intervention. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Numeric abnormalities'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The term supernumerary marker chromosome (SMC) refers to any extra, small, structurally altered chromosome in addition to the normal diploid cell line. Identification and characterization of marker chromosomes has diagnostic and prognostic value, and may provide information for a more accurate estimation of recurrence risk. (See",
"      <a class=\"local\" href=\"#H11375661\">",
"       'Supernumerary marker chromosome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Structural chromosomal defects include deletions, duplications, translocations, and inversions. Cri-du-chat (cat cry) syndrome is one of the most common human deletion syndromes. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Structural defects'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/1\">",
"      Reddy UM, Page GP, Saade GR. The role of DNA microarrays in the evaluation of fetal death. Prenat Diagn 2012; 32:371.",
"     </a>",
"    </li>",
"    <li>",
"     Hsu LYF. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Genetic disorders and the fetus, 4th ed, Milunsky A (Ed), The Johns Hopkins University Press, Baltimore 1998. p.179.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001. MMWR Morb Mortal Wkly Rep 2006; 54:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/4\">",
"      Collins VR, Muggli EE, Riley M, et al. Is Down syndrome a disappearing birth defect? J Pediatr 2008; 152:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/5\">",
"      Weijerman ME, van Furth AM, Vonk Noordegraaf A, et al. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr 2008; 152:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/6\">",
"      Warren JE, Turok DK, Maxwell TM, et al. Array comparative genomic hybridization for genetic evaluation of fetal loss between 10 and 20 weeks of gestation. Obstet Gynecol 2009; 114:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/7\">",
"      Shaffer LG, Dabell MP, Fisher AJ, et al. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat Diagn 2012; 32:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/8\">",
"      Hook EB. Spontaneous deaths of fetuses with chromosomal abnormalities diagnosed prenatally. N Engl J Med 1978; 299:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/9\">",
"      Hook EB. Chromosome abnormalities and spontaneous fetal death following amniocentesis: further data and associations with maternal age. Am J Hum Genet 1983; 35:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/10\">",
"      Loane M, Morris JK, Addor MC, et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet 2013; 21:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/11\">",
"      Savva GM, Morris JK, Mutton DE, Alberman E. Maternal age-specific fetal loss rates in Down syndrome pregnancies. Prenat Diagn 2006; 26:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/12\">",
"      Egan JF, Smith K, Timms D, et al. Demographic differences in Down syndrome livebirths in the US from 1989 to 2006. Prenat Diagn 2011; 31:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/13\">",
"      Kratzer PG, Golbus MS, Schonberg SA, et al. Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing maternal age. Am J Med Genet 1992; 44:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/14\">",
"      Hassold T, Chiu D. Maternal age-specific rates of numerical chromosome abnormalities with special reference to trisomy. Hum Genet 1985; 70:11.",
"     </a>",
"    </li>",
"    <li>",
"     Warburton D, Kline J, Stein Z, et al. Cytogenetic abnormalities in spontaneous abortions of recognized conception. In: Perinatal genetics diagnosis and treatment, Porter IH, Willey A (Eds), Academic Press, New York 1986. p.133.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/16\">",
"      Wolstenholme J. An audit of trisomy 16 in man. Prenat Diagn 1995; 15:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/17\">",
"      Langlois S, Yong PJ, Yong SL, et al. Postnatal follow-up of prenatally diagnosed trisomy 16 mosaicism. Prenat Diagn 2006; 26:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/18\">",
"      Yong PJ, Barrett IJ, Kalousek DK, Robinson WP. Clinical aspects, prenatal diagnosis, and pathogenesis of trisomy 16 mosaicism. J Med Genet 2003; 40:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/19\">",
"      Korteweg FJ, Bouman K, Erwich JJ, et al. Cytogenetic analysis after evaluation of 750 fetal deaths: proposal for diagnostic workup. Obstet Gynecol 2008; 111:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/20\">",
"      Alberman ED, Creasy MR. Frequency of chromosomal abnormalities in miscarriages and perinatal deaths. J Med Genet 1977; 14:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/21\">",
"      Staebler M, Donner C, Van Regemorter N, et al. Should determination of the karyotype be systematic for all malformations detected by obstetrical ultrasound? Prenat Diagn 2005; 25:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/22\">",
"      Michalski ST, Porter J, Pauli RM. Costs and consequences of comprehensive stillbirth assessment. Am J Obstet Gynecol 2002; 186:1027.",
"     </a>",
"    </li>",
"    <li>",
"     Jones KL. Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/24\">",
"      Reeves RH, Baxter LL, Richtsmeier JT. Too much of a good thing: mechanisms of gene action in Down syndrome. Trends Genet 2001; 17:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/25\">",
"      Sheets KB, Crissman BG, Feist CD, et al. Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the national society of genetic counselors. J Genet Couns 2011; 20:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/26\">",
"      Chandra N, Cyril C, Lakshminarayana P, et al. Cytogenetic evaluation of Down syndrome: A review of 1020 referral cases. Int J Hum Genet 2010; 10:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/27\">",
"      Alberman E, Mutton D, Morris JK. Cytological and epidemiological findings in trisomies 13, 18, and 21: England and Wales 2004-2009. Am J Med Genet A 2012; 158A:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/28\">",
"      Antonarakis SE, Adelsberger PA, Petersen MB, et al. Analysis of DNA polymorphisms suggests that most de novo dup(21q) chromosomes in patients with Down syndrome are isochromosomes and not translocations. Am J Hum Genet 1990; 47:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/29\">",
"      Epstein CJ, Korenberg JR, Anner&eacute;n G, et al. Protocols to establish genotype-phenotype correlations in Down syndrome. Am J Hum Genet 1991; 49:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/30\">",
"      EDWARDS JH, HARNDEN DG, CAMERON AH, et al. A new trisomic syndrome. Lancet 1960; 1:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/31\">",
"      Kosho T, Nakamura T, Kawame H, et al. Neonatal management of trisomy 18: clinical details of 24 patients receiving intensive treatment. Am J Med Genet A 2006; 140:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/32\">",
"      Lin HY, Lin SP, Chen YJ, et al. Clinical characteristics and survival of trisomy 18 in a medical center in Taipei, 1988-2004. Am J Med Genet A 2006; 140:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/33\">",
"      Pont SJ, Robbins JM, Bird TM, et al. Congenital malformations among liveborn infants with trisomies 18 and 13. Am J Med Genet A 2006; 140:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/34\">",
"      Lakovschek IC, Streubel B, Ulm B. Natural outcome of trisomy 13, trisomy 18, and triploidy after prenatal diagnosis. Am J Med Genet A 2011; 155A:2626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/35\">",
"      Burke AL, Field K, Morrison JJ. Natural history of fetal trisomy 18 after prenatal diagnosis. Arch Dis Child Fetal Neonatal Ed 2013; 98:F152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/36\">",
"      Rasmussen SA, Wong LY, Yang Q, et al. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 2003; 111:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/37\">",
"      Vendola C, Canfield M, Daiger SP, et al. Survival of Texas infants born with trisomies 21, 18, and 13. Am J Med Genet A 2010; 152A:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/38\">",
"      Nelson KE, Hexem KR, Feudtner C. Inpatient hospital care of children with trisomy 13 and trisomy 18 in the United States. Pediatrics 2012; 129:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/39\">",
"      PATAU K, SMITH DW, THERMAN E, et al. Multiple congenital anomaly caused by an extra autosome. Lancet 1960; 1:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/40\">",
"      Wyllie JP, Wright MJ, Burn J, Hunter S. Natural history of trisomy 13. Arch Dis Child 1994; 71:343.",
"     </a>",
"    </li>",
"    <li>",
"     Tolmie JL. Down syndrome and other autosomal trisomies. In: Emery and Rimoin's principles and practice of medical genetics, 3rd ed, Rimoin DL, Connor JM, Pyeritz RE (Eds), Churchill Livingstone, 1996. p.925.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/42\">",
"      Baty BJ, Blackburn BL, Carey JC. Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 1994; 49:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/43\">",
"      Baty BJ, Jorde LB, Blackburn BL, Carey JC. Natural history of trisomy 18 and trisomy 13: II. Psychomotor development. Am J Med Genet 1994; 49:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/44\">",
"      Hall HE, Chan ER, Collins A, et al. The origin of trisomy 13. Am J Med Genet A 2007; 143A:2242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/45\">",
"      Plaiasu V, Ochiana D, Motei G, et al. Clinical relevance of cytogenetics to pediatric practice. Postnatal findings of Patau syndrome - Review of 5 cases. Maedica (Buchar) 2010; 5:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/46\">",
"      Jinawath N, Zambrano R, Wohler E, et al. Mosaic trisomy 13: understanding origin using SNP array. J Med Genet 2011; 48:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/47\">",
"      Griffith CB, Vance GH, Weaver DD. Phenotypic variability in trisomy 13 mosaicism: two new patients and literature review. Am J Med Genet A 2009; 149A:1346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/48\">",
"      Tsukada K, Imataka G, Suzumura H, Arisaka O. Better prognosis in newborns with trisomy 13 who received intensive treatments: a retrospective study of 16 patients. Cell Biochem Biophys 2012; 63:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/49\">",
"      Bruns D. Birth history, physical characteristics, and medical conditions in long-term survivors with full trisomy 13. Am J Med Genet A 2011; 155A:2634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/50\">",
"      Riccardi VM. Trisomy 8: an international study of 70 patients. Birth Defects Orig Artic Ser 1977; 13:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/51\">",
"      Chen CP, Chen M, Pan YJ, et al. Prenatal diagnosis of mosaic trisomy 8: clinical report and literature review. Taiwan J Obstet Gynecol 2011; 50:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/52\">",
"      Karadima G, Bugge M, Nicolaidis P, et al. Origin of nondisjunction in trisomy 8 and trisomy 8 mosaicism. Eur J Hum Genet 1998; 6:432.",
"     </a>",
"    </li>",
"    <li>",
"     Schinzel A. Trisomy 8 mosaicism. In: Catalogue of unbalanced chromosome aberrations in man, 2nd ed, Schinzel A.  (Ed), Water de Gunter, GmbH&amp;Co, Berlin 2001. p.384.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/54\">",
"      Miller K, Arslan-Kirchner A, Schulze B, et al. Mosaicism in trisomy 8: phenotype differences according to tissular repartition of normal and trisomic clones. Ann Genet 1997; 40:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/55\">",
"      van Haelst MM, Van Opstal D, Lindhout D, Los FJ. Management of prenatally detected trisomy 8 mosaicism. Prenat Diagn 2001; 21:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/56\">",
"      Hsu LY, Yu MT, Neu RL, et al. Rare trisomy mosaicism diagnosed in amniocytes, involving an autosome other than chromosomes 13, 18, 20, and 21: karyotype/phenotype correlations. Prenat Diagn 1997; 17:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/57\">",
"      Schinzel A. Trisomy 8 and trisomy 9 are distinctly different clinical entities. Am J Med Genet 1993; 46:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/58\">",
"      G&uuml;n I, Akpak YK, M&uuml;ngen E. Common sonographic characteristics of trisomy 8 mosaicism. Int J Gynaecol Obstet 2012; 119:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/59\">",
"      Katz-Fuller B, Raff R, Eggermann T, et al. Longitudinal study in patient with trisomy 8 mosaicism: Cytogenetic and molecular-genetic investigations over a period of eleven years. Int J Hum Genet 2002; 2:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/60\">",
"      Webb AL, Wolstenholme J, Evans J, et al. Prenatal diagnosis of mosaic trisomy 8 with investigations of the extent and origin of trisomic cells. Prenat Diagn 1998; 18:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/61\">",
"      James RS, Jacobs PA. Molecular studies of the aetiology of trisomy 8 in spontaneous abortions and the liveborn population. Hum Genet 1996; 97:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/62\">",
"      Danesino C, Pasquali F, Dellavecchia C, et al. Constitutional trisomy 8 mosaicism: mechanism of origin, phenotype variability, and risk of malignancies. Am J Med Genet 1998; 80:540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/63\">",
"      Machin GA, Crolla JA. Chromosome constitution of 500 infants dying during the perinatal period. With an appendix concerning other genetic disorders among these infants. Humangenetik 1974; 23:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/64\">",
"      Arnold GL, Kirby RS, Stern TP, Sawyer JR. Trisomy 9: review and report of two new cases. Am J Med Genet 1995; 56:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/65\">",
"      Wooldridge J, Zunich J. Trisomy 9 syndrome: report of a case with Crohn disease and review of the literature. Am J Med Genet 1995; 56:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/66\">",
"      Mantagos S, McReynolds JW, Seashore MR, Breg WR. Complete trisomy 9 in two liveborn infants. J Med Genet 1981; 18:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/67\">",
"      Kannan TP, Hemlatha S, Ankathil R, Zilfalil BA. Clinical manifestations in trisomy 9. Indian J Pediatr 2009; 76:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/68\">",
"      Bruns D. Presenting physical characteristics, medical conditions, and developmental status of long-term survivors with trisomy 9 mosaicism. Am J Med Genet A 2011; 155A:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/69\">",
"      Zen PR, Rosa RF, Rosa RC, et al. New report of two patients with mosaic trisomy 9 presenting unusual features and longer survival. Sao Paulo Med J 2011; 129:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/70\">",
"      Slater HR, Ralph A, Daniel A, et al. A case of maternal uniparental disomy of chromosome 9 diagnosed prenatally and the related problem of residual trisomy. Prenat Diagn 2000; 20:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/71\">",
"      Fujimoto A, Allanson J, Crowe CA, et al. Natural history of mosaic trisomy 14 syndrome. Am J Med Genet 1992; 44:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/72\">",
"      von Sneidern E, Lacassie Y. Is trisomy 14 mosaic a clinically recognizable syndrome?--case report and review. Am J Med Genet A 2008; 146A:1609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/73\">",
"      Shinawi M, Shao L, Jeng LJ, et al. Low-level mosaicism of trisomy 14: phenotypic and molecular characterization. Am J Med Genet A 2008; 146A:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/74\">",
"      Merritt TA, Natarajan G. Trisomy 14 Mosaicism: a case without evidence of neurodevelopmental delay and a review of the literature. Am J Perinatol 2007; 24:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/75\">",
"      Hsu LY, Shapiro LR, Gertner M, et al. Trisomy 22: a clinical entity. J Pediatr 1971; 79:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/76\">",
"      Bacino CA, Schreck R, Fischel-Ghodsian N, et al. Clinical and molecular studies in full trisomy 22: further delineation of the phenotype and review of the literature. Am J Med Genet 1995; 56:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/77\">",
"      Mokate T, Leask K, Mehta S, et al. Non-mosaic trisomy 22: a report of 2 cases. Prenat Diagn 2006; 26:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/78\">",
"      Tinkle BT, Walker ME, Blough-Pfau RI, et al. Unexpected survival in a case of prenatally diagnosed non-mosaic trisomy 22: Clinical report and review of the natural history. Am J Med Genet A 2003; 118A:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/79\">",
"      Tonni G, Ventura A, Pattacini P, et al. Complex cardiac defect, bowing of lower limbs and multiple anomalies in trisomy 22. Ultrasound, post-mortem CT findings with necropsy confirmation. Fetal Pediatr Pathol 2012; 31:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/80\">",
"      Mazza V, Latella S, Fenu V, et al. Prenatal diagnosis and postnatal follow-up of a child with mosaic trisomy 22 with several levels of mosaicism in different tissues. J Obstet Gynaecol Res 2010; 36:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/81\">",
"      Leclercq S, Baron X, Jacquemont ML, et al. Mosaic trisomy 22: five new cases with variable outcomes. Implications for genetic counselling and clinical management. Prenat Diagn 2010; 30:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/82\">",
"      McWeeney DT, Munn&eacute; S, Miller RC, et al. Pregnancy complicated by triploidy: a comparison of the three karyotypes. Am J Perinatol 2009; 26:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/83\">",
"      Yilmaz Z, Sahin FI, Tarim E, Kuscu E. Triploidies in first and second trimesters of pregnancies in Turkey. BJMG 2007; 10:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/84\">",
"      McFadden DE, Kalousek DK. Two different phenotypes of fetuses with chromosomal triploidy: correlation with parental origin of the extra haploid set. Am J Med Genet 1991; 38:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/85\">",
"      Miny P, Koppers B, Dworniczak B, et al. Parental origin of the extra haploid chromosome set in triploidies diagnosed prenatally. Am J Med Genet 1995; 57:102.",
"     </a>",
"    </li>",
"    <li>",
"     Hsu LYF. Prenatal diagnosis of chromosomal abnormalities through amniocentesis. In: Genetic disorders and the fetus, 4th ed, Milansky A (Ed), The Johns Hopkins University Press, Baltimore 1998. p.179.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/87\">",
"      Nielsen J, Wohlert M. Chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 1991; 87:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/88\">",
"      Blennow E, Bui TH, Kristoffersson U, et al. Swedish survey on extra structurally abnormal chromosomes in 39 105 consecutive prenatal diagnoses: prevalence and characterization by fluorescence in situ hybridization. Prenat Diagn 1994; 14:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/89\">",
"      Huang B, Solomon S, Thangavelu M, et al. Supernumerary marker chromosomes detected in 100,000 prenatal diagnoses: molecular cytogenetic studies and clinical significance. Prenat Diagn 2006; 26:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/90\">",
"      Gorla N, Slavutsky I, Lisanti J, et al. Cytogenetic characterization of an extra structurally abnormal chromosome associated with severe mental retardation: inv dup (15) (q13). Hereditas 1998; 129:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/91\">",
"      Battaglia A. The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J Rare Dis 2008; 3:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/92\">",
"      Spinner NB, Zackai E, Cheng SD, Knoll JH. Supernumerary inv dup(15) in a patient with Angelman syndrome and a deletion of 15q11-q13. Am J Med Genet 1995; 57:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/93\">",
"      Robinson WP, Wagstaff J, Bernasconi F, et al. Uniparental disomy explains the occurrence of the Angelman or Prader-Willi syndrome in patients with an additional small inv dup(15) chromosome. J Med Genet 1993; 30:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/94\">",
"      Kotzot D, Bundscherer G, Bernasconi F, et al. Isochromosome 18p results from maternal meiosis II nondisjunction. Eur J Hum Genet 1996; 4:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/95\">",
"      Eggermann T, Schubert R, Engels H, et al. Formation of supernumerary euchromatic short arm isochromosomes: parent and cell stage of origin in new cases and review of the literature. Ann Genet 1999; 42:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/96\">",
"      Swingle HM, Ringdahl J, Mraz R, et al. Behavioral management of a long-term survivor with tetrasomy 18p. Am J Med Genet A 2006; 140:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/97\">",
"      Sebold C, Roeder E, Zimmerman M, et al. Tetrasomy 18p: report of the molecular and clinical findings of 43 individuals. Am J Med Genet A 2010; 152A:2164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/98\">",
"      Abeliovich D, Dagan J, Levy A, et al. Isochromosome 18p in a mother and her child. Am J Med Genet 1993; 46:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/99\">",
"      Boyle J, Sangha K, Dill F, et al. Grandmaternal origin of an isochromosome 18p present in two maternal half-sisters. Am J Med Genet 2001; 101:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/100\">",
"      Vogel I, Lyngbye T, Nielsen A, et al. Pallister-Killian syndrome in a girl with mild developmental delay and mosaicism for hexasomy 12p. Am J Med Genet A 2009; 149A:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/101\">",
"      Yeung A, Francis D, Giouzeppos O, Amor DJ. Pallister-Killian syndrome caused by mosaicism for a supernumerary ring chromosome 12p. Am J Med Genet A 2009; 149A:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/102\">",
"      Giordano L, Viri M, Borgatti R, et al. Seizures and EEG patterns in Pallister-Killian syndrome: 13 new Italian patients. Eur J Paediatr Neurol 2012; 16:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/103\">",
"      Filloux FM, Carey JC, Krantz ID, et al. Occurrence and clinical features of epileptic and non-epileptic paroxysmal events in five children with Pallister-Killian syndrome. Eur J Med Genet 2012; 55:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/104\">",
"      McDermid HE, Duncan AM, Brasch KR, et al. Characterization of the supernumerary chromosome in cat eye syndrome. Science 1986; 232:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/105\">",
"      Mears AJ, el-Shanti H, Murray JC, et al. Minute supernumerary ring chromosome 22 associated with cat eye syndrome: further delineation of the critical region. Am J Hum Genet 1995; 57:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/106\">",
"      Berends MJ, Tan-Sindhunata G, Leegte B, van Essen AJ. Phenotypic variability of Cat-Eye syndrome. Genet Couns 2001; 12:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/107\">",
"      Rosias PR, Sijstermans JM, Theunissen PM, et al. Phenotypic variability of the cat eye syndrome. Case report and review of the literature. Genet Couns 2001; 12:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/108\">",
"      Rosa RF, Mombach R, Zen PR, et al. Clinical characteristics of a sample of patients with cat eye syndrome. Rev Assoc Med Bras 2010; 56:462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/109\">",
"      Jacobs PA, Browne C, Gregson N, et al. Estimates of the frequency of chromosome abnormalities detectable in unselected newborns using moderate levels of banding. J Med Genet 1992; 29:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/110\">",
"      Niebuhr E. The Cri du Chat syndrome: epidemiology, cytogenetics, and clinical features. Hum Genet 1978; 44:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/111\">",
"      Cerruti Mainardi P. Cri du Chat syndrome. Orphanet J Rare Dis 2006; 1:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/112\">",
"      Overhauser J, Huang X, Gersh M, et al. Molecular and phenotypic mapping of the short arm of chromosome 5: sublocalization of the critical region for the cri-du-chat syndrome. Hum Mol Genet 1994; 3:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/113\">",
"      Church DM, Bengtsson U, Nielsen KV, et al. Molecular definition of deletions of different segments of distal 5p that result in distinct phenotypic features. Am J Hum Genet 1995; 56:1162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/114\">",
"      Gersh M, Goodart SA, Pasztor LM, et al. Evidence for a distinct region causing a cat-like cry in patients with 5p deletions. Am J Hum Genet 1995; 56:1404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/115\">",
"      LEJEUNE J, LAFOURCADE J, BERGER R, et al. [3 CASES OF PARTIAL DELETION OF THE SHORT ARM OF A 5 CHROMOSOME]. C R Hebd Seances Acad Sci 1963; 257:3098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/116\">",
"      Mainardi PC, Perfumo C, Cal&igrave; A, et al. Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlation. J Med Genet 2001; 38:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/117\">",
"      Van Buggenhout GJ, Pijkels E, Holvoet M, et al. Cri du chat syndrome: changing phenotype in older patients. Am J Med Genet 2000; 90:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/118\">",
"      Marinescu RC, Mainardi PC, Collins MR, et al. Growth charts for cri-du-chat syndrome: an international collaborative study. Am J Med Genet 2000; 94:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/119\">",
"      Silverman GA, Schneider SS, Massa HF, et al. The 18q- syndrome: analysis of chromosomes by bivariate flow karyotyping and the PCR reveals a successive set of deletion breakpoints within 18q21.2-q22.2. Am J Hum Genet 1995; 56:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/120\">",
"      Strathdee G, Sutherland R, Jonsson JJ, et al. Molecular characterization of patients with 18q23 deletions. Am J Hum Genet 1997; 60:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/121\">",
"      Safi KH, Fathalla BM. Inflammatory and noninflammatory arthropathy in patients with 18q deletion syndrome. J Clin Rheumatol 2012; 18:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/122\">",
"      Lomenick JP, Smith WJ, Rose SR. Autoimmune thyroiditis in 18q deletion syndrome. J Pediatr 2005; 147:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/123\">",
"      Jayarajan V, Swan IR, Patton MA. Hearing impairment in 18q deletion syndrome. J Laryngol Otol 2000; 114:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/0/23562/abstract/124\">",
"      Ghidoni PD, Hale DE, Cody JD, et al. Growth hormone deficiency associated in the 18q deletion syndrome. Am J Med Genet 1997; 69:7.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 452 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.25.216.6-A93D27A9D4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23562=[""].join("\n");
var outline_f23_0_23562=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H71\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Total versus live birth prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Data from spontaneous abortuses",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Data from stillbirths and neonatal deaths",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fetuses with congenital anomalies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H857674\">",
"      WHEN TO REFER FOR GENETIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      NUMERIC ABNORMALITIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Trisomy 21 (Down syndrome)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Trisomy 18 syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Trisomy 13 syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Trisomy 8 syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Trisomy 9 syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Other rare autosomal trisomies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18961578\">",
"      Triploidy syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11375661\">",
"      Supernumerary marker chromosome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11375668\">",
"      - 47,+inv dup(15)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11375675\">",
"      - 47,+i(18p)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11375682\">",
"      - 47,+i(12p)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11375689\">",
"      - 47,+inv dup(22)(q11)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      STRUCTURAL DEFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      5p deletion syndrome (cri-du-chat syndrome)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      18q deletion syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H71\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/452\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/452|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/3/23602\" title=\"figure 1\">",
"      Robertsonian translocation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/23/33150\" title=\"figure 2\">",
"      Cri du chat syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/452|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/3/34876\" title=\"table 1\">",
"      Liveborn chromosome abn rate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/60/17357\" title=\"table 2\">",
"      Maternal age-related Down syndrome risk at 3 gestational ages",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=related_link\">",
"      Approach to congenital malformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31751?source=related_link\">",
"      Basic principles of genetic counseling for the obstetrical provider",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28169?source=related_link\">",
"      Chorionic villus sampling: Risks, complications, and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18167?source=related_link\">",
"      Chromosomal translocations, deletions, and inversions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26874?source=related_link\">",
"      Clinical features and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/8/134?source=related_link\">",
"      Clinical features, diagnosis, and treatment of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=related_link\">",
"      Cytogenetic and molecular genetic diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/3/38969?source=related_link\">",
"      Diagnosis of autism spectrum disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/11/16570?source=related_link\">",
"      Diagnostic amniocentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/7/31865?source=related_link\">",
"      Effect of advanced age on fertility and pregnancy in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/8/16516?source=related_link\">",
"      Epidemiology and genetics of Prader-Willi syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38839?source=related_link\">",
"      Evaluation of stillbirth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/13/7386?source=related_link\">",
"      Genetic and environmental causes of birth defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=related_link\">",
"      Genetic counseling and testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=related_link\">",
"      Genomic disorders: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/31/13816?source=related_link\">",
"      Gestational trophoblastic disease: Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=related_link\">",
"      Glossary of genetic terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/36/31306?source=related_link\">",
"      Incidence, etiology, and prevention of stillbirth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/1/42010?source=related_link\">",
"      Initial prenatal assessment and patient education",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/10/26793?source=related_link\">",
"      Intellectual disability (mental retardation) in children: Definition; causes; and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13224?source=related_link\">",
"      Management of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/14/34025?source=related_link\">",
"      Microdeletion syndromes (chromosomes 1 to 11)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/44/11978?source=related_link\">",
"      Microdeletion syndromes (chromosomes 12 to 22)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/17/37143?source=related_link\">",
"      Microduplication syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/46/43750?source=related_link\">",
"      Non-Mendelian inheritance patterns of monogenic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/63/5112?source=related_link\">",
"      Overview of genetic variation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/27/22969?source=related_link\">",
"      Overview of prenatal screening and diagnosis of Down syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/44/2762?source=related_link\">",
"      Prenatal diagnosis of CNS anomalies other than neural tube defects and ventriculomegaly",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/35/43576?source=related_link\">",
"      Routine prenatal ultrasonography as a screening tool",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/50/10024?source=related_link\">",
"      Sex chromosome abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22170?source=related_link\">",
"      Sonographic findings associated with fetal aneuploidy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/2/7208?source=related_link\">",
"      Use of array comparative genomic hybridization (aCGH) in obstetrics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_0_23563="Manifestations of lipodystrophy";
var content_f23_0_23563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F79962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F79962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical features of patients with lipodystrophic disorders",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Lipodystrophy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acanthosis nigricans (associated with severe hyperinsulinemia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Muscle hypertrophy, prominent veins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Hepatomegaly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Fatty liver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ci",
"        <span class=\"sublist1\">",
"         r",
"        </span>",
"        rhosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypertrichosis, hirsutism (occasionally)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiomegaly due to hypertrophic cardiomyopathy (occasionally)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mental retardation (occasionally)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Metabolic abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hyperglycemia, but no ketosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Insulin resistance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hypertriglyceridemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Increased metabolic rate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23563=[""].join("\n");
var outline_f23_0_23563=null;
var title_f23_0_23564="Enhanced elimination drugs and toxins";
var content_f23_0_23564=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66414&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Intoxications in which enhanced elimination techniques may be used",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Ion Trapping",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aspirin",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Phenobarbital",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Multi-dose Charcoal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Phenobarbital",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Dapsone",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aspirin",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Quinine/quinidine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Theophylline",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Carbamazepine",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Hemodialysis",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ethylene glycol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Methanol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Isopropyl alcohol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ethanol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aspirin",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Theophylline",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Phenobarbital",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lithium",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Hemoperfusion",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Theophylline",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Chelation",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Iron",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Mercury",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Lead",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Arsenic",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23564=[""].join("\n");
var outline_f23_0_23564=null;
var title_f23_0_23565="External otitis microbiology A";
var content_f23_0_23565=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F64716%7EPC%2F78637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F64716%7EPC%2F78637&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Acute external otitis microbiology",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Organism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"2\" rowspan=\"1\">",
"        Aerobic bacteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Pseudomonas",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        S. aureus",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Strep group D &amp; G",
"       </td>",
"       <td>",
"        6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3_start\" colspan=\"1\">",
"        Other gram negative",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"4\">",
"        4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        H. influenzae",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        Proteus sp",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\">",
"        E. coli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\">",
"        Anaerobic bacteria",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Bacteroides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Clostridii",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Streptococci",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\">",
"        Commensals",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        46",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        S. epidermis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Diptheroids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"2\" rowspan=\"1\">",
"        Fungal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Candida albicans",
"       </td>",
"       <td>",
"        8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Aspergillus",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\">",
"        No growth",
"       </td>",
"       <td>",
"        7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Number of organisms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Single organism",
"       </td>",
"       <td>",
"        32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mixed",
"       </td>",
"       <td>",
"        5",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Percent of total patients with growth of this organism (n = 100).",
"    </div>",
"    <div class=\"reference\">",
"     Data from Russell, JD, Donnelly, M, McShane, DP, et al, J Laryngol Otol 1993; 107:898.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Acute external otitis microbiology",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Organism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"2\" rowspan=\"1\">",
"        Aerobic bacteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Pseudomonas",
"       </td>",
"       <td>",
"        41",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        S. aureus",
"       </td>",
"       <td>",
"        15",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"2\" rowspan=\"1\">",
"        Anaerobic bacteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Peptostreptococcus",
"       </td>",
"       <td>",
"        22",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Bacteroides",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\">",
"        Fungal",
"       </td>",
"       <td>",
"        6.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Mixture of organisms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aerobic only",
"       </td>",
"       <td>",
"        67",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anaerobic only",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mixed aerobic and anaerobic",
"       </td>",
"       <td>",
"        9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\" rowspan=\"1\">",
"        Number of organisms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Single organism",
"       </td>",
"       <td>",
"        65",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Two organisms",
"       </td>",
"       <td>",
"        24",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        More than three organisms",
"       </td>",
"       <td>",
"        11",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Percent of total patients with bacterial who had growth of this organism (n = 46).",
"    </div>",
"    <div class=\"reference\">",
"     Data from Brook, I. Acta Otolaryngol 1980; 91:285.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_0_23565=[""].join("\n");
var outline_f23_0_23565=null;
var title_f23_0_23566="Contents: Congenital heart disease adults";
var content_f23_0_23566=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?5/3/5182\">",
"       Cardiovascular Medicine",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Congenital heart disease adults",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Congenital heart disease adults",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Aortic valve disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/1/6169\">",
"           Clinical manifestations and diagnosis of bicuspid aortic valve",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/25/27032\">",
"           Pregnancy in women with a bicuspid aortic valve",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/27/33207\">",
"           Subvalvar aortic stenosis (subaortic stenosis)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/52/40774\">",
"           Supravalvar aortic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/58/7078\">",
"           Treatment of bicuspid aortic valve stenosis in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Atrial septal defect",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/48/39689\">",
"           Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Atrial septal defects and patent foramen ovale",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/48/39689\">",
"           Atrial septal abnormalities (PFO, ASD, and ASA) and risk of cerebral emboli in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/62/36837\">",
"           Devices for percutaneous closure of a secundum atrial septal defect",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/48/5896\">",
"           Identification and assessment of atrial septal defects in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/0/25610\">",
"           Management of atrial septal defects in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/32/3593\">",
"           Patent foramen ovale",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/27/16825\">",
"           Pathophysiology and clinical features of atrial septal defects in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Complications",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/54/24422\">",
"           Neurologic complications of congenital heart disease in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Conduction abnormalities",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/23/8568\">",
"           The anti-Ro/SSA and anti-La/SSB antigen-antibody systems",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Patent ductus arteriosus",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/52/35656\">",
"           Clinical manifestations and diagnosis of patent ductus arteriosus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pregnancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/25/27032\">",
"           Pregnancy in women with a bicuspid aortic valve",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/7/29818\">",
"           Pregnancy in women with congenital heart disease: General principles",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/21/35159\">",
"           Pregnancy in women with congenital heart disease: Specific lesions",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary hypertension",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/55/6007\">",
"           Evaluation and prognosis of Eisenmenger syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/20/7496\">",
"           Medical management of Eisenmenger syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/35/39478\">",
"           Medical management of cyanotic congenital heart disease in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonic valve disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/62/39910\">",
"           Clinical manifestations and diagnosis of pulmonic stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/27/12727\">",
"           Natural history and treatment of pulmonic stenosis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Systemic disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/59/22456\">",
"           Non-coronary cardiac manifestations of systemic lupus erythematosus in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?38/45/39641\">",
"           Pregnancy in women with systemic lupus erythematosus",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Tetralogy of Fallot",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/7/28794\">",
"           Overview of the management of tetralogy of Fallot",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/27/13752\">",
"           Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ventricular septal defect",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/1/3096\">",
"           Echocardiographic evaluation of ventricular septal defects",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/52/14154\">",
"           Ventricular septal defect in adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-37AB82E4B6-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f23_0_23566=[""].join("\n");
var outline_f23_0_23566=null;
var title_f23_0_23567="Contents: Primary care neurology";
var content_f23_0_23567=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Primary care neurology",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Primary care neurology",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Cerebrovascular disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/32/42506\">",
"           Antithrombotic therapy to prevent embolization in atrial fibrillation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/27/40378\">",
"           Carotid endarterectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/11/31930\">",
"           Cerebrovascular complications of sickle cell disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/17/40216\">",
"           Clinical diagnosis of stroke subtypes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/21/18773\">",
"           Definition of transient ischemic attack",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/37/36439\">",
"           Differential diagnosis of transient ischemic attack and stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/63/9208\">",
"           Etiology and classification of stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/39/38522\">",
"           Etiology, clinical manifestations, and diagnosis of aneurysmal subarachnoid hemorrhage",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/29/33242\">",
"           Initial assessment and management of acute stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/11/10426\">",
"           Initial evaluation and management of transient ischemic attack and minor stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/59/4026\">",
"           Lacunar infarcts",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/47/28410\">",
"           Overview of the evaluation of stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/24/9608\">",
"           Pathophysiology of symptoms from carotid atherosclerosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/8/41098\">",
"           Reperfusion therapy for acute ischemic stroke",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/35/34361\">",
"           Screening for asymptomatic carotid artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/33/32281\">",
"           Secondary prevention for specific causes of ischemic stroke and transient ischemic attack",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/61/30682\">",
"           Secondary prevention of stroke: Risk factor reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/54/37738\">",
"           Treatment of aneurysmal subarachnoid hemorrhage",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cranial nerve dysfunction",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/23/36216\">",
"           Bell's palsy: Pathogenesis, clinical features, and diagnosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/27/9655\">",
"           Bell's palsy: Prognosis and treatment in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/46/25320\">",
"           Overview of diplopia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/3/34873\">",
"           Trigeminal neuralgia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dementia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/55/1913\">",
"           Cholinesterase inhibitors in the treatment of dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/55/1914\">",
"           Clinical features and diagnosis of dementia with Lewy bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/61/12249\">",
"           Dementia and delirium in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/41/34455\">",
"           Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/57/37786\">",
"           Etiology, clinical manifestations, and diagnosis of vascular dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/25/28057\">",
"           Evaluation of cognitive impairment and dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/20/12618\">",
"           Frontotemporal dementia: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/25/408\">",
"           Frontotemporal dementia: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/36/15946\">",
"           Parkinson disease dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/25/41369\">",
"           Prevention of dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/34/21031\">",
"           Prognosis and treatment of dementia with Lewy bodies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/22/36202\">",
"           Risk factors for dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/28/4552\">",
"           Safety and societal issues related to dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/55/10104\">",
"           Treatment and prevention of vascular dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/48/27402\">",
"           Treatment of behavioral symptoms related to dementia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/4/33865\">",
"           Treatment of dementia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Disorders of myelin",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/19/35130\">",
"           Diagnosis of multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/44/32458\">",
"           Epidemiology and clinical features of multiple sclerosis in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/7/41082\">",
"           Treatment of relapsing-remitting multiple sclerosis in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dizziness; nystagmus; and vertigo",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/43/23223\">",
"           Approach to the patient with dizziness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/19/32057\">",
"           Approach to the patient with vertigo",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/13/19673\">",
"           Benign paroxysmal positional vertigo",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/61/32729\">",
"           Meniere disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/23/34165\">",
"           Overview of nystagmus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/15/13559\">",
"           Treatment of vertigo",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Epilepsy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/9/25753\">",
"           Evaluation of the first seizure in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/39/40570\">",
"           Overview of the management of epilepsy in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/61/43994\">",
"           Pharmacology of antiepileptic drugs",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/6/22633\">",
"           Risks associated with epilepsy and pregnancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/11/19642\">",
"           Status epilepticus in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Headache",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/44/21194\">",
"           Acute treatment of migraine in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/19/31033\">",
"           Evaluation of carotid artery stenosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/34/3624\">",
"           Headache syndromes other than migraine",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/4/26698\">",
"           Pathophysiology, clinical manifestations, and diagnosis of migraine in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Lumbar puncture",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/10/17576\">",
"           Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/39/33402\">",
"           Evaluation and management of elevated intracranial pressure in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/6/19561\">",
"           Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Miscellaneous diseases",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/22/5481\">",
"           Clinical features and diagnosis of Guillain-Barr syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/19/25913\">",
"           Clinical features and diagnosis of narcolepsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/46/25320\">",
"           Overview of diplopia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/36/22087\">",
"           Overview of hiccups",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/6/40038\">",
"           Pathogenesis of Guillain-Barr syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/16/265\">",
"           Treatment and prognosis of Guillain-Barr syndrome in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/57/7066\">",
"           Treatment of myasthenia gravis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/62/4071\">",
"           Treatment of narcolepsy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Movement disorders",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/26/18857\">",
"           Motor fluctuations and dyskinesia in Parkinson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/46/10984\">",
"           Overview of tremor",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/63/32762\">",
"           Pharmacologic treatment of Parkinson disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/50/32554\">",
"           Restless legs syndrome",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Muscle disease",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/4/26694\">",
"           Approach to the patient with muscle weakness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/32/8712\">",
"           Differential diagnosis of peripheral nerve and muscle disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/44/6856\">",
"           Drug-induced myopathies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/40/23173\">",
"           Glucocorticoid-induced myopathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/56/36745\">",
"           Muscle enzymes in the evaluation of neuromuscular diseases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/24/29060\">",
"           Muscle examination in the evaluation of weakness",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/0/33802\">",
"           Statin myopathy",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurologic examination",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/8/31879\">",
"           Approach to the patient with sensory loss",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/30/38377\">",
"           The detailed neurologic examination in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Peripheral neuropathy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/7/18551\">",
"           Clinical manifestations and diagnosis of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/46/8938\">",
"           Diabetic autonomic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/32/8712\">",
"           Differential diagnosis of peripheral nerve and muscle disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/41/12951\">",
"           Mechanisms, causes, and evaluation of orthostatic and postprandial hypotension",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/15/42233\">",
"           Overview of lower extremity peripheral nerve syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/12/7369\">",
"           Overview of polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/44/8906\">",
"           Overview of upper extremity peripheral nerve syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/60/41928\">",
"           Pathogenesis and prevention of diabetic polyneuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/43/12986\">",
"           Treatment of diabetic neuropathy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/2/5161\">",
"           Treatment of orthostatic and postprandial hypotension",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-D47D9212B2-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f23_0_23567=[""].join("\n");
var outline_f23_0_23567=null;
